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GLOSSARY AND ABBREVIATIONS 
AR  Action Research 
BPR  Business process re-engineering 
Case study I use the term ‘case study’ descriptively (i.e. a ‘particular case’, rather 
 than in a methodological sense). 
CNST  Clinical Negligence Scheme for Trusts 
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CQC  Care Quality Commission 
DH Department of Health 
EBME  Electronic and Biomedical Engineering 
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MHRA  Medicines and Healthcare Products Regulatory Agency 
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NAO  National Audit Office 
NHS  National Health Service 
NHSLA   National Health Service Litigation Authority 
NPM  New public management 
NPSA  National Patient Safety Agency 
Participant  A person who has voluntarily agreed to take part in the research  
PCT Primary Care Trust 
PES Property Expenses Scheme 
Stakeholder   A person upon whom the policy will have an impact 
WHO  World Health Organisation 
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Hospitals have always faced fundamental questions of patient safety, care, and 
budgetary concerns. There has been increasing recognition recently of the serious 
issue of medical devices management, covering the areas of procurement, training, 
maintenance, and governance. This issue, documented by the National Audit Office, 
National Patient Safety Agency, Medicines and Healthcare Products Regulatory 
Agency, National Health Service Litigation Authority, and World Health Organisation, 
impacts on healthcare costs and patient safety. It has led to new Health and Social 
Care Act Regulations, enforced by the Care Quality Commission.  
As a result of my work as a consultant in the field of medical devices management, I 
constructed a policy model based on my own specialist experience and knowledge. 
This research sought to improve that model through participatory research conducted 
at an NHS Hospital in London. It took the form of a case study that specifically explored 
the core policy areas, but this time in collaboration with participants with expertise in 
one or more of the four interrelated policy areas of procurement, training, maintenance, 
and governance. This collaboration involved researching and analysing the external 
demands from regulatory agencies and internal demands from the organisation, 
centred on procurement, budgetary, and policy issues.  
The action research informed changes in policy, especially around procurement, 
leading to improvements in practice. The challenge of keeping policy up to date, and 
consistent with the external regulations and internal operational demands, is discussed 
in the case study. The Hospital’s internal politics and culture were found to be a help 
when starting up the case study, but a hindrance when it came to getting agreement 
and approvals to change the policy content, because of multiple committees and 
competing interests.  
The overall outcome of the project was an organisationally approved best practice 
policy model for medical devices management within a governance framework that 
meets the needs of the external regulators, and the management of the organisation. 
More specifically it was discovered that the use, maintenance, and governance of 
medical equipment were all reliant on a central issue, namely procurement practice. 
Procurement conduct for the organisation was redefined within the Hospital policy, and 
is making training, maintenance, and governance easier to achieve, thereby reducing 
risk and cost. A major consequence is that all budget holders need to be trained in 
procurement itself. Moreover, it is anticipated that the model could be used at similar 
healthcare organisations, ultimately leading to a contribution to knowledge and practice 
which assists in patient safety and meeting budgets.  
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Chapter 1: Introduction  
Context and background to this case study 
I am a professionally registered healthcare engineer with membership of the Institute of 
Engineering and Technology, also the Institute of Healthcare Engineering and Estate 
Management. I act as a specialist healthcare consultant in medical equipment asset 
management and policy. I operate as a consultant at senior management level within 
the case-study hospital. I am the Managing Director of my company, currently 
operating in the United Kingdom, Ireland and the Middle East. My company employs 
185 people, with annual business revenues in 2013 of £19 million. These revenues 
come from ongoing healthcare contracts worth approximately £50 million across 168 
sites. The business has grown 10 per cent in the last year, and that trend is expected 
to continue due to the demand from NHS and private hospitals for technology 
management solutions. 
The problem of device management policy is that hospitals face fundamental questions 
of patient safety, care and budgetary concerns, which have been identified in research 
and reports from reputable organisations such as the National Audit Office (NAO), the 
National Patient Safety Agency (NPSA), the Medicines and Healthcare Products 
Regulatory Agency (MHRA) and the World Health Organisation (WHO). The issues 
identified by these organisations have concerned the government to such a degree that 
they introduced new health and social care regulations in 2011. To enable me, as a 
specialist healthcare consultant, to assist the Hospital to meet the new regulations, I 
agreed to carry out a case study specifically exploring improvements in the core policy 
areas related to the regulations. This involved working with participants exploring the 
four interrelated policy areas of procurement, training, maintenance, and governance. I 
use the term ‘case study’ descriptively (i.e. A ‘particular case’ rather than in a 
methodological sense). 
I was initially motivated to take up this work-based learning opportunity in 2009 to 
further my learning and to hone my ability as a specialist change management 
consultant by improving my understanding of different methods of investigation. My 
specialist area of knowledge was already addressing change, especially in regard to 
medical devices management policy, but I looked at this work-based professional 
doctorate as an opportunity to improve device management policy further by using a 
rigorous academic methodology. Ultimately, I believed that this work-based learning 
opportunity could lead to an application of new knowledge that could improve patient 
safety and reduce harm, while saving money for the Hospital. I was also motivated by 
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the fact that this new knowledge and doctoral status may lead to wider business 
opportunities. 
The research question I wanted to address was: How can participants from all levels 
within the organisation impact on medical devices policy to ensure stakeholders meet 
the needs of the regulators, the organisation, and the patient, thereby leading to 
regulatory and practice improvements in the light of new or revised legislation? 
To enable me to analyse and review the best way forward for improvements to policy, I 
decided to use Action Research (AR), working closely with the selected participants. 
My methodological choices originate in my consultancy role, which has always involved 
my immersion within the client organisation, and the literature leads me to the belief 
that people-based organisations need practitioner-based solutions. After reviewing my 
research choices, I decided to take up a case-study approach, cooperating and 
collaborating with participants from within the organisation and using the knowledge 
and relationships already developed to gain approval and recruit participants.  
This research and development project is predicated on knowledge described in my 
successful accreditation and recognition of learning for advanced developments in 
professional practice (RAL 8) claim, which forms the broader context to this project, 
that there are issues relating to medical devices management policy impacting on 
patient safety, care and budgets. In that claim, I argued that there are policy issues: 
From RAL 8; p. 4: The main problem I have identified is the failure of some 
organisations to develop and implement policy due to poor communication and 
untested management assumptions.  
These issues involve how devices are purchased, used, maintained and managed, and 
that its importance lies with the conduct of practitioners, directed through policy, in 
maximising the benefits to patients while minimising risk and cost. This policy needs to 
guide practitioner conduct in an accepted way that not only meets the needs of the 
organisation and requirements of the regulators, but primarily must ensure the 
wellbeing of the patients. 
Hence, this project builds on and refines the model I had created and described in the 
RAL 8 claim, where it was shown that the core issue of managing medical devices in 
hospitals was the formation and implementation of device management policy.  
This involved the management of change, which presented many problems, perhaps 
the most important of which is that policy had to take account of the imposition of 
national governmental standards and regulations; but how did this fit with the culture 
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and organisation of the hospital in question? Therefore, while the main argument of this 
study is that an improved model for the formation and delivery of policy can ultimately 
assist in delivering better device management leading to more efficient, cheaper and 
safer practice, it was apparent from the outset that this would be a complicated and 
complex process. The problem with regard to change management in this context is 
policy. (This statement relates to my experience of policy previously discussed in my 
RAL 8, and discussion of change management and policy literature to be discussed in 
Chapter 2).   
The underlying problems for change management therefore, becomes both the 
formation of policy and its effective implementation. It is important that I consider the 
questions raised relating to these problems when researching the Hospital to change 
its policies and processes. I aim to improve my understanding of these problems in 
later chapters, but it is already apparent that this study is about change management 
that specifically relates to public policy and policy within an NHS hospital, which 
involves other important concepts. These include for instance the learning organisation, 
management theory and practice, public policy, NHS policy, organisational innovation, 
communications and professional practice, which I shall examine from the contextual 
standpoint of this study. 
Consequently, this study takes my previous work further, delving more deeply through 
a collaborative approach into the work described in the RAL 8 with the intention of 
achieving an organisationally approved best practice model in medical devices 
management policy which may be adopted by others in the field. 
Through this case study I intend to illustrate the scope for an insider–researcher to 
undertake AR, collaboratively working with participants towards a shared objective of a 
best practice model for development, implementation and continuous improvement of 
policy. As the policy model designer, individual, and insider–consultant–researcher, I 
will work with the participants to improve the current model.  
As my role is highly complex within the Hospital, being an insider–consultant–
researcher, my position may attract allegations of invalidity from the participants in the 
research. In later chapters, I will discuss why I consider an Action Research approach 
is appropriate for this project and the questions raised.  
The hospital concerned agreed to take part in this project because it is worried about 
medical device management within the organisation and whether it meets the needs of 
the regulators and the patients. I have anonymised the location of my professional 
practice in this project report. Henceforth it will be referred to as ‘the Hospital’. 
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There are over 3000 practitioners either buying using or maintaining medical devices at 
the Hospital. If any one of these practitioners makes a mistake, it can lead to patients 
being seriously harmed or killed. The individual and the hospital may be held 
accountable for poor practice by the Care Quality Commission. The Care Quality 
Commission is responsible for upholding the law with regard to patient safety. The 
government is extremely concerned about patient safety and the costs involved in 
updating technology. Medical technology is a core part of healthcare delivery, but only 
if procured, used and maintained correctly for the benefit of the patient. 
The Hospital must consider the laws, costs, and internal policy requirements to buy 
equipment, ensure adequate training, carry out maintenance, and manage budgets for 
the ongoing benefit and safety of patients. 
The proper management of medical equipment has been an acute problem in the 
healthcare sector for many years, owing to the multitude of devices in use, changes in 
technology, changes in regulatory requirements and the need to manage all these 
issues.  
Over the last thirty years there have been many attempts by government and 
healthcare agencies to address the policy issues faced when managing medical 
technology. In broad terms, these policy issues have always involved the procurement, 
use, maintenance and governance of medical technology. 
A 2004 National Patient Safety Agency project report stated that: 
uncontrolled purchasing and device management, in the absence of 
competency-based training, were contributing factors in causing incidents. 
(National Patient Safety Agency, 2004, p. 2) 
Moreover, the literature discussed later in this study confirms that this is a nationwide 
issue, in fact a worldwide issue, that impacts on patient care, professional practice and 
costs. For instance, a recent HM Government report, ‘Strength and Opportunity 2011’, 
states that the medical technology market will continue to grow year-on-year, 
potentially putting further pressure on NHS funding:  
The medical technology market is estimated to be worth £150–170bn worldwide 
with growth rates forecast at 10% per annum over the next 5–6 years and a 
market size approaching £300bn by 2015. This growth is driven by the ageing 
of the world’s population and the per capita income increases in healthcare 
expenditure across developed countries. (HM Government - Strength and 
opportunity, 2011) 
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These cost pressures on the NHS will continue to grow owing to an ageing population. 
There are also cost pressures from negligence claims. As at 31 March 2012, the 
NHSLA estimated that it had potential liabilities of £18.9 billion, of which £18.6 billion 
related to clinical negligence claims (see Appendix 6, NHSLA Factsheet 3). 
The case-study hospital 
The case-study hospital is a typical acute NHS Hospital in London. It provides a 
comprehensive range of acute medical services to the local population. The Hospital 
treats over 500,000 patients each year; it has an annual budget of over £300 million, 
with 3400 directly employed NHS staff and approximately 600 contracted staff used for 
various services, including my own of medical devices management. The annual 
spending across the Hospital on medical devices procurement, training, maintenance 
and governance is approximately £4.5 million, of which £600,000 is paid to my 
company, and I have a team of staff on site responsible for maintaining and managing 
approximately 3500 items of medical equipment.  
This NHS hospital has struggled to manage the devices they own, owing to the 
increasing volume, variety and complexity of devices, changes in regulations and new 
devices coming onto the market. There are also more demands from nurses and 
doctors for access to new devices and for training to enable them to use these devices 
effectively. Even though the average life recommended by the manufacturers is five to 
seven years, the average life of equipment at this Hospital is above ten years. The 
replacement value of this equipment is approximately £15 million. This means that to 
replace every device at least once every ten years requires an annual investment of 
£1.5 million. To make the most of the money available, it is absolutely vital that 
equipment is professionally managed in accordance with an agreed management 
policy, and this must include the procurement, user training, maintenance and 
governance. The demand from nurses and doctors for new technology is insatiable, 
and this can result in unnecessary cost, additional risk and practical constraints of how 
to procure such a wide variety of equipment, how to train staff to use it and how to 
maintain it. It is imperative to manage the conduct of all areas of medical devices 
practice by forming and implementing a policy that guides practice. 
Medical devices policy is important to patient safety, to patient comfort and to other 
patient health needs. Although all this technology is available for patient care, the 
quantity and variety of devices available can introduce risks of misuse, risks of 
overspend and risks where equipment is unavailable due to lack of maintenance. The 
government has therefore decided to regulate, in order to mitigate these risks. 
























































I review and 
improve with 
participants 
Practice influencing  
policy here 
The impact of legislation and standards 
The Government introduced new legislation in April 2010, because it recognised there 
are problems with managing medical devices that pose a risk to patient safety and 
result in increasing costs. In Figure 1-0-1, the outer circle shows the impact of new 
government policy on UK regulations, and the inner circle shows my responses as the 
person responsible for policy in this area. This new healthcare policy relates to the safe 
use of medical technology. As a result of this new legislation, a new regulation was 
approved in October 2010 as the Health and Social Care Act Regulation 16, Outcome 
11, which is enforced by the Care Quality Commission (CQC) and specifically relates to 




























Figure 1-0-1: The chain effect of regulation on policy 
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The CQC monitors compliance with the Health and Social Care Act regulations and 
government policy, thereby allowing the government to understand compliance and 
subsequently review and improve government policy.  
The National Health Service Litigation Authority (NHSLA) sets the risk management 
standards for the National Health Service (NHSLA, 2010). The Medicines and 
Healthcare Products Regulatory Agency (MHRA) regulates specific medicines and 
healthcare products (MHRA, 2006). The European Union (EU) regulates the 
manufacture of medical devices (EU Commission, 1993). These are the four key 
external governance and regulatory areas that influence the Hospital’s medical devices 
policy. These external influences that impact on the Hospital’s medical devices policy 













Figure 1-0-2: External Governance and Regulatory Demands 
If any of these four external organisations issues new standards or regulations, the 
Hospital must ensure the medical devices policy is updated and then implement those 
changes, as shown in Figure 1-0-1. 
Consequently this study is based on the view of these authoritative bodies that an 
improved, robust, medical devices management policy for the Hospital will ensure 
medical devices are managed more safely, thereby ensuring patients have access to 
safe and effective good-quality medical devices. This is vital for the Hospital because, 
of the 3400 staff, there are approximately 2500 staff operating medical devices that 
require training in their safe use for the benefit of clinical care. Moreover, the patients at 
the Hospital expect to be treated with up-to-date equipment, allowing them to have the 
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available to do exactly that, although there is a limited amount of money available to 
enable regular replacement of the equipment.  
Work-based learning and research 
I recognise the value of work-based learning, particularly its principle of collaboration to 
help improve understanding of the issue and its congruence with AR within a case 
study setting to deliver continuous improvement to professional practice. I believe that 
this will widen my knowledge, and that of the participants involved, allowing us to assist 
with improving a number of different policy areas. I recognise that it is important to 
understand that policies are not the same as objectives or plans. Objectives are a 
means to achieve an aim or goal, i.e. they are the end product; plans provide a 
framework within which actions can take place to attain objectives, that is, they are a 
means:  
Policies, on the other hand, are neither the ends nor the means, they are 
statements of conduct. Policies cause managers to take actions in a certain 
way, but they are not actions in themselves. Policies both reflect and contribute 
to the organisation's culture.  
As a specialist in this field for many years, I embrace all the four areas of policy and 
practice shown below in Figure 1-0-3. 
 
Figure 1-0-3: Medical devices areas of policy and practice 
However, I need to go beyond my own specialist knowledge and experience if I am to 
achieve the key objective of this case study, which is to produce an organisationally 
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practitioners from different fields of expertise in the Hospital to link practice to policy in 
a reiterative way. Throughout this reiterative process, I will work with the participants in 
improving the formation and delivery of policy, thus acknowledging that policy and 
practice is a two-way process that can ultimately assist in delivering improvement 
through closer understanding and involvement with policy, leading to more efficient and 
safer management of devices. This will also deliver substantial benefits to the 
participating Hospital in terms of both cost and patient safety.  
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Chapter 2: Terms of Reference 
Introduction 
My studies have brought about a realisation that, to achieve my ambition, I must 
address and analyse the issue of medical devices management policy more deeply 
and critically. This entails an effective case study through which I could explore the four 
core interrelated processes with the intention of enabling continuous improvement. 
Thus, this project has an educative purpose both for the participants and myself. Its 
focus will be on policy problems that are specific to medical devices management. In 
short, the aim of the project is to deliver improvements to my existing model that will 
contribute to continuous improvement of hospital services for patients. 
The Hospital has struggled for many years to: 
 Implement medical devices policy  
 Meet the National Health Service Litigation Authority (NHSLA) standards  
 Meet the Care Quality Commission (CQC) regulations. 
I have been employed as a contracted consultant at the Hospital for over five years in a 
management consultancy position. During this period I have worked with the senior 
management team, wards and departments to write and rewrite their medical devices 
policy.  
Informing this work was all my previous work in this field, and I have seen NHS hospital 
culture and practice changing over the past twenty years mainly due to pressures from 
funding, regulations, and higher expectations from patients. Boundaries are being 
constantly redefined in response to pressures from government, patients and 
technology. Also, it seems that there is a change in the nature of NHS professionalism 
with regard to healthcare technology. This change is being driven by the demands for 
more up-to-date technology from the consultants, nurses and patients. Additionally, 
there is commercial competition between NHS Trusts and private healthcare providers, 
impacting on culture and attitudes. As Malin (2000) observes, NHS Partnerships, 
Foundation Trusts and commercial participation are now considered appropriate goals 
for professionalism. Consequently, personal and professional values are changing 
professional–client relationships, definitions of being a professional and professional 
boundaries in healthcare practice. The sociological literature on healthcare professions 
(Malin, 2000) has identified some of the values associated with professionalism as 
altruism, personal detachment and public service as substantiation of claims by 
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professional groups for privileged status. For instance, in some NHS healthcare 
professions the boundaries are particularly hard to maintain: 
The nature of professional practice, as it relates to scope, competence, level of 
discretion and power, has been linked to organisational culture within the NHS. 
A notable example of the need for boundary redefinition arises from current 
links between professionalism and market/enterprise culture. (Malin, 2000, p. 7) 
Also, we can look at NHS professionalism as workplace practices interacting with 
patients, which stresses the containment of subjective feelings (positive or negative) 
that a doctor, nurse, carer and so on might entertain regarding the patient. Professional 
training often provides for ways in which over-empathy with the patient is avoided or 
managed, and codes of ethics are used to police personal and professional 
boundaries.  
As indicated in a recent report by the Competition Commission, the NHS healthcare 
market is opening up to the private sector and challenging current occupational, 
functional and professional segmentation, NHS monopoly and division (Competition 
Commission, 2013). Patients are now accessing services delivered by different 
professional practitioners due to the deregulation of professions and monopolies of 
competence, allowing nurses to do work previously assigned to doctors, and carers 
allowed to do the work previously assigned to nurses, and so on.  
The fall of these barriers between occupations and practices within healthcare 
organisations means that members of different occupational groups are now required 
to work in multifunctional teams and are able to prescribe devices and drugs if 
considered appropriately qualified. For instance in the UK, in addition to doctors and 
dentists, a number of supplementary prescribers and appropriately qualified nurses, 
optometrists and pharmacists can also write prescriptions for patients (Department of 
Health, 2013, p. 188). This has resulted in the rise of the ‘organisational professional’, 
with a shift from productive behaviour to a different emphasis on the total behaviour, 
attitudes and self-understanding of individual employees. Challenges are posed by this 
enterprise culture but, as shown in the example above about prescribing, there is a 
definite stride towards removing boundaries and improving the flexibility of the 
healthcare workforce, both private and public. 
Learning how to prescribe, manage or use healthcare technology is something 
undertaken and developed by individuals, but Hospital policy can promote or inhibit the 
learning process by guiding the conduct of practitioners. The Hospital culture, within 
which stakeholders work, shapes their engagement with the learning process. More 
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than this, there are real questions as to whether and how the Hospital is able to tap into 
the learning achieved by its stakeholders. Continued professional development (CPD) 
is promoted as being part of the NHS culture, but evidence suggests a lack of 
professional development and that the learning needs to have more emphasis laid 
upon it. Hospitals that position learning as a core characteristic have been termed 
‘learning organisations’ (Senge, 2006) and this concept itself sits within the wider field 
of organisational development (Linstead, et al., 2009).  
It is difficult to define NHS culture because of the complexity of NHS services and the 
wide variety of professional groups involved, with sub-cultures of their own. As 
discovered by Davies et al (2000, p. 112): 
Culture may emerge somewhat unpredictably from the organisation’s 
constituents (making it not necessarily controllable), but nonetheless 
characteristics of that culture may be described and assessed in terms of their 
functionality vis à vis the organisation’s goals. 
NHS stakeholders have different views of culture, dependent upon their profession and 
personal outlook. Despite acknowledging problems with defining NHS culture, Hospital 
stakeholders can engage with the medical devices policy as a framework to think about 
and do things pertaining to the technology and its application. They are also able to 
identify areas that they think will help cultural change and areas that will not. As 
Kernick (2004, p. 114) observes: 
Policymakers recognise the limitations of a culturally reductionist framework–
that cultural change cannot easily be brought from top-down exhortation and 
the danger of eroding beneficial cultural traits that already exist, for example, a 
commitment to equity in the NHS.  
My previous work led me to believe that, if the culture in the Hospital is naturally 
evolving at stakeholder level, even if policies are produced to meet the needs of the 
regulators, they can only work if the fears and motivations of staff are taken into 
account. Therefore policymakers need stakeholder buy-in as their lever for cultural 
change. This study is intended to test this belief and question or confirm whether by 
removing existing barriers and facilitating interactions new cultures can emerge, 
ensuring that the Hospital can respond to the changing demands placed on it by the 
regulators. 
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Scope and limitations of this research 
For the purpose of this doctoral case study, the scope of the research project is limited 
to medical devices policy at the Hospital and will specifically concentrate on producing 
a best practice model for production, implementation, and monitoring of medical 
devices management policy. Hence, the goal of this project is to use the case-study 
research to review and improve medical devices policy at the Hospital. To this end, this 
project will compare current policy and practice against the latest regulatory standards 
agreed by the UK government in April 2010 (Care Quality Commission, 2010). 
The research question  
In view of the foregoing, the research question at the centre of this case study is: 
How can participants from all levels within the organisation impact on medical 
devices policy to ensure stakeholders meet the needs of the regulators, the 
organisation, and the patient, thereby leading to regulatory and practice 
improvements in the light of new or revised legislation?  
This case study will raise many further subsidiary questions, such as: 
 What knowledge is already available in this subject area? 
 How does the research impact on the Hospital? 
 How does my position as a consultant impact on the researcher role? 
Hospital requirements from the case study 
This case study involves working with participants from the senior management team, 
wards and departments, to review and improve their medical devices policy, and also 
improve my existing model. It is taking place by mutual agreement between the 
Hospital, myself, and the University, bringing together the insider–consultant–
researcher with participant practitioners to identify problems and find solutions that 
deliver improvements. Problems must be solved in accordance with the management 
aims of the organisation to successful deliver tangible outcomes against the defined 
regulations and standards.  
In other words, a best practice model, in this context, entails organisational approval, 
which is likely to be forthcoming if key members of that organisation are fully involved 
in its creation. This, of course, will be a key difference from my original model, which I 
personally created through my consultancy role. 
  
















Demands on medical devices policy  
Figure 2-0-1 visualises the core demands that impact on the Hospital’s medical devices 
management policy. The medical devices policy is at the centre. The blue circle 
revolving around the policy asks questions about the internal needs of the organisation, 
especially with regards to buying, training, maintenance, patient safety and regulatory 
demands.  
The external white circle, revolving around the internal questions, indicates the external 
organisations that must be considered when developing medical devices management 
policy in order to answer the questions that relate to the medical devices policy. The 
medical devices policy model developed as a result of this case study must lead to 
safer use of devices for the patient, and improved utilisation of devices, leading to less 
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Literature relevant to my case study 
The objective of my literature review is to understand the social, economic, and 
structural factors that affect health policy innovation and practice. Analysing the 
effectiveness of the policy at the Hospital was a key part of understanding the impact 
on improvements to policy: Is it the system, the stakeholders, the additional resources 
or something else? 
As part of the case study, and as intimated earlier, I needed to compare my current 
methods with other management concepts being used for generating, developing and 
delivering policy improvements. The findings could then be used to develop my 
knowledge of current thinking on policy and change management innovation for 
organisational change requirements. I would also use this more robust knowledge to 
convince participants that the process to deliver innovation and improvements was 
founded on research. 
I decided to include a review of change management literature such as Business 
Process Re-engineering (BPR) (Linstead, et al., 2009), improvements management 
(Bryman & Bell, 2003), and healthcare innovation (Bevan, 2007) to understand what 
new learning has already been achieved. The point of the management research within 
this Hospital should be to achieve change that would benefit both the Hospital and the 
patients. To this end, this case study should enable me to make recommendations on 
how to deliver policy change in a safe, more reliable and efficient method for the 
Hospital. Obviously, that change needs to be managed and should not happen in an ad 
hoc fashion. My belief is that the Hospital I work within is socially constructed and best 
understood by those individuals with detailed knowledge of the organisation, that is, 
individuals such as myself who have worked there for many years. This enables me to 
understand better the requirements when working with the case-study participants who 
understand and are involved in the areas that can be improved. 
Due to the way these policy improvement ideas arise (predominantly due to interaction 
between myself and the participants) and the way in which the process is managed, I 
believe that a qualitative AR approach is applicable because the core difficulties within 
the Hospital appear to relate to lack of ownership and lack of management 
understanding. The organisations departments tend to be isolated from each other, 
sometimes described as working in ‘silos’, with directors, senior managers and line 
managers all using their own management techniques (or not). 
The reason for choosing a qualitative AR approach is that it can be construed as a 
research strategy that emphasises interaction with the participants to discuss their 
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ideas and beliefs taking a critical approach to identify problems and find solutions. As 
Bryman and Bell (2003, p. 303) discuss: 
There is no single type of action research but broadly it can be defined as an 
approach in which the action researcher and a client collaborate in the 
diagnosis of a problem and in the development of a solution based on the 
diagnosis.  
This aligns not only with the way I already work, but with my own beliefs about how to 
implement organisational change in a practice setting that is primarily people, leading 
and delivering Hospital services in the real world. As Robson (2002, p. 540) indicates, 
you will need to find out a substantial amount about the client needs and 
expectations, and to be aware of the setting and context in which the study will 
take place. 
Currently, the literature I have read indicates that there is no ‘recognised accepted 
methodology’ for improving policy and performance in an NHS hospital. The majority of 
the literature indicates many different approaches depending on the improvement 
target.  
Throughout the literature review, I have considered the critical points of current 
knowledge on NHS organisational change and some of the methods being adopted by 
various NHS Trust to initiate change, such as: lean, business process re-engineering, 
balanced scorecard, benchmarking, and continual improvement through quality 
management.  
A literature search was carried using four major sources:  
1. Work Based Learning recommended reading (reading recommended by my 
supervisors/consultant) 
2. The NHS network 
3. The internet 
4. The Hospital library.  
I concentrated on an analysis of the literature from the standpoint of my Hospital case 
study. What emerged is a significant contribution to my project from texts in the areas 
of: Government, business and change management literature, which I shall now 
consider and comment on in light of their influence on my project thinking and actions.  
   
17 
Government literature 
There is already much regulatory and advisory information relating to various 
management processes that has been commissioned by the NHS Executive and the 
Department of Health. I will review these sources, but not limit myself to them. 
Some of the official sources from UK Government and EU agencies include: 
 International Electro-technical Commission, (2004), IEC60601 Safety of Medical 
Electrical Equipment. This detailed technical document relates to the quality and 
safety of actual devices and how they should be type tested by testing houses for 
manufacturers. I thought this might be relevant as I intended to concentrate my 
efforts in the areas of highest risk and expenditure, that is, medical devices. The 
document contains some interesting information for operational managers of 
biomedical departments and will be useful when looking at supply chain issues 
and quality of goods. As far as helping to develop management and policy 
strategy, it was of little use, and therefore excluded. 
 European Economic Commission (1993) Medical Devices Directive 93/42/EEC, 
EEC, the Medical Devices Directive MDD93/42 is aimed at manufacturers but 
written by bureaucrats. The main focus of this document is about how 
manufacturers should manufacture to European customer requirements. Some 
information is useful from an operational procurement point of view but was not 
relevant to this study and therefore excluded.  
 Health and Safety Executive (HSE, 1974), Health and Safety at Work Act, 1974. A 
useful reference for governance and risk issues. I need to be aware of its 
existence when looking at changes in operational or strategic processes to ensure 
any changes meet the HSE requirements, but it was of limited use with regard to 
this study and therefore excluded. 
 ISO Quality Management. A useful process-based quality management model 
based on internationally recognised business management models. It was recently 
amended to focus on processes and is a structured guide to implementing, running 
and auditing management processes, procedures and work instructions. This is a 
system I have used at a departmental level in the past and is used by large 
corporate organisations. It describes a systematic approach to business 
management. It lays out detailed recommendations on how to evaluate processes 
using a ‘closed loop’ methods, similar to the feedback loops in AR, where any 
process within the management system is reviewed for consistency and any 
changes are documented. It allows for both correction and change and therefore 
aided my thought processes for the development of this study.  
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 National Audit Office NAO, HC 475 (National Audit Office, 1999), The Management 
of Medical Equipment in NHS Acute Trusts in England. This study, commissioned 
by the Department of Health, describes the management of medical equipment in 
the NHS. It explains the weaknesses and refers to MDA DB9801 [Medicines and 
Healthcare Products Regulatory Agency (1998) (Medical Devices Agency, 1998)] 
and lack of implementation. I believe both this study and the management advice 
from the Medicines and Healthcare Regulatory Agency [Medicines and Healthcare 
Products Regulatory Agency (1998)] were issued in the same year to focus on poor 
management of medical devices within NHS organisations. It uses quantitative 
research such as number of incidents involving injury or death to explain the 
weaknesses. It goes on to make references to NHS Executive guidance on 
management and the high costs of litigation fees and claim pay-outs directly related 
to not managing devices correctly. This cost of claims against the NHS was 
estimated at £1.2 billion in 1998.This litigation cost now stands at £21 billion in 
2013. The management advice was a summary of the Medicines and Healthcare 
Products Regulatory Agency (1998). This National Audit Office document was very 
useful as a tool to convince the executives at the Hospital to move forward with the 
case study, because they hold the National Audit Office in high regard. 
 Medicines and Healthcare Products Regulatory Agency, MHRA DB2006(05) 
(MHRA, 2006) Medical Device and Equipment Management for Hospital and 
Community-based Organisations. This document lays out in detail how medical 
devices should be managed. It covers operational processes such as maintenance, 
and strategic processes such as purchasing. The information is well researched, 
citing data from the National Audit Office among its many references. This was also 
discussed with the executives at the Hospital as a way of convincing them to move 
forward with the case study. It was also of benefit to me because it asks NHS 
Trusts to ensure their medical devices are managed in accordance with appropriate 
policy. 
 Modernisation Agency. Ten High-Impact Changes (Institute for Innovation and 
Improvement, 2007), Department of Health. My original thought for carrying out a 
piece of research was to review processes from a best practice point of view. 
Fortunately, through carrying out this literature review, I found this recent extensive 
piece of work carried out by the NHS Modernisation Agency. This study involved 
visits to many NHS Trusts to look at processes and best practice. It identifies best 
practice based on quantitative data and research carried out over three years with 
thousands of clinical teams. The information has been correlated and the ten 
highest impact processes are presented in this book. Every organisation is 
expected to find its own ways to create the change. It advises on what resources 
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may be required, but is vague and does not offer any advice on how to implement 
the system to create the results evident from this benchmarking research. What can 
be gained from this research is the end goal. I can see from the research that we 
are under-performing in key areas. I can see how well some hospitals are doing in 
specific areas. This information is very useful in focusing my attention on our 
weaker processes, because it already gives me benchmarks based on other 
hospitals carrying out the same processes but achieving much better outcomes. 
While reviewing these case studies, it raised questions in my mind about why we 
are not we doing as well as them. How did they set up their system for 
improvements? After making several phone calls I realised that these ten high-
impact statements are based on individual case studies and I was unable to find 
any organisation that has taken a systematic approach to achieving excellence in all 
these areas. I discovered that these case studies identified hospitals that had 
achieved excellence in specific processes relating to specific disciplines. It raised 
the question in my mind of how to develop a case study for the Hospital being 
researched, to move from our current position to an improved position with regard to 
device policy.  
Change management and internal change agents 
Business process re-engineering (BPR) 
BPR is an organisational change management approach adopted by some of the 
organisations I have worked with. Its appeal peaked in the mid-1990s. BPR is the 
consideration of business processes. Definitions of business processes vary, but 
underpinning the definitions is the concept of a series of interrelated activities, crossing 
functional boundaries, with specific inputs and outputs. BPR is essentially about the 
redefinition and redesign of these business processes, eliminating activities that do not 
add value to the process goals, and driving the application of information technology. It 
primarily focuses on core processes and its unique contribution has been process 
awareness in change projects. I have used elements of this approach in many of my 
own projects. Besides process thinking, BPR is characterised by fundamental, radical 
and dramatic changes. Revolutionary tactics to achieve such changes are, however, 
frequently substituted by evolutionary ‘wants’, devaluing the original BP approach so 
that it may be put in the same category as quality and other process-oriented 
improvement approaches. I have discovered that ‘Revolutionary BPR tactics’ are 
considered risky in an NHS healthcare environment and evolutionary methods are 
preferred. My objective is to speed up the evolutionary methods by working closely with 
the stakeholders. Ulbrich (2006) found that ‘Many BPR projects failed due to resistance 
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to change. Therefore, it is important to motivate and include employees in the change 
process’ (Ulbrich, 2006). 
The comment from Ulbrich, that projects fail ‘due to resistance’, correlates with my own 
experience, that I must have the majority of stakeholders supporting change 
management projects to ensure success. It appears that there is much confusion about 
the terminology ‘BPR’, with some authors considering it to be a radical change of 
process and others a less radical incremental change of process. For example, 
Armistead and Machin (1998, p. 323) observe: 
process simplification, which results in incremental change, and process re-
engineering, which aims for a more fundamental change in practice, both are 
labelled as BPR.  
Business process and management policy are highly complex. I have discovered 
through my experience as a consultant that policies, processes, productivity and staff 
morale are all inextricably linked and the success of implementing change is generally 
associated with those who facilitate the change process. The change agent, as defined 
by Saka (2003, p. 480), is considered to be a manager who seeks ‘to reconfigure 
organisational roles, responsibilities, structures, outputs, processes, systems, 
technology or other resources’.  
In the case of the internal change agent, there is evidence to suggest that 
organisations are not uniform in the manner in which they respond to change. The 
internal change agent (as I am, during this case study) is likely to be influenced by the 
culture within the organisation. In an ideal sense, change from within an organisation 
may be seen as sufficient to initiate changes in mind-sets. However, in practice, in the 
projects in which I am involved, internal change agents are normally evoked by an 
external stimulus such as regulatory change to initiate change in mind-sets. In my 
experience, stakeholders tend not to question the status quo unless they are faced with 
an obligatory change factor such as new regulations, or financial or political crisis. It is 
difficult to break habitual routines that are embedded in past learning. What appears to 
be needed is encouragement for people to accept change. Under the above 
circumstances, the ‘unfreezing’, a term commonly used in AR, of the organisation can 
be achieved by: 
three very different processes, each of which must be present to a certain 
degree for the system to develop any motivation to change: (1) enough 
disconfirming data to cause serious discomfort and disequilibrium; (2) the 
connection of the disconfirming data to important goals and ideals, causing 
   
21 
anxiety and/or guilt; and (3) enough psychological safety, in the sense of being 
able to see a possibility of solving the problem and learning something new 
without loss of identity or integrity. (Schein, 2010, p. 301) 
When discussing AR in more detail later in this chapter I will discuss the theory and 
practice of developing a ‘learning organisation’ and the influences of Zuber-Skerritt 
(Zuber-Skerritt, 1996) and Senge (Senge, 2006) on my thinking. 
Balanced scorecard  
The ‘balanced scorecard’ (BSC) envisages executives as pilots with a range of controls 
and indicators in front of them, based upon which they make decisions and develop 
strategies. Kaplan and Norton (2004) introduced the term as a concept for measuring a 
company's activities in terms of its vision and strategies. 
This concept gives managers a comprehensive view of the performance of a business. 
It is a strategic management system that forces managers to focus on the important 
performance metrics that drive success. It balances a financial perspective with 
customer, internal process, and learning and growth perspectives. The BSC method 
can facilitate the separation of strategic policymaking from the implementation, so that 
organisational goals can be broken into task-oriented objectives that can be managed 
by front-line staff. This impacted on my thinking around developing policy reporting 
improvements to the relevant committees. 
Public sector balanced scorecard 
I discovered that BSC was originally introduced as a tool for improving performance in 
commercial organisations (which are focused on financial performance). It has found 
considerable support and is widely used in the NHS and the rest of the public sector, 
particularly popular as a public sector performance management tool in the USA, UK, 
Australia and Scandinavia. 
The purpose of the BSC is to: 
 Clarify and update strategy  
 Communicate strategy throughout the company  
 Align unit and individual goals with strategy  
 Link strategic objectives to long-term targets and annual budgets  
 Identify and align strategic initiatives  
 Conduct periodic performance reviews to learn about and improve strategy.  
(Kaplan & Norton, 2004) 
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As the BSC has already been widely adopted as a change and performance tool in the 
NHS, especially with regard to finance, I have reviewed in terms of this study and found 
elements of it to be useful, especially with regard to identifying strategic initiatives such 
as policy improvement and implementation. 
Business analysis metrics 
Business Analysis Metrics for Business Process Redesign (Valiris & Glykas, 2004, p. 
445) gives a seven-stage performance management development guide. This shows 
the stages of evolution that the organisation has to go through before it achieves a 
proper performance measurement system. Stage five indicates that there should be an 
improvement process. In this Hospital case study, the improvement process will be 
designed using AR methods in collaboration with stakeholders.  
Much of the literature shows that improvement comes through stakeholder 
involvement. The most difficult improvements to achieve are those which cross 
operational boundaries within the Hospital. I believe that the policy improvement 
process is directly linked to the conduct of practitioners. The benefits of implementing 
such an AR process to improve policy should include risk reduction, revenue 
enhancement, diversification, and cost reduction. 
Critical systems approach 
Some organisations find changing policy to be difficult because their systems are rule-
bound. Within the NHS, the metaphor ‘swimming in treacle’ is often used. Despite the 
fact that many internal change agents are offered an opportunity to become involved in 
the planning process, many of those approached would argue that they do not have the 
time.  
A study undertaken within the prison service indicates that organisations in the private 
and public sectors must learn to: 
 Manage multiple-participant planning events, where those involved may be 
suffering from ‘change fatigue’, or a fatalistic attitude towards the effect of 
change 
 Facilitate dialogues between viewpoints that conflict, and 
 Create working situations in which employees at all levels feel empowered to 
participate in meaningful ways in a full range of activities of the organisation. 
(Clayton & Gregory, 2000, p. 140) 
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Critical systems approaches can assist change in organisations, and the process of 
managing change in difficult situations.  
I believe hospitals that are rule-bound require a different approach by practitioners, 
which involves the recognition and valuing of change as perceived by other 
participants, even when this only amounts to opening up the channels for 
communication. From my experience and studies I have come firmly to believe that 
stakeholders must be consulted during this case study to achieve the best innovations 
in policy. 
Public management 
New approaches to public management are continuously emerging, partly due to 
inadequate performance of the public sector and partly due to political intervention. 
Since the mid-1970s there appears to have been a drive to bring public management in 
line with commercial management, thus MacCarthaigh observes that: 
A key challenge for leaders is to articulate a coherent set of values that guide its 
work and the activities of its employees. (MacCarthaigh, 2008, p. 60) 
Policy serves to guide conduct in a Hospital but must reflect the stakeholders’ values, 
and have the stakeholders’ involvement if the challenges are to be overcome. The shift 
from the traditional model of central control, with separation of functions and diffusion 
of responsibility, towards a strategic model based on goal setting, decentralisation, 
effective management systems, greater responsibility and accountability and ensuring 
quality to service users, presents challenges to those in management positions within 
the Hospital. The shift from the controlling management style typically associated with 
hospitals to the more facilitative and supportive style of management required in the 
current circumstances cannot be achieved overnight. While there are obvious 
difficulties in generalising from case-study research, the findings highlight the potential 
of bottom-up change, based on direct participation with stakeholders. For instance, 
O’Brien (O'Brien, 2002) indicates that an approach to change based on task alignment, 
starting at the periphery and moving steadily towards the corporate core, is an effective 
way to achieve in during organisational change: ‘This approach relies on direct 
participation of the workforce, which, when successfully applied, can lead to a self-
reinforcing cycle of commitment’ (O'Brien, 2002). She also points out that moving 
towards implementation of these ideals will, of course, present management with a 
very considerable challenge. 
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Lean thinking for the NHS 
An NHS Confederation leading edge report entitled ‘Lean Thinking for the NHS’ 
espouses the ‘lean’ concept as the way forward for NHS hospitals. The report was 
commissioned by the NHS and is a highly interesting commentary. The foreword by 
Nigel Edwards, Policy Director for the NHS Confederation, mentions the Toyota system 
and the successes that have been achieved. He says: 
a number of things that struck me about places I've visited, where people are 
implementing lean. Firstly, the clinicians are involved and enthusiastic. People 
seem to be having fun. Secondly, the scale of the improvements is often 
extraordinary. More problematically, the transformations require the whole 
process is to be looked at with teams, sometimes taking an entire week out—
often more than once. (Jones & Mitchell, 2006, p. 2) 
On first reading this document I felt uncomfortable with the complete lack of reference 
to any academic material. The methodology described in the document explains 
process mapping, process analysis, why lean works, how lean works, and provides an 
example from Australia. It is a useful working document to enable an internal change 
agent to think about and review processes. The report gives a euphoric account of how 
successful are ‘lean methods’ in the medium to long term. This does not agree with the 
academic literature I have reviewed, which indicates a 70 per cent failure rate of lean in 
service-based industries (as opposed to manufacturing industry), but Kallio cautions 
against this assertion: ‘many previous studies mention of failure rates of up to 70%, the 
failure or success of a change project, however, heavily depends on the objectives of 
the initiative’ (Kallio, 2002, p. 80). 
My understanding from reading the NHS Confederation literature is that the lean 
management tool will help deliver major improvements to the NHS. In reality, I am not 
sure about this, as it contradicts much of the academic literature I have already read. It 
implies a high success rate in the NHS when using the lean management tool. I can 
find no real evidence to support this point of view in public sector research on lean. The 
document states that, ‘without standardisation, you have no foundation to improve on. 
Indeed, without standardisation any improvements you make are unlikely to last’ 
(Jones & Mitchell, 2006). This statement appears to be a generalisation, as academic 
research shows that standardisation needs to be carefully considered in complex 
service organisations: for instance, ‘Standardisation can become an inhibitor to change 
when dealing with complex service delivery processes’ (Valiris & Glykas, 2004, p. 445). 
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The document concludes, ‘The “lean” message is hundred percent positive’. On first 
reading, this makes me feel that ‘lean’ is a hundred per cent effective. It goes on to say 
that ‘lean’ can improve the safety and quality, improve staff morale and reduce costs-all 
at the same time. It reads like an advertisement for the lean tool and many NHS staff 
will have read this document and believe it, because it has come from an NHS source. 
Although it states at the end of the document, ‘The NHS Confederation’s leading edge 
publications are designed to stimulate debate’, this does not take away the fact that 
many NHS stakeholders will believe its message without debate. 
New public management 
Brown, Waterhouse and Flynn (2003, pp. 230-241) ask the question, ‘Is a hybrid 
model, a better alternative for public sector agencies?’ It is argued that new public 
management (NPM) has also meant the introduction of managerial practices that are 
ideologically opposed to the traditional public service ethos. Unlike their private sector 
counterparts, public sector organisations have not been required to be inured to the 
ideals of a competitive market. They are now being required to implement such 
practices as sub-contracting, the creation of internal markets, local pay bargaining and 
performance-related pay. The impact of the degree of change demanded and the 
culturally opposing nature of such change has been evidenced in the example by 
Brown of the Australian public service, where the introduction of performance-based 
pay failed to achieve the desired strong performance culture: 
The ideology behind individual performance-based pay was demonstrated to 
undermine the culture of teamwork. This demonstrates how NPM initiatives 
aimed at improving performance can stall when insufficient attention is paid to 
the culture of the organisation into which it is being implemented. While allowing 
managers to manage, senior civil servants have been faced with growing job 
insecurity creating a paradox of managerial reforms where control over policy 
decisions has, in reality, been removed through in security of tenure. This 
process has led to the greater involvement of elected officials in the 
management of public sector departments. However, the threat exists to 
elected representatives who overlooked that their main function is politics, not 
management. (Brown, et al., 2003, p. 230) 
In this case, adoption of new public management methods resulted in a backlash 
against the Conservative government, resulting in a surprise electoral defeat. This case 
also supports the argument that initiatives required to achieve political re-election often 
conflict with what is purported to be managerial best practice.  
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Business process management (BPM) 
Gulledge & Sommer (2002, p. 364) discusses how public organisations reorganise to 
accommodate business process management. They suggest that it is important to 
precisely define ‘process’ for each implementation context, otherwise it is impossible to 
communicate. However, process management does not work well when overlaid on a 
hierarchical ‘command and control’ management structure. Hence, the shift to process 
management requires a restructuring (that is, re-engineering of management). 
Business process management has received much attention in the private sector 
management literature and its benefits are well known; much less has been written in 
the public sector management literature, and what has been written has been 
extremely general. In the context of this case study, processes should be considered 
for certain aspects of the study, but due to the current hierarchical nature of the 
organisation and complexity of practices involved, in my opinion the processes must be 
designed by the practitioners if the policy is to succeed. 
Conclusion 
There are common themes in the literature that lead me to believe that there is an 
opportunity to introduce policy change into public sector organisations through 
research in collaboration with the participant practitioners. In the context of this study, 
these changes to Hospital policy will aim to meet the needs of the Hospital executives, 
the patients, the staff (stakeholders), and the politicians (voters). The current focus, in 
this NHS hospital context, is cost savings and improvements in quality. My belief from 
working in hospitals is that delivering change and innovation in policy to bring about 
change and subsequent improvements can only be done with the ‘buy-in’ of front-line 
staff, supported by senior management. As an internal change agent (and after reading 
the literature in this field), I believe there is an opportunity to introduce policy change 
that involves both policy formation and implementation which is both systematic and 
effective. I will test this hypothesis during the case study using AR methods. I will now 
go on to discuss my research focus and further discuss AR. 
 
Research focus 
For the purposes of this case study, as shown in Figure 2-0-2, the research focus is 
medical devices management policy, therefore I have searched for specific texts and 
articles in this area. I have also read all internal minutes of the Hospital’s Medical 
Devices Management Committee meetings and relevant policy documents within the 
Hospital. 
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Core focus  
Relevant Literature 
Research Area Medical Devices Management Policy 
Research 



















Figure 2-0-2: Research focus 
World Health Organisation  
A paper entitled ‘Development of Medical Devices Policies’ was published by the World 
Health Organisation (WHO) and specifically relates to the development of medical 
devices policy at country level. This 2011 paper discusses the importance of medical 
devices, recognising the important role of health technologies in the prevention, 
diagnosis, and treatment of illness and disease, as well as patient rehabilitation. 
Although this document discusses policies, strategies and action plans, it fails to go 
into sufficient detail to actually aid an organisation or country to understand fully the 
issues that would stop them from properly delivering the advice given. This WHO paper 
is aimed at national and government level to raise the awareness that every country 
should have a medical technology policy. For the purposes of this case study, this 
document can be used to raise awareness of the importance of medical technology to 
the participants involved in the case study, but does not offer a solution to the policy 
problem; it is more about raising awareness of the policy problems, and states that 
every country should therefore adopt a national policy.  
The WHO goes on to say in the conclusion: 
Data shows that policies, strategies, and action plans for medical devices are 
being developed in member states.… Recommendations from the first global 
Forum on medical devices in 2010 will continue to raise the awareness of the 
crucial role that medical devices play in the prevention, diagnosis, and 
treatment of disease and rehabilitation. The hope is that the higher profile of 
medical devices will translate into better healthcare for the global population, 
allowing them to enjoy a better quality of life. (World Health Organisation, 2011, 
p. 37)  
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I have found this paper to be useful in understanding the worldwide problems facing 
healthcare organisations, but it does not address the question of what a hospital would 
actually do to manage medical devices properly, nor what risks are posed by an 
organisation not managing the medical devices properly they have acquired. The paper 
has raised further questions for me to address throughout this case study.  
Medicines and Healthcare products Regulatory Agency (MHRA) 
Organisational responsibilities are described by the MHRA in ‘Managing Medical 
Devices, Guidance for Healthcare and Social Services Organisations (Medicines and 
Healthcare Products Regulatory Agency, 2006): 
Responsible organisations should appoint a director or board member with 
overall responsibility for medical devices management. There should be clear 
lines of accountability throughout the organisation leading to the board. These 
lines of accountability should be extended, where appropriate, to include 
general practitioners, residential and care homes, community-based services, 
independent hospitals providing services for NHS patients, managed care 
providers, PFI organisations and other independent contractors. It is important 
to establish who is accountable, and where there is a need for joint 
accountability arrangements. 
This bulletin from the MHRA, like many other government agency advisory papers, 
gives good advice about the problems relating to the management of devices but does 
not offer solutions on how to achieve this objective. This again is the sort of document 
that can be used to raise awareness of poor device management practice. It is not a 
‘how to’ document, such as the AR tool I designed for this case study, detailed in later 
chapters. 
In the literature I found on medical devices management policy, there is recognition of 
the many problems surrounding management policy for medical devices and 
opportunities for improving healthcare through the use of medical devices. However, I 
have found nothing that would tell me how to write, implement, and continually manage 
a medical devices policy within a healthcare organisation for the benefit of the patients, 
the device users and the organisation. 
A 2004 project paper from the NPSA shows that many organisations were operating 
under an inefficient device management policy. I will discuss this in much more detail in 
later chapters but, as can be seen from the extract below, many organisations may 
face similar problems. 
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These audits established the following averages across the six pilot sites: 
 65% of available stock in each site was under-utilised; 
 the range of infusion devices available for use was 31; 
 infusion device stock was 1065; 
 the cost of this stock was £1.6m. 
These findings reflected an inefficient system in which infusion devices are 
purchased, managed and used. This is probably a national issue supported by the 
fact that 93 Trusts initially expressed an interest in participating in this pilot work 
(implying that they needed help). (National Patient Safety Agency, 2004, p. 6) 
The Hospital must be able to deal with internal and external demands on policy by 
implementing a systematic approach that can deliver best practice through an effective 
policy. The medical devices policy is important to the organisation to ensure that 
selection, use and maintenance of all devices is carried out to meet the clinical needs 
of the patient and external regulatory demands.  
National Health Service Litigation Authority (NHSLA) 
The Hospital pays an annual fee to the NHSLA, based on the NHSLA’s perceived risk 
from compliance audits. There are three levels of discount: 
1. 10% for having policies in place 
2. 20% for having implemented those policies 
3. 30% for keeping policies up to date, implemented, and monitored. 
The current NHSLA premium is approximately £4M for a hospital of this size. 
Therefore, if the best level of policy and implementation is achieved, £1.2M may be 
discounted. 
The regulations and risk management standards concentrate on two areas, firstly, the 
use of medical devices: 
Diagnostic and therapeutic equipment is used every day by most healthcare 
professionals in the course of their work to support the treatment and care of 
patients. It is the responsibility of each organisation to ensure that healthcare 
professionals are using equipment safely and for the purpose it was intended. 
The delivery of safe and effective treatment in healthcare settings is dependent 
on the correct use of medical devices in a range of applications. These 
interventions can optimise treatment, reduce length of stay and improve the 
patient experience of care. However, when used inappropriately medical 
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devices carry the associated risk of causing harm to patients that can, if 
unchecked, be serious. It is therefore essential that all organisations have 
overarching medical devices training programmes to minimise the risk of errors 
occurring. (NHS Litigation Authority, 2012, p. 128) 
Secondly comes maintenance of medical devices: 
The organisation’s medical devices management policy must cover the 
provision of maintenance and repair of all medical devices, including 
reconditioning and refurbishment. (Medicines and Healthcare Products 
Regulatory Agency, 2006, p. 36) 
Action research literature 
I reviewed a number of texts on Action Research (AR). I found a book by Hart and 
Bond concentrating on AR case studies for health and social care, most useful when 
designing the project approach because it is based on three case studies and outlines 
the methods involved, giving examples within the text (Hart & Bond, 1995). Hart and 
Bond conclude that:  
Our purpose in writing this book has been to explore the potential of action 
research to bring about improvements in professional practice and service 
delivery through collaborative working. (Hart & Bond, 1995, p. 223) 
The results of this case study are based upon the transformational methods that can be 
applied when embedding oneself within an organisation. As a specialist insider–
researcher, being embedded within the Hospital allows me to carry out a preliminary 
diagnosis of the problems by working with participants in the Hospital to create 
solutions that lead to improved policies and strategies for organisational change, which 
bring improvements in medical devices management policy. 
As a practitioner who has been working within healthcare organisations to assist with 
change for many years, it is completely natural for me to work as an insider–researcher 
within an AR framework on this NHS case study. This is similar to the way I am used to 
working, although I shall discuss later the similarities between being an insider–
consultant and subsequently an insider–consultant–researcher.  
Taking an AR approach has enabled me to convince Hospital management to allow me 
to carry out this research and also to participate. Some of the individuals taking part are 
also the managers responsible for approving the improved policy model and signing it 
off. Other important influences on my thinking include Ernest Stringer, who states: 
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In practice, the look, think, and act phases not only are reiterative but tend to 
fold into each other as people review and reflect on the events and activities in 
which they are involved. (Stringer, 1999, p. 187)  
Although I am actually a consultant to the organisation, I prefer to operate as one of the 
team. Stringer discusses methodology and the position of the researcher. My position 
as an insider–consultant–researcher allows me to collect the data through interviews, 
observations, and documentation, making best use of my relationships with the 
participants. 
In New Directions in Action Research, Zuber-Skerritt (1996) discusses emancipatory 
AR for organisational change and management development. She states that the aim 
of any AR project is to bring about practical improvement, innovation, change or 
development of social practice, and the practitioners better understanding of their 
practices (Zuber-Skerritt, 1996, p. 83). Indeed, I am taking aspects from her approach 
to AR to ‘observe and problematise’ throughout the case study, not least because I 
agree with her argument that problems can be solved through social enquiry.  
Action research is not a method or a procedure for research but a series of 
commitments to observe and problematise through practice a series of 
principles for conducting social enquiry (The praxis of a critical social science?). 
(Zuber-Skerritt, 1996, p. 248) 
  








Figure 2-0-3: The ‘live’ medical device policy 
A key issue, however, will be if Zuber-Skerritt’s ideas fully take on board all the needs 
that are vital in a continuous cycle of change with competing internal and external 
demands.  
Medical devices management policy can be likened to a clock, where the hands may 
appear static at first glance but have cogs moving in the background that keep the 
clock operating correctly and accurately. Hence, device management policy, which 
guides conduct in practice, ensures that internal and external demands are continually 
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Zuber-Skerritt (1996) further describes a cyclical process for emancipatory AR as a 
collaborative, critical and self-critical enquiry by practitioners into a major problem or 
issue of concern in their own practice (see Figure 2-0-4). 
 
Figure 2-0-4: Emancipatory action research model 
In this model, the participants 'own the problem' and feel responsible and accountable 
for solving it through teamwork and through following a cyclical process of:  
1. Strategic planning 
2. Implementing the plan (action) 
3. Observation, evaluation and self-evaluation 
4. Critical reflection; and making decisions for the next cycle of action i.e. a 
revised plan, followed by action, observation and reflection, and so on. (Zuber-
Skerritt, 1996, p. 84) 
She concludes that AR may be described as: Critical, Reflective, Accountable, Self-
evaluating, and Participatory (the CRASP model). 
Zuber-Skerritt (1996) goes on to discuss the ‘learning organisation’ and building a 
culture that enables innovation and change (Zuber-Skerritt, 1996, p. 91). She says that 
building a ‘learning organisation’ is a relatively new concept, mentioning Senge’s book, 
The Fifth Discipline (2006), as ‘a breakthrough’.  
In this book, Senge discusses the theory and practice of developing a ‘learning 















   
34 
If people imagine their organisation as an ocean liner and themselves as the 
leaders, what is their role? For years, the most common answer I received 
when posing this question to groups of managers was ‘the captain’. Others 
might say, ‘the navigator, setting the direction’. A few would say ‘the helmsman, 
actually controlling the direction’ or ‘the engineer down below stoking the fire, 
providing energy’, or even ‘the social director, making sure everybody is 
enrolled, involved, and communicating.’ While these are legitimate leadership 
roles, there is another which, in many ways, eclipses them all in importance. 
Yet, rarely do people think of it. 
The neglected leadership role is that of the design of the ship. No one has a 
more sweeping influence on the ship than the designer. What good does it do 
for the captain to say, turn starboard thirty degrees, when the designer has built 
a rudder that will only turn to port, or that takes six hours to turn starboard? It's 
fruitless to be the leader of an organisation that is poorly designed. (Senge, 
2006, p. 321) 
As the insider–researcher, the participatory approach that I am using is aligned with 
this CRASP model, and positively and collaboratively employ the participants’ expertise 
in redesigning and improving the previous model. I shall compare current policy and 
practice in the areas of device procurement, user training, equipment maintenance, 
and governance (outlined in Figure 2-0-5), while considering internal and external 
requirements for medical devices management policy that can potentially lead to the 
Hospital becoming a ‘learning organisation’ in this area of policy.  
External and internal demands on my existing model 
The current Hospital policy model was developed within the confines of the current 
organisational management structures and conformed to the current external 
regulations and standards laid down by the Department of Health and the Government, 
but this uncritical approach will be challenged in this study with the aim of identifying 
weaknesses in my previous policy model. One of the reasons for weaknesses is 
because I was not sufficiently critical, and did not fully utilise the expertise of 
practitioners within the Hospital. 
The Hospital medical devices policy is produced as a result of analysis of many factors 
affecting patient care. This includes funding, new devices, new drugs, new techniques, 
and pressure from manufacturers and service providers to open up the NHS market to 
external providers. This also impacts on the Hospital policy in that they must update 















Figure 2-0-6: Medical Devices internal policy questions 
their own policy to reflect changes made at higher levels. We need a best practice 
model that is able to keep up to date. 
The Hospital must also address the staff’s needs for medical devices, and also the 
internal governance demands to ensure safe practice and policy compliance, as shown 
below in Figure 2-0-5.  
 
Figure 2-0-5: Requirements for medical devices policy 
 
Medical Devices internal policy questions  
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We shall now look at these four questions in turn. 
1. How do we buy devices? 
Poor procurement leads to variation and ultimately higher risk to the patient. This is 
recognised by research carried out by the World Health Organisation: 
A number of studies have shown that between 39% and 46% of adverse events 
resulting from misuse of medical devices take place in the operating room (86–
89). In most of these studies, the cause is only indicated as operation related.… 
Variation in medical devices between hospitals (and even within the same 
hospital) is one of the causes of these accidents. (World Health Organisation, 
2010, p. 14) 
Illustration 1: Procurement of infusion devices 
When I was contracted to work at the Hospital, there were 
approximately 600 technology groups in use. As an 
illustration, I will focus on only one technology group: 
Infusion devices. 
When I arrived at the Hospital, there were 18 different 
models of infusion devices across the Hospital, with an 
inventory size of approximately 500 devices for this 
technology group. An infusion device is used to pump drugs 
or fluids into the veins of patients. These devices were being 
bought by ward or department managers at local level when 
they needed one. This type of procurement did not allow for 
economy of scale or standardisation, with devices being 
purchased at list price, or limited discounts due to low 
volumes. Infusion devices were also being given to the 
Hospital by charities and philanthropic individuals.  
The net result is an increase in cost and risk, because each 
time an infusion device is used there is a single use plastic 
tube required, connecting the pump to the patient, and every 
plastic tube is different for every pump. These plastic tubes 
vary in price, and they can only be used for the infusion 
pump there were manufactured to connect to.  
There were also inefficiencies in nursing time being wasted: 
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for example, If you were a nurse on a ward, you could go to 
a cupboard and waste time looking for a pump that you 
have been trained to use, and waste further time looking for 
the right plastic tube that fits in that pump. The Hospital 
uses 200,000 tube sets each year. The Hospital was 
spending £700,000 a year on these tubes. Many of the 
pumps were old and required replacing, but the policy on 
purchasing infusion devices did not allow for bulk buying. I 
worked with the procurement department and the infusion 
device users to find a device that was suitable for all staff to 
use. I replaced all 500 infusion pumps in the Hospital within 
one year, for more modern infusion devices that have more 
functionality and used cheaper tube sets. The 200,000 new 
tube sets had an annual cost of £200,000, resulting in a 
£500,000 saving per year on consumable costs. The cost of 
buying the infusion pumps was £400,000. There was a net 
saving in year one of £100,000, with an overall saving over 
the 7 year life of these devices of £3.1M.  
There were many difficulties along the way which I will 
discuss in later chapters. 
In my experience, improved procurement not only delivers benefits such as cost 
savings, but is also the key to improving training, governance, and maintenance 
practices. Therefore, the Hospital medical devices management policy must include 
procurement practices if the Hospital is serious about meeting its regulatory goals. 
Good procurement of medical technology can reduce the size of the inventory, its value 
and the annual spend on replacing assets. It can also result in improved utilisation of 
the assets, realising improved outcomes for patients, throughput of patients and 
revenues for the Hospital. The procurement policy for medical technology has an 
impact on the organisation in terms of cost, availability, suitability, and strategic needs. 
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2. How do we use devices safely? 
Good policy for training can result in better use of the assets, reducing the risks to 
patients, and improving outcomes for patients. The effective use of medical technology 
has a major impact on the business of the Hospital and the outcomes for patients. 
Illustration 2: Training in the use of infusion devices 
Training is an emotive subject at the Hospital because staff 
feel they do not have enough time to be trained on the wide 
variety of medical technology available to them.  
In Illustration 1, Procurement of Infusion Devices, I started 
at the Hospital with 18 different models of infusion devices 
and reduced this to three different models of infusion device. 
These three were required for clinical reasons and could not 
be reduced any further. When these infusion devices were 
purchased, they were introduced into the organisation in a 
phased approach, ensuring that all users were trained and 
competent to use the devices before they were placed on 
the ward. The old infusion devices were then removed and 
disposed of in accordance with Hospital policy. 
The training benefits of moving from 18 different models of 
infusion device to three were that I had fewer manufacturers 
that I had to work with to organise training, and the 
manufacturers involved were much more willing to come in 
to the organisation on a more regular basis because they 
had a larger installed base of their devices at the Hospital. 
This allowed me to deliver training to the users more easily, 
while also developing a better relationship with the 
suppliers. The end goal was to ensure that users of infusion 
devices could use them safely for the benefit of the patient. I 
was able to organise and deliver training across the whole 
organisation over a three-month period on the three new 
models of infusion devices. To do this level of training on 18 
different models of device would have taken me six times 
longer, i.e. 18 months. 
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Lack of adequate operator training is considered as a high risk by the government, as it 
may lead to clinical incidents. As a result of this they have introduced the regulations 
previously discussed. The World Health Organisation recognises the benefits of 
medical equipment training in their paper ‘Increasing complexity of medical technology 
and consequences for training’, but also points out the risks of underestimating the 
importance of training: 
The influence of the operator on the effective and safe application of medical 
technology is generally underestimated. In an investigation on incidents 
involving defibrillators in the US (2), it was concluded that the majority of the 
incidents were due to incorrect operation and maintenance. A study of 2000 
adverse incidents in operating theatres in Australia showed that only 9% were 
due to pure equipment failure (9). In two reports on the use of critical care 
equipment by nursing staff, 19% (10) and 12.3% (11) of nurses, respectively, 
indicated that they had used equipment improperly, which had consequently 
harmed a patient. (World Health Organisation, 2010, p. 5) 
However, policymakers at a government level may not understand the practical 
difficulties of implementing training across 600 technology groups, especially when 
there is limited standardisation across many other groups of medical devices.  
3. How do we maintain devices? 
Similarly, maintenance policy for medical technology is important to the efficient 
running of the organisation, aiding therapeutic and diagnostic care of patients, and also 
to the volume of equipment required by the organisation. 
Illustration 3: Maintenance of infusion devices 
Illustrations 1 and 2 describe procurement and training in the 
use of infusion devices, and the impact this had on cost and 
safe use. Maintenance of infusion devices requires holding 
spare parts and special tools for the devices. The more often a 
technician works on an infusion device, the more experience 
and expertise that technician builds up in repairing and 
maintaining that infusion device. Reducing the volume of 
infusion devices from 18 devices to three devices has enabled 
the maintenance department to carry fewer spare parts, 
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4. How do we manage devices? 
Governance policy for medical technology is carried out in accordance with the 
requirements of the Hospital policy for medical devices management, which must meet 
the requirements of the regulators. 
Illustration 4: Governance of medical devices 
The governance department at the Hospital must ensure that 
all policies meet the requirements of the regulators. There are 
50 core areas that are recognised within the governance 
department and must appear within Hospital policies. Two of 
these areas are medical devices training, and medical device 
maintenance. 
As the Medical Devices Manager for the Hospital for the past 
four years, it is my responsibility to keep up to date with the 
regulations and ensure Hospital policy is regularly updated 
and the organisation meets the demands of the regulators. 
Approximately three years ago there was an incident when a 
patient was injured while connected to a piece of medical 
equipment, and the clinician using the device had not been 
trained. This was despite having a policy in place which stated 
reducing the cost of parts they needed to hold. It has also 
allowed them to reduce the cost of technical training, and the 
number of service manuals in their service library. 
The end result of a technician spending more time on one 
technology group with limited models is improved practice in 
maintenance for that technology group. This improves 
turnaround time for broken equipment to be repaired, and 
thereby allows users to receive the infusion devices back more 
quickly, which ultimately benefits the patient experience. Also, 
if there is less down-time, the volume of equipment can be 
reduced because of increased utilisation rates. This has an 
impact on the size of the inventory required, and therefore also 
the cost. 
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that staff were not to use equipment without training. 
I spoke to the clinician involved, who was very upset at having 
harmed the patient. As a result of this incident, I spoke at a 
meeting of 120 clinicians, and asked them to provide evidence 
of their training on the devices they use. This was three years 
ago, and they could not provide evidence of training on their 
high-risk devices. A high-risk device is defined as something 
that can kill or seriously harm if it is not correctly used. The 
number of staff using high-risk devices in this Hospital is 
approximately 2500. 
The current 2013 external audit criteria from the NHS Litigation Authority is only 
concerned with maintenance and training. The latest additions to the criteria 
(introduced in 2012) are shown below: 
5.4  Maintenance of Medical Devices and Equipment 
b. how the organisation includes all items of 
diagnostic and therapeutic equipment on an 
inventory 
5.5  Medical Devices Training 
b. how the organisation includes all items of 
diagnostic and therapeutic equipment on 
an inventory 
g. how the organisation follows up those who do not 
complete training 
h. action to be taken in the event of persistent non-
attendance 
(NHS Litigation Authority, 2012, p. 170) 
These new criteria from the NHS Litigation Authority are evidence that external 
agencies make changes that the Hospital must be aware of and incorporate into their 
medical devices management policy. I need to be improving and implementing medical 
devices policy at the Hospital, working with governance, procurement, clinical and 
nursing teams.  
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Funding and budgetary issues  
Crucial to all the above, to meet the key requirements of the regulations and standards 
funding is required to:  
 Employ qualified staff who are able to implement the regulations and standards 
 Carry out training on the actual changes to the regulations and standards with 
the relevant management teams 
 Carry out training on the actual medical devices. 
Staff requiring training at the Hospital normally find it difficult to leave their posts 
because there is insufficient funding in managers budgets to temporarily replace them. 
For example, if 2500 staff require training on five pieces of medical equipment, each 
equipment training course taking one hour, this requires 12,500 hours of replacement 
staff time. 
Staff at the Hospital have told me that there are serious issues with being allowed time 
off for training. Management staff are worried that spending money on backfilling staff 
to allow them to go for further training will result in redundancies because of 
overspend. They are encouraging staff to go on training courses in their own time. It is 
not unusual to see staff out of uniform on training courses, because this is the only time 
they can actually do the training. 
There are organisational sensitivities about increasing budgets to allow more staffing when 
the Government is insisting on reducing spending in the NHS. This does not allow flexibility 
for staff to learn about new policies, or have training on how to use new devices. 
Some staff are left ‘holding the fort’, while other staff leave their ward or department to 
go on training courses, when they are still meant to be on shift looking after patients. 
This reduces the overall staffing on the ward or department, ultimately leading to higher 
risks in those areas.  
If there are insufficient staff on duty, because some staff have gone for training, this not 
only puts additional pressure on the nurses and doctors in those areas but puts 
patients at risk.  
Poor devices management has been linked to poor clinical practices. The Times on-
line stated:  
The critical research conducted by Dr Foster, a consultancy that collates 
independent league tables on NHS Trusts, also identified 27 Trusts with 
unusually high death rates involving the deaths of 5,000 more patients in the 
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past year than had been expected. A CQC spot-check last month had 
uncovered soiled mattresses, poor clinical practices, mould growing in suction 
machines and out-of-date medical equipment. (Watts & Oakeshot, 2009)  
Summary 
In this chapter, I have outlined my terms of reference and literature review, expanding 
upon those mentioned previously within my RAL8. As much of the literature is 
regulatory in nature, and this case study is related to policy, these particular texts must 
influence the focus of this study. The other literature reviewed describes case-study 
approaches and AR methods used by other researchers, and has informed me about 
the risks associated with bias, ethics and trying to maintain impartiality and to allow 
critical reflection of the data. In the next chapter, I shall argue that using the Hospital as 
a case study for my doctoral project enables me to deliver a work-based project that 
satisfies the above terms of reference.   
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Chapter 3: Action Research Approach and Methodology 
Introduction 
As previously mentioned in this study (and described in my RAL8), I had designed what 
I deemed to be an effective policy model (see Figure 3-0-1). The four core areas of 
practice designed into the policy model were: purchasing, training, maintenance, and 
quality management, and were based on my experience up to that point. I gave equal 
weighting within the policy to each core area of practice within the model. This case 
study is intended to test and improve this previous policy model. As can be seen from 
this figure, my previous approach was process-driven. My intention is to closely involve 
the stakeholders using AR methods. 
 
Figure 3-0-1: Medical devices management Policy Model 
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Case-study considerations  
Choosing action research  
After reading the literature discussed in Chapter 2, I chose AR targeted at participative 
transformation for Hospital policy where the participants and I, as the researcher, 
interact in the production of new knowledge, that is, an improved policy developed from 
the AR cycle. Drawing on existing research and studies discussed earlier, I developed 
a pedagogical process for AR that tackles the issue of the coherence between my 
ontology and the epistemology. I chose AR because I needed an open methodology 
that allowed flexibility and openness when working with the participants. As Carr and 
Kemmis note: 
Action researchers accept that transformations of social reality cannot be 
achieved without engaging the understanding of the social actors involved. 
(Carr & Kemmis, 2006, p. 181) 
In AR, social praxis is the point of departure or arrival in the construction or re-
signification of knowledge. This allows the process of knowledge to be dynamically built 
in multiple layers with the participants, working across many professional boundaries. 
This case study has been carried out in the participants’ natural environment under 
consideration, that is, the Hospital. The flexibility of AR procedures is essential and the 
methodology allows for continual adjustments in accordance within the structure of the 
case study. AR methods enable the continual transformational exercise of cyclic spirals 
such as: planning; action; reflection; research; review; transformation; and re-
planning. This allows for actions that can be adjusted to meet the participant needs 
and participant/researcher reflections. The relevance of my experience and subject-
knowledge allows me to use this developed ‘know-how’ to assist the participants in 
evaluating the case-study data that they themselves understand and put forward, 
bringing about practical knowledge of how to transform policy, and knowledge that is 
important in understanding how policy can be improved and delivered in practice.  
I believe that to answer the question of what has been guiding my research methods I 
need to consider what I mean when referring to AR. The ontological dimension of this 
AR asks, what we intend to know when we use AR based on the current policy 
assumptions. This emphasises considerations that should be given special attention in 
the process of AR to ensure the articulation of its ontological, epistemological and 
methodological assumptions. Pedagogical dynamics require that I ensure involvement, 
participation, commitment and production of new knowledge in collaboration with the 
participants at the Hospital. The participants must be given priority in the AR process. 
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The pedagogical AR processes that I feel are important to this case study are 
summarised as follows: Bringing together collective knowledge; re-signification of the 
cyclic spirals to re-assess current practice and policy; production of new knowledge for 
the improvement of policy; analysis/redirection and evaluation of practices; and 
awareness of the new dynamics of understanding. 
It was necessary to establish methods for the question of how research and action 
come together in practice. The work highlights the fact that AR, structured according to 
its generating principles, is pedagogical research. This case study, being a 
transformational and pedagogical exercise, is configured as an action that tests the 
healthcare practice and policy, starting from ethical principles behind the continual 
formation and emancipation of the participants’ practice. From a methodological point 
of view the case study articulates the ontology of the participants and myself. The 
methodology is that of dialogical, participative and transforming principles and 
practices. Establishing the grounds for using AR within a perspective of scientific case 
study at the Hospital requires that the transformation is imagined in an open manner, in 
which science is not synonymous with positivism, functionalism, and other labels.  
My case study uses an AR approach and involves working closely with selected 
participants from the four core professional practice areas most closely involved in 
medical devices policy and practice. The intention of the project is to unfreeze the 
policy, enabling transformational changes. Once the changes have been agreed by the 
participants, executive approval is required to refreeze the policy for an agreed term, 
one year in this case. The Hospital has thus learnt from the project and has the 
opportunity to unfreeze and restart the planning process at agreed intervals, thus 
understanding that policy formation is not a ‘once for all time’ exercise but rather, there 
will be an ongoing need to for cycles of ‘unfreezing’ and ‘refreezing’ of policy. 
Action research cycles for Hospital policy transformation 
An important point to make during this process was that all the participants were 
positive and interested in making a difference, because they all had responsibilities for 
specific areas of policy. The AR tool for policy transformation is outlined below in three 
steps: 
1. INPUT (Preparatory) 
2. ACTION (Informative) 
3. OUTPUT (Transformational). 
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To work, this AR tool 
requires an experienced 
researcher with detailed 
knowledge of the subject 
area to take control of the 
case study thereby 
‘unfreezing’ the policy.  
I, as the researcher, used 
my work-based experience 
to assess the current policy and any other available data that is coming from the 
Hospital or external agencies. Once the Hospital management had accepted that I 
would lead the case study process, the scope of the project needed to be agreed with 
them. When the scope is agreed, I was then able to use my specialist knowledge, 
working with the Hospital management team, to select the best participants who could 
collaborate and be able to influence other stakeholders in the Hospital. Once the 
participants were selected, they were approached to see if they had the time, and were 
willing to take part in the case study.  
Once the participants had 
been recruited and signed 
up to being part of this 
transformational project, 
they needed to be 
interviewed in a semi-
structured way to ensure 
that their thoughts for 
improvement were 
confidentially recorded 
and documented.  
It was also important to follow up on a regular basis with each of the participants 
throughout the project, which meant regular planned meetings to discuss momentum 
and any potential changes in direction. The data being gathered at all times needed to 
be managed and analysed with the participants for further transformational 
opportunities.  
In this case study, the opportunities were discussed with the participants at a monthly 
meeting throughout the project (as previously described). Separate meetings were held 
Figure 3-0-2: STEP 1 - INPUT (Preparatory cycles) 
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affirm commitment, discuss any new ideas, and give feedback from the project.  
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there was an objective to 
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Some of the participants were executive level managers within the Hospital. The 
collaborative methods required reporting progress to the executive and allowing them 
to also participate in the process. The participants’ ideas for improvement were taken 
into account in all cycles but, ultimately, the output cycle would require sign off and 
agreement by the senior management committees. For this reason, it was important to 
have some of the senior managers acting as participants. That allowed their influence 
to be taken into consideration, and allowed them to be immersed in the transformation 
of policy, thus enabling them to convince their colleagues (who were not participants) 













and set review 
date 
Figure 3-0-4: STEP 3—OUTPUT (Transformational cycles) 
Figure 3-0-5: Action research approach 
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 Once the project was concluded, it was important to consider that the Hospital activity 
is constantly changing and regulations change, therefore the revised policy would have 
to be reviewed, and again transformed, subject to changes in the needs of the 
organisation or the needs of the regulators. Therefore, even when this case study is 
complete, there is a need to set dates to restart the process allowing unfreezing and 
further improvement to the policy.  
The case study poses the research question: 
How can participants from all levels within the organisation impact on medical 
devices policy to ensure it meets the needs of the regulators, the organisation, 
and the patient, thereby leading to regulatory and practice improvements in the 
light of new or revised legislation? 
This is a complex case study using AR to address the issue of satisfying the command 
element from government, i.e. the regulations, with the practice element of the Hospital 
guided by their medical devices policy. I designed this AR tool for the case study, and it 
is illustrated on the following page in Figure 3-0-6: The AR tool for policy 
transformation.  
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Further revisions at 
approval cycle may be 
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Figure 3-0-6: The AR tool for policy transformation 
   
51 
Insider–consultant–researcher  
I have mentioned several times that I am already an insider, a consultant, and that this 
project will further complicate these roles in that it will make me an insider–consultant–
researcher. It will be important therefore that, before the case study commences and 
the data are gathered, the participants must understand that I am an insider–
researcher with a contractual agreement to carry out this case study at the Trust as a 
paid consultant. Hence, the Hospital and the participants will need to be made fully 
aware of the case-study goals. I have therefore devised a participant agreement to 
ensure all the participants are fully aware of my position as a contracted management 
consultant (see Appendix 1). 
The next stage of the project will involve working through that data with the 
participants, specifically with regard to the policy and regulatory compliance for 
management of medical devices, and then working with them to identify improvements 
that can be made. This will very likely raise questions in the participants’ minds about 
their levels of knowledge and ability with regard to their understanding of medical 
devices policy, and may raise further questions and discussion of why there are gaps in 
their knowledge, and how to improve practice and policy.  
Finally, I need to justify why I have chosen AR to undertake this case study and to 
discuss its implications. It was important for me to consider the validity of using AR for 
this case study, and whether it is right and appropriate that I should carry out this 
research as an insider–consultant. There is no real test for validity, but I would argue 
that the only way to understand a work-based problem such as why a hospital has 
issues with implementing policy is to immerse oneself within the hospital and work with 
the participants to gain a deeper understanding of the issue. In considering whether 
this is an appropriate methodology I would argue that, because of my specialist 
knowledge across all four core areas of policy, I can work with participants from across 
the organisation to understand the issues, and enable better analysis of the data. In my 
opinion, for this case study to have validity it must impact in a positive way on all those 
within the organisation that are involved with, or connected to, the medical devices 
management policy. Zuber-Skerritt remarks:  
It is not just, ‘is this appropriate from the shared understanding of this group of 
people?’ But ’is it appropriate for all those whom the policy or practice might 
touch?’ (Zuber-Skerritt, 1996, p. 113) 
This case study must have value in the areas of risk, cost and practice. As a case 
study that is being carried out in a real situation, where there is a real perceived risk 
   
52 
and the organisation is paying for the research to be carried out, I must ensure that the 
focus of the project has validity not only on my eyes but in the eyes of the participants, 
the management of the Hospital and the University. 
This project has an objective grounded in clinical practice that reflects the aspirations of 
the Hospital to improve medical devices management policy and practice, using an AR 
approach. To accomplish this goal requires my active collaboration as the insider–
researcher with selected and willing participants.  
I shall be working with the participants to examine the boundaries of regulation and 
management structure, thereby revealing new opportunities for policy improvement. I 
will, with the participants, critically reflect on why we see similar procurement, training, 
and maintenance issues recurring, and what their solutions might be to enable us to 
achieve a best practice model for medical devices management policy.  
The research methods to be used involve collaboration with the Hospital participants 
jointly to review and then improve the medical devices management policy by 
comparing current policy, processes and practices against my current good practice 
medical devices management model for policy improvement and then improving that 
model.  
It is important to identify suitable participants (insider–experts) who can assist me in 
creating the improved policy model and communicate the vision. I will recruit a key 
participant sponsor who I can use to help me identify and recruit other participants as 
collaborators on the project.  
My intention is to recruit 14 participants professionally linked to the policy areas of 
procurement, training, maintenance, and governance. The recruitment of participants is 
discussed more fully in Chapter 4. Working with these participants, I will use qualitative 
methods including semi-structured interviews and Medical Devices Committee 
meetings to gather information for later analysis, and to communicate my progress to 
the Hospital and participants.  
The purpose of this case study is to work with participants to positively transform the 
policy through the discovery and application of their expertise linked to device 
management.  
This study applies nine cycles of AR, where each cycle achieves improved 
understanding and action that stimulates further questions.  Hence, the intention of this 
study is to transform the previous policy model into an improved model, through 
spiralling ongoing cycles of action. To solve the problem, I have taken an investigative 
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approach and then take action based on my finding, thereby going from action cycle to 
action cycle. These cycles will be discussed in more detail in later chapters. 
The ultimate goal would be to identify weaknesses in the current policy model and find 
solutions that can strengthen it, then work with participants to test the solutions. I will 
test this revised model, because I believe that nothing is perfect and there is always 
room to evolve and improve through systematic critical reflection upon one's own 
professional practice, as described by Zuber-Skerritt (1996) in the following extract:  
Emancipatory action research produces power effects that are easy to oversee 
when seeking consensual development. The role of the researcher (or 
facilitator) could be described by three basic functions. First the researcher 
facilitates actions in the research field, thus contributing to a politicisation of the 
organisation. The task in this respect might be to formulate the knowledge that 
guides the action of the members of the field in a discursive way and thus to 
trigger reflective processes. Second, researchers could reveal the 
consequences of action that the members of the field are not aware of. Third, 
researchers could also have the task of bringing the structural conditions of 
actions to a conscious level and to show that the structural conditions are not 
only restrictions to but also resources for action. (Zuber-Skerritt, 1996, p. 132) 
In working collaboratively with participants to explore the problems surrounding 
implementation of medical devices policy and regulations and assisting in facilitating 
changes to policies and processes, I would need to ensure that we do not lose current 
good practices, but rather enhance and develop those practices. This direct 
involvement with the participants, however, raises a question of validity.  
As an insider–consultant researcher, the concept of ‘validity’ is an issue because I work 
at the Hospital (as a contracted consultant). I also have strong views on the case study 
subject, that is, medical devices management policy at the Hospital. Some may argue 
that because of my close involvement I am no longer ‘objective' and any results 
obtained during this research may be distorted. On the other hand, I would argue that 
complete objectivity is impossible and that my expertise allows me to work closely with 
participants to obtain and analyse the data in ways that produce real improvements in 
policy and practice. My biases will only threaten the validity or trustworthiness of the 
study if I do not take them into consideration during analysis of the data. As will be 
discussed in the next chapter, I will try to ensure that my research methodology and 
data collection techniques are well aligned and that the latter fulfil the criteria of 
reliability, validity and empirical rigour. 
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The blurring of boundaries between myself as the insider–consultant–researcher and 
the participants taking part in the research could attract allegations of invalidity but, as 
Hart and Bond suggest: 
In many respects descriptions of practitioner research are very similar to 
Lewin's (1946) accounts of action research written almost 50 years ago. It is our 
recognition of this which leads us to suggest that the arguments in favour of 
practitioner research and research into practice of social work and social care 
can also be seen as arguments in favour of action research as a potential 
methodology of choice for exploration, enquiry and problem solving about the 
workings of human service agencies. (Hart & Bond, 1995, p. 218) 
Clearly, I agree with Hart and Bond as, in my experience, within any service 
organisation, whether private or public, there is not only reliance on practitioner 
expertise and their communication skills but on the use of methods that continually 
explore policy through action, with a view to ensuring it can change in actual time with 
the demands of the customer, organisation, or the organisation's masters, that is, the 
government.  
In short, I would want to scrutinise practice with the selected participants to answer the 
burning question at the Hospital of how best to achieve improvements in policy that 
would lead to policy compliance, ultimately meeting the regulatory standards for 
medical devices management.  
This accords with Hart and Bond’s thinking that: 
By exposing our practice to scrutiny by others we have illustrated some of the 
opportunities which exist to work from the project perspective and within an 
action research framework. Our experience suggests that the adoption of such 
an approach leads workers to pay enhanced attention to the processes of 
generating change and that this can be challenging, effective and enriching. 
(Hart & Bond, 1995, p. 224) 
Project design 
In designing the project, I have reviewed relevant literature pertaining to this project. 
Medical device management is considered to be a worldwide policy issue, as stated by 
the World Health Organisation:  
Healthcare technology has become an increasingly visible policy issue, and 
healthcare technology management (HTM) strategies have repeatedly come 
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under the spotlight in recent years. While the need for improved HTM practice 
has long been recognised and addressed at numerous international forums, 
health facilities in many countries are still burdened with many problems, 
including non-functioning medical equipment as a result of factors such as 
inadequate planning, inappropriate procurement, poorly organised and 
managed healthcare technical services, and a shortage of skilled personnel. 
(Lenel, et al., 2011) 
Hence, it would be important to ensure that I have a good grasp and understanding of:  
 the literature relating to policy issues that impact on medical devices 
 methods for managing change, and 
 issues that arise when participating in that change.  
In discussing some of the key features of the proposed project strategy in my DPS4561 
project proposal, I highlighted the importance of the underlying benefits of using 
collaborative relationships within an AR cycle aimed at policy improvement.  
My methods would therefore include preliminary data gathering, then investigation of 
the data to diagnose problems within the organisation, followed by more detailed 
participatory work with the participants to review and improve policy. This preliminary 
data is qualitative. It includes: Medical Devices Committee meeting minutes, current 
policies, reports, and recorded interviews from the participating hospital.  
Mapping out the project 
To answer the research question, there are many other questions that I need to ask, 
and mapping out the key areas has helped me to focus on the important issues.  
However, before I can engage in a detailed examination of the policy I needed to 
address some overriding issues around the design, selection of participants and 
desired outcome of the study.  
Although I have a detailed understanding of the four elements of the policy, I shall need 
to focus more critically on the core elements of the project, including the policy content, 
proposition and impact in order to develop my approach and methodology. To do this I 
initially drew a project map outlining the key areas to focus on (see Appendix 4). 
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The project map in Appendix 4 focuses on the following areas: 
I. Review of the medical devices policy  
II. The proposition of the study 
III. The impact of the study. 
 
The review of the medical devices policy in the Hospital needed to take into 
consideration the current policy content. The content of the policy needed to guide 
specific areas of conduct, those being procurement, training, maintenance and 























The review prompts further questions, especially how to agree the policy content, 
project proposition and the proposed impact. 
I needed to understand the case study proposition in my own mind, such as how to 
recruit the most appropriate participants already involved in medical devices 
management policy and implementation. Who should participate in this research 
 
Review of medical 
devices policy 
 










Figure 3-0-7: Review of medical devices policy 
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project? Who are the key people involved in the procurement, training, maintenance 
and governance? What is the burning issue with regard to the proposition I have 
formulated? The burning issue, as outlined in the previous two chapters, is failure with 
regard to implementation of medical devices management policy. Ultimately, the impact 
I want from this study is a best practice model for medical devices management policy, 
but to enable me to do that I need to review the data gathered from the participants in 
line with the project focus. 
In Figure 3-0-8, derived from my original mapping ideas shown in Appendix 4, I draw 
out my ideas focusing on the case study, the data required and the objective of a best 
practice model for medical devices management policy.  
The proposition: 
Creation of a best practice policy 
model  
  





knowledge; recruit & 
interview participants 
Check and select 




Interpret data with 
participants 
Indentify effective 
relationships to avoid 
blockages, aiding 
implementation 
Case study to review 
and improve current  
policy model 
Figure 3-0-8: The proposition 
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Regarding the impact of the study, I wanted to ensure that I understood the impact of 
this study on the participants and Hospital. Ultimately, my project would result in a 
contribution to knowledge for policy and practice.  
Figure 3-0-9 was derived from my original mapping ideas (shown in Appendix 4), 
mapping out the areas of knowledge improvement for myself, the participants and the 
Hospital, and thus considers the outcomes of the study.  
 
To recapitulate, the objective of this research is to build on the ‘Medical devices 
management policy model’ shown in Figure 3-0-1, with the intention of improving 
policy, strategy, practices, and the knowledge for device management policy at the 
Hospital and securing organisational approval for it. As a designer, individual, and 
insider–consultant–researcher, I would work with participants to propose new courses 
of action through reviewing what the Hospital was currently doing. The feedback from 
the participants in the Hospital would enable further improvements to be made, as in 
Lewin’s ‘spiral steps’ (Lewin, 1958) 
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An organisationally approved  
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Share knowledge  
with participants 
contribution to  
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design 
Share outcomes of  
the study 
Improvement in policy 
and practice 
 
Figure 3-0-9: The impact 
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Deconstructing the policy  
Once the project had been agreed by the Hospital executives, I would need to consider 
the data and participant involvement required that would enable me to use my 
specialist knowledge to critically analyse the data, with the objective of producing a 
best practice model for implementation of that policy. As mentioned earlier, I would 
need to decide which participants should be recruited. To enable me to make this 
decision, I would have to consider the four core areas of procurement, training, 
maintenance, and governance. Deconstructing the medical devices policy into its core 
constituents would allow me to identify the most appropriate participants and literature 
requirements. I would be able to deconstruct the policy because I am the specialist that 
authored this approved Hospital policy, and I have a detailed knowledge of the content 
and where that content has come from. Therefore, as the case study hinges on the 
medical devices management policy, it is imperative that the Hospital medical devices 
management policy should be the first piece of data used.  
Deconstructing and analysing the policy would allow critical consideration of the key 
components, participants, and processes that the Hospital is reliant upon, and the 
conduct that practitioners need to abide by. In all this I would have to be clear about the 
meaning and implications of policy. Colebatch, for instance, asks what is implied by 
policy? 
We should ask, first, what it is about policy that gives it force? What are people 
using it to mean? We can identify (at least in contemporary Western discourse 
about policy) three underlying themes: order, authority and expertise. 
(Colebatch, 2009, p. 8) 
When considering policy, as Colebatch rightly points out, it is important to ensure that 
order, authority and expertise are maintained, and those responsible for specific areas 
are identified to ensure the content is correct. With regard to order, I understand this to 
mean the structure and ease with which the document can be understood and used. 
With regard to authority, the policy must refer back to the regulations and standards as 
laid out by the CQC and NHSLA, and the expertise must not only be the expertise of 
the policy author (myself), but participants who are expert in the subject matter 
considered core components of the policy. If these experts cannot be identified within 
the organisation, further clarification must be sought from outside the organisation, 
either by a literature review or consultation with other professional peers. 
As the researcher, responsible for working with participants to develop, implement and 
monitor this medical devices management policy, I might use my current model to 
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visualise the core areas that would require researching, thereby enabling me to make 
my decisions on who should be involved as participants. I should also need to 
understand what other data were required to ensure the policy was in line with current 
regulatory requirements, such as that of the CQC, and their role in regulating Hospital 
policy. It would therefore be important to gather this data from the latest guidance, 
Regulation 16 (Outcome 11) (Care Quality Commission, 2010).  
I would also need to access the latest NHSLA medical devices risk management 
standards. (NHSLA, 2010) Also, the CQC and NHSLA both refer to the MHRA in the 
standards and regulations, specifically with regard to: Managing Medical Devices, 
Guidance for Healthcare and Social Services Organisations (MHRA, 2006).  
 
Figure 3-0-10 visualises my thinking around the deconstruction of the medical devices 
management policy, breaking it down initially into Hospital data and participant data, 





















Figure 3-0-10: Data focus, Hospital medical devices management policy 
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Ethical issues 
In addition to the foregoing technical and organisational issues, there are underlying 
ethical issues. For instance, the Chartered Institute of Management defines codes of 
ethics as:  
a set of moral principles of values used by organisations to steer the conduct 
both of the organisation itself and its employees, in all their business activities, 
both internal and in relation to the outside world. (Cole, 2006, p. 150)  
Ethical issues are focused on matters of what is morally right and what is morally 
wrong, rather than just standards of behaviour for myself or participants within the 
context of this case study. This means that I must not only adhere to my own 
professional code of ethics, but also to the Hospital code that applies ethics individually 
as well as collectively, and which impact on internal affairs as well as those of its 
external stakeholders. Hospital ethics have the advantage of providing explicit 
guidance on key moral issues that might arise during the course of this project's 
activities. Examples from Hospital conduct documents are shown below: 
From the Hospital code of conduct: 
Trust Board code of conduct 2012: (Extract) 
Public sector values matter in the Trust and members of the Board have a duty 
to conduct Trust business with probity. They have a responsibility to respond to 
staff, patients and their families, and other stakeholders impartially, to achieve 
value for money from the public funds with which they are entrusted and to 
demonstrate high ethical standards of personal conduct. 
Trust standards of business conduct 2012: (Extract) 
All staff who are in contact with suppliers, contractors or external consultants, in 
particular those staff who are authorised to sign purchase orders, or place 
contracts for goods, materials or services, are expected to adhere to 
professional standards set out in the Ethical Code of the Institute of Purchasing 
and Supply (IPS). 
An important ethical area for medical devices policy development and consideration is 
that of ‘social responsibility’. Being socially responsible implies the Hospital is expected 
to play a direct role in meeting community needs in health matters, including the 
provision of medical devices, and support within an economic framework. Healthcare 
must come first, but money is inextricably linked to that provision of care and I must 
ensure that cost is considered as part of the policy analysis. A change in policy can 
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have a negative, positive or neutral impact on Hospital budgets. The Hospital is 
expected to provide suitable medical technology while ensuring that patients are given 
quality care and remaining within budget. Therefore, procurement must be a 
consideration but must be conducted in an ethical way, so that it does not adversely 
impact on patient care. This is a requirement under the Health and Social Care Act and 
is monitored by the Care Quality Commission under Regulation 16, Outcome 11 (Care 
Quality Commission, 2010). 
Attention to ethical considerations in the conduct of this project is vital because this 
research is to be carried out in real circumstances and will involve close and open 
communication between the participants involved and result in changes in policy and 
practice impacting upon individuals at the Hospital. The impact will be felt not just at 
participant level, but across all users, buyers, and maintainers of medical equipment 
across the Hospital. 
In the spirit of double-loop learning, my knowledge and skills acquired over many years 
would be important in aiding this Hospital to interpret the regulations and ensure this 
political initiative is implemented in an ethical way. It must be implemented to improve 
organisational compliance, while taking into consideration my position as a researcher 
within the Hospital and my position as a company director with a multi-million pound 
contract with the Hospital.  
Thus, throughout this process I need to question my motives, my thinking, my loyalties 
and my previous practice. Obviously, I do not want to fail the Hospital, but I have to 
ensure that I understand what is relevant and important, and ensure I reflect on how 
my business interests may impact upon my thinking and actions when carrying out this 
project.  
I would say that this project could be transformational for:  
(i) me 
(ii) my business, and 
(iii) the Hospital.  
Therefore I can describe some of these intuitive leaps of understanding as 
transformational. It could be said by others that my motives for engaging in this project 
may be considered to range from the height of altruism to the most calculating self-
interest for my business, so it is important to ensure transparency. There are several 
types of activity which this project could benefit, such as:  
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 work creation 
 contributions to knowledge  
 support for educational institutions 
 new paradigms for policy, and  
 supporting further research. 
To ensure that I ethically reflect on the relevance of my thinking, I would need to 
discuss my ideas with my professional peers. For instance, I chaired an educational 
seminar on 20 March 2012 organised by SBK Healthcare Ltd (http://www.sbk-
healthcare.com/) entitled 'Improving Your Approach to NHS Medical Devices 
Compliance’. As the Chairman, I was leading the discussion of approximately 35 of my 
professional peers on improving medical devices policy compliance, sharing my best 
practice experiences from the Hospital with leading NHS compliance managers, 
trainers, and coordinators. This dedicated forum assisted me to refine my methodology 
and approach for the case study. I wrote a paper for the delegates at this seminar 
which was subsequently published in Clinical Services Journal (Sandham, 2012, p. 29) 
(see Appendix 3). 
I also organised and chaired an educational seminar on 2 May 2012 in Milton Keynes, 
the theme of which was 'Medical Devices Innovation'. There were 170 attending 
delegates present. I discussed ‘Achieving Regulatory Compliance in Medical Devices 
Management in my Healthcare Organisation’ with the audience, and asked them how 
they currently achieve compliance within their organisations. This allowed me to 
consult many colleagues, from many organisations, to find out if they experience 
similar issues to those that I experienced at the Hospital, thus allowing me to further 
refine my thinking.  
As discussed earlier, in my position as a researcher at the Hospital, it would be naïve 
to think that my position could be neutral. I am the subject expert and therefore 
expected to assist the participants to facilitate changes that are in line with the finding 
of the research and within the remit of my expert knowledge of the regulatory 
standards.  
I accept that my knowledge, values, attitudes and feelings will play an important part in 
everything I do on this project, and what I say or think. However, I will aim to be 
constantly aware of my position as a facilitator involved in interpreting the new 
regulations and using my knowledge and experience to aid the participants to construct 
and deliver a policy that meets their needs as well as the demands of the regulators.  
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There are arguments about the acknowledgement of values with regard to the 
positioning of researchers. In one corner we have W. Carr (Carr & Kemmis, 2006: 495–
501), who argues that partisanship is not simply unavoidable; rather, it is essential. As 
Carr observes:  
Far from being some unwelcome intruder whose presence or absence can be 
empirically detected, partisanship is an essential ingredient in educational 
research whose elimination could only be achieved by eliminating the entire 
research enterprise itself. The existence of partisanship in educational research 
is, therefore, not an empirical matter concerning what, as a matter of fact, is the 
case but a logical necessity which it is neither possible nor desirable to avoid.… 
In empirical research there is no telling is as it is. There is only telling it from a 
theoretically partisan point of view. 
In another corner, Malcolm (1993, p. 142–144) questions the integrity of partisan 
researchers and suggests that such a stance may lead to questionable practices in the 
use, selection, manipulation and interpretation of data: ‘Partisanship will act to confirm 
or reinforce the researcher’s own theoretical framework and lead to “unhealthy 
professional entrenchment”’. She suggests that a deliberately self-critical approach 
would be more effective in order to make explicit the evidence and arguments needed 
to defend a position: 
It requires us to explore more fully the subtle distinctions between an admitted 
lack of neutrality and a straightforward surrender to bias, and to seek an 
unaccustomed distance between ourselves and our practice. (Malcolm, 1993, p. 
142–144) 
Critically reflecting on myself and my position within the study is called ‘reflexivity’. This 
doctoral study has prompted me to critically question what I had previously been doing, 
and come to the realisation that there were new questions that I had not previously 
asked, potentially leading to new paradigms that I will discuss more fully in later 
chapters. Greenbank (2003) discusses the effects of different types of values and 
interests. He points, for example, to the potentially distorting effects on research of 
factors not often discussed, such as the career aspirations of the researcher. He also 
draws attention to potential conflicts between a researcher’s values or morality and 
generally accepted social values and the values of those being researched.  
His main argument is that: 
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Users of both quantitative and qualitative methods all need to recognise the 
influence of values on the research process.… The inclusion of reflexive 
accounts and the acknowledgement that educational research cannot be value-
free should be included in all forms of research… researchers who do not 
include a reflexive account should be criticised. (Greenbank, 2003) 
Halliday (2002) also discusses the values of the ‘researched’ in relation to those of the 
‘researcher’. He argues that researchers should be open to the values and viewpoints 
of all concerned with the research and be willing to engage in dialogue: 
The researcher or writer is likely to have calculated how best to further her or 
his values without appearing to be biased or prejudiced. The outcome of 
research must not appear to be a prejudgement arrived at without due 
examination. (Halliday, 2002) 
Consequently, I shall need to ensure that all participants are allowed to influence the 
work, and the wishes of those who do not wish to participate shall be respected. The 
development of the work shall remain visible and open to suggestions from participants 
within the Hospital, from my company, EBME Ltd, and from the University. 
Thus, as part of the participant agreement I have clearly stated my intentions with 
regard to the research study:  
My name is John Sandham, I am the researcher on a project entitled: 
‘Achieving a best practice model for medical devices management policy’. This 
project is being sponsored by EBME Ltd. (See Appendix 1.) 
This is necessary because the medical devices management policy is often thought by 
participants in the Hospital to be my responsibility, as the Medical Devices Manager. 
However, as the policymaker, I see it very differently. Policy must be made so that it 
impacts across all areas with responsibility involving medical devices. As the author of 
the policy (Sandham, 2012), I report to a specific group of decision-makers who have 
senior positions in the Hospital and must sign off on policy and compliance with the 
organisational needs. Therefore, policy is made by those with the expertise to enable 
them to make decisions for a particular policy area. As Buse et al. (2011) observe: 
‘Policy’ is not a precise or self-evident term, for example, Anderson (1975) says 
policy is a purposive course of action followed by an actor or set of actors in 
dealing with a problem or matter of concern. (Buse, et al., 2011, p. 8) 
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Criteria from the CQC and NHSLA underpin the policy and therefore form the basis of 
all the discussions with the participants. The criteria are discussed in more detail in 
Chapter 4, but the core elements are: 
 Regulation 16, Outcome 11, which specifically relates to the safety, 
suitability, and safe use of medical devices. (Care Quality Commission, 
2010) 
 NHSLA Standard 5.4 Maintenance of Medical Devices and Equipment; 
and Standard 5.5 Medical Devices Training. (NHS Litigation Authority, 
2012, p. 170) 
As this is a case study that involves participants, it is important when working with the 
participants that I maintain a good relationship and manage their expectations for the 
outcomes of the case study. There may also be stakeholders within the Hospital who 
would not be interested in participating, and may even wish to block this type of case 
study. In any type of AR case study, there will always be those who question the 
validity and need for the study. It is important that I understand the concerns of those 
stakeholders who are on the periphery of the study and may feel threatened by the 
outcomes. This will involve attending committees, interviewing participants and being in 
regular contact with the participants to discuss the ongoing study. 
Another consideration must be time. I must consider the time it will take to work with 
the participants, and what a reasonable amount of time would be out of my own diary 
to dedicate to this case study. If sufficient time is not available from the participants, it 
could lead to the failure of the case study. Also, it is important that I give sufficient time 
to the project to ensure I am able to complete it. 
There is a spiral of cycles that first involves the design of the project, and then involves 
the acceptance of the project, requiring sign off by the Hospital, the University and my 
company. Even after the sign off, it requires the voluntary recruitment of participants 
from within the Hospital who are willing to be involved and give up some of their time. 
There is also a recognition when carrying out this type of AR project that giving up my 
time, and the time of the participants, may also impact on our day jobs. I must be 
careful to ensure that I gather enough information to enable me to analyse and develop 
the project in step-by-step, yet not take up so much of my time, and the participants’ 
time, that it damages the operational requirements of the Hospital. 
I also have personal considerations that I need to think about, specifically with regard 
to the amount of personal time I allocate to this case study. Ultimately, this personal 
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time will impact on my personal life, and this needs to be balanced to ensure I can 
achieve my ultimate goal of an improved policy. 
Outline of the AR steps  
Carrying out the AR involves multiple visits to multiple participants, and continual 
analysis of the data from those visits. Each individual participant who is involved may 
see things differently from other participants. For example, each nurse manager has a 
budget and wants to spend that budget based on their own needs.  
The procurement manager, on the other hand, may think it is more sensible to combine 
budgets and make a single large purchase to gain economies of scale. These internal 
political sensitivities will need to be managed as part of the case study. This means 
there is not a smooth upward spiral of improvement, but it is more like climbing the 
ladder to move forward, but then subsequently being knocked backwards, because of 
disagreements with the route chosen.  
Using a mixture of methods for communication, these hurdles can be overcome and, 
although this is not a smooth upward spiral, ultimately I believe that it will be successful.  
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In my view, this case study can lead to improvements in knowledge, learning and action, 
which leads me now to Chapter 4 to say what actually happened.  
1. INPUT 
Preparitory cycles 






•Manage and analyse data 








•Report and discuss 
opportunites with  
participant and executive 
•Approve (Freeze) improved 
policy 
•Evaluate , and set date to  
restart  input process 
Once the Policy is agreed, a 
review date will be set to 
‘unfreeze’ the policy and carry 
out another AR cycle. 
Feedback loops 
Figure 3-0-11: Outline of the AR steps 
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Chapter 4: Case-study Activity 
This chapter presents the spiral of cycles, each with its own set of problems, 
comprising this case study on medical device management policy and development of 
an organisationally approved best practice policy model for ongoing implementation 
within the Hospital. It involves the description and discussion of the case study, the 
scope, the choice of data, the selection and recruitment of participants, and the 
collection of data. This involves me being actively involved in developing improvements 
to Hospital policy and securing approvals by the appropriate Hospital committees. 
As discussed in Chapter 2, there was a reasonable range of literature on medical 
devices management, policy and regulations. The initial stage was to review this 
literature and use that review as the basis of discussions with both the University and 
the Hospital. 
What became clear from the review is that there is an ongoing issue recently described by 
the World Health Organisation in research papers published in 2011. This concerns the 
adequacy of medical devices management policy. The importance of this cannot be 
overestimated because, as explained earlier, it has an impact on both patient safety and 
cost.  
In light of these patient safety and cost issues, I decided to carry out an in-depth study 
addressing these issues in a single hospital because I wanted to understand why 
hospitals are still experiencing device management related deaths and serious injuries 
on a worldwide scale. Also, as described earlier in Chapter 1, the use of technology is 
increasing and therefore a solution to these issues needs to be found. From reading 
WHO literature I gained a deeper understanding of the issues, and central to the issue 
was production and implementation of device management policy. I started looking at 
the impact in terms of patient harm and organisational costs, initially from a global, then 
from the UK, and eventually from a local hospital perspective. 
As described in Chapter 2, in carrying out this case study it was important in the early 
stages of the project to review the latest information available on medical devices 
management and policy. I carried out a number of searches, and I also consulted my 
professional peers to try to identify new data available, specifically with regard to the 
production and implementation of medical devices management policy. In so doing, I 
was directed to literature that I was already aware of, but I also discovered new advice 
on the development of medical devices policy from the World Health Organisation. One 
of the World Health Organisation's strategic objectives is to ensure improved access, 
quality and use of medical products and technologies. This objective, together with a 
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World Health Assembly resolution, forms the basis for establishing the global initiative 
on health technologies, with funding from the Bill and Melinda Gates Foundation.  
The World Health Organisation had two specific objectives in mind: 
1. To challenge the international community to establish a framework for the 
development of national essential health technology programs that would have 
a positive impact on the burden of disease and ensure effective use of 
resources. 
2. To challenge the business and scientific communities to identify and adapt 
innovative technologies that can have a significant impact on public health. 
(World Health Organisation, 2011, p. 3) 
To meet these objectives requires development of tools and guidance to increase 
access to appropriate medical devices. It was important for me to understand the 
impact of the WHO research to validate the benefit of my case study with the 
participants. It was important to explain it in the context of the impact it could have on 
the case study.  
I also reviewed the latest UK government legislation impacting on device management 
policy, relating to healthcare providers meeting care quality standards. The Department 
of Health assures legal compliance through the CQC. This monitors healthcare 
providers to ensure that they are adhering to the new legislation, which relates to 
quality provision: 
A new law governing the way we regulate health and adult social care in 
England came into force on 1 October 2010. This introduced a new set 
of essential standards of quality and safety that all care providers must meet. 
(Care Quality Commission, 2010)  
CQC Regulatory demands 
There are many regulations which impact on medical devices policy. 
The issue with regulations is that, unless the organisation has 
mechanisms in place to deal with implementation, these regulations 
are ignored, and the Hospital could be seen as breaking the law. 
NHSLA Standards 
The National Health Service Litigation Authority issues and updates 
standards every year. NHS organisations are expected to be aware 
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The law plays an important, though not dominant, role in regulating the relationships 
between the Hospital and their various stakeholders, including patients and commercial 
suppliers. I discovered, for example, there are laws specifically designed to protect 
patients with regard to use of medical devices, and there are laws specifically designed 
to ensure suppliers provide services within agreed legal terms of reference. 
I know that device management is a burning public issue because it has now been 
enshrined in law through the Health and Social Care Act 2010 (Care Quality 
Commission, 2010). This Act is in an area that is politically significant, impacting on 
levels of risk to patients and the NHS’s organisational reputation. The Care Quality 
Commission has made medical devices management a priority (under Regulation 16, 
Outcome 11) and lists device management as one of the worst performing areas of 
NHS management in its 2010 report (Care Quality Commission, 2010). All this 
information provided me with a strong argument for the need and value of the case 
study that resulted in the following cycles being developed.  
I will now describe the cycles of AR undertaken to enable the transformation of Hospital 
policy. 
Input (preparatory) cycles (One to Three) 
Cycle One—Project Scope agreed with Hospital, Work Based 
Learning at Middlesex University and my company 
Project scope agreed with Hospital 
As previously mentioned, I was already involved with the Hospital as a consultant 
delivering medical devices management solutions, which also included the medical 
devices management model discussed in my RAL 8. I began to problematise with the 
Hospital, University Work Based Learning team and potential participants and decided 
on a case study with the focus for the research being device management policy at this 
single NHS hospital, using a participatory AR approach.  
As Hart and Bond observe (Hart & Bond, 1995), emphasis on the active role of 
participants is important as long as it is meaningful and effective: 
of these updates, and implement any changes. It is only possible to 
implement these changes if the organisation has firstly been made 
aware of the standards, and secondly has somebody in place able 
to implement the changes. 
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We have placed considerable emphasis on the active role of participants in the 
change process and we would agree with Roberts that drawing on the active 
contribution of citizens to research is a necessary way of ensuring that politics 
which arise from that research can in a meaningful way and effective way be 
connected with the lives of those towards whom they are directed (Roberts 
1992: 190). 
I held discussions with a deputy director at the Hospital to discuss the possibility of 
using the organisation to carry out my doctoral research. I discussed the draft research 
proposal with the intention of completing this research project with a multidisciplinary 
team of participants. One manager in particular expressed concern that the project 
would subject them to scrutiny that might impact on their reputation. These fears were 
allayed by agreeing that the paper and any recommendations would be shared with the 
Hospital, and anonymity would be provided for the Hospital and participants. Overall, 
the senior managers felt that this would benefit the Hospital and therefore there would 
be no objection to the case study going forward. Once he had agreed the outline 
proposal, a meeting was arranged with senior managers at the Hospital to obtain 
formal permission and signatures.  
This part of the project took over three months to complete because access to many of 
the managers was restricted due to workload and busy diaries. There were also 
meeting cancellations that I had to contend with, which added time to this process. Not 
only was there much to discuss about the device management case study and the 
approach to the research, there were concerns to overcome from some of the 
managers, which meant I had to make return visits while they consulted their superiors.  
Formal permission was finally agreed and signed off by the designated manager. The 
main focus was agreed with the Hospital senior management, with the remit to create a 
best practice model for development, implementation and continuous improvement of 
device management policy and practice.  
Project scope agreed by Middlesex University 
I discussed the outline project with my advisors at Middlesex University. This first idea 
involved three NHS Trusts and 30 participants. My advisors advised me that my initial 
ideas for the project would be extremely difficult to achieve. After taking their advice, I 
decided to do an in-depth case study at one NHS hospital with 15 participants. I 
presented this revised project outline to the advisors and it was subsequently agreed 
and signed off by the University. 
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Project scope agreed by my company 
It was necessary to discuss this project with my fellow directors and ensure that this 
project would ultimately benefit the client, and potentially lead to new business. This 
took the form of a meeting where we discussed the difficulties posed to our engineers 
from poor management of medical devices. We felt that this research would benefit the 
whole business, and reputation of our company and the client. We therefore decided 
that my time should be committed to carrying out this research with the understanding 
that there would be some impact on the business and I would need to dedicate time to 
this case study. As the project was signed off by my company, the Hospital, and the 
University, I then started to identify and recruit participants. 
During Cycle 1, it was necessary to visit and re-visit the Hospital to discuss and explain 
the project to senior managers in order to gain approval but, while this was agreed, it 
raised the question of who should be involved. 
Cycle Two—Suitable participants discussed and agreed with Hospital 
An important part of this case-study process was to understand the individual 
practitioners who needed to be recruited as participants. It was important that I gained 
a deeper insight to see what they currently did, what they understood with regard to the 
case study, and what they would do differently to improve policy and practice.  
The MHRA state that device management policy should cover: 
 selection, acquisition, acceptance and disposal of all medical devices 
 training of all those who will use them 
 decontamination, maintenance, repair, monitoring, traceability 
 record keeping and replacement of reusable medical devices. 
(MHRA, 2006, p. 8) 
I selected a cross-section of potential participants based on the guidance from the 
MHRA. One of the potential participants expressed concern about, and initially was 
against the idea of, running this case study research at the Hospital but I was able to 
convince her of the benefits with the support of the main sponsor. Even with this slight 
opposition at the start, the overall feeling was one of optimism and interest in the 
project. It was important to me, the Hospital and the University that my plan had 
different timelines set.  
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I initially thought about having 30 participants, but after receiving advice from the 
University I reduced this to 15, which initially ended up being 14 after a participant left 
the Hospital. Fortunately, all 14 of these participants have remained working within the 
Hospital throughout the project. Later in the case study, I added three further 
participants at their request, and thus ended up with 17 participants in total.  
Collaborative relationships were also formed with practitioners aligned to the main 
participants and, although these were at a distance, it was still worth engaging these 
practitioners that were on the periphery because the main participants took their views 
into consideration. Meetings were conducted with a cross-section of potential 
participants mainly from the Medical Devices Committee members. These members 
included directors, deputy directors, senior managers, nursing managers, nurses and 
medical consultants. During this time, I was still developing my approach with regard to 
this project, so I was able to test my ideas in discussions with the potential participants. 
This strengthened my resolve and direction with the project. As I was working on a 
number of different fronts across procurement, training, maintenance and governance, 
specifically with regard to medical devices management policy, I needed to engage 
with potential participants who had expertise in these specific areas. For example, I 
engaged the procurement manager for procurement policy and advice, the 
maintenance manager for maintenance policy and advice, and the NHSLA internal 
advisor for support from the governance team. Thus I was engaged in early 
discussions with a number of would-be participants, who would subsequently become 
strong advocates of the project. This early part of the project was exploratory, and 
testing the ideas for my case study approach.  
Ultimately, I drew up a list of potential participants and discussed it with the Chairman 
of the Medical Devices Committee, a keen advocate of the project. The crucial issue 
was to obtain permission to approach suitable participants. As Hart and Bond have 
indicated, it is important to make sure permission is gained before starting the 
research:  
Make sure that the relevant persons, committees and authorities have been 
consulted and permissions gained, and that the principles guiding the work are 
accepted in advance by all participants. (Hart & Bond, 1995, p. 198) 
I explained what I foresaw as the benefits to the Hospital with regard to this case study. 
The executive responsible could see the potential benefits from the project and agreed 
to become a participant. As the Chairman of the Committee, he has considerable 
influence with every committee member and with senior Hospital management.  




























This relationship was crucial to enable this project to take place within this Hospital, 
because he was able to help me identify participants and to support my personal 
discussions with the participants, thereby helping to obtain their permission to 
participate. It was also important to ensure that the participants recruited were able to 
represent a good cross-section of professional practitioners able to promote and 
communicate the project throughout the organisation.  
This would involve participants from the following professional areas or departments, 











Cycle Three—Participant recruitment 
Clearly, it was important to recruit participants who were closely involved in the device 
management areas of procurement, training, maintenance, and governance and who 
wanted to have an input into development and implementation of the medical device 
management policy. This would allow those participants to have a greater depth of 
understanding, and enable them to spread the message thereby empowering other 
stakeholders within the Hospital to be active in the business of the Hospital. Ultimately, 
without participant ‘buy-in’, the project cannot proceed and the benefits cannot be 
realised. Hence, participants were recruited from the professional areas identified in 
Table 4.0.1.  
Table 4.0.1: Participant professions 
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Interview ID no Professional Role Position Gender
Participant 
agreement 
completed? Relationship Interview date
Participant 1
Doctor, 
Anaesthetist ITU Director Male Yes Client colleague 23/10/2012
Participant 2 Nurse
Infection Control 
nurse Female Yes Client colleague 25/10/2012
Participant 3
Senior Auditor / 
Facilitator Senior Manager Male Yes
Employee 
colleague na
Participant 4 Auditor / Facilitator Project Manager Male Yes
Employee 
colleague 23/10/2012
Participant 5 Inventory Manager EBME manager Male Yes
Employee 
colleague 23/10/2012
Participant 6 Administrator EBME Administrator Female Yes
Employee 
colleague 23/10/2012
Participant 7 Manager Head of purchasing Female Yes Client colleague 23/10/2012
Participant 8 Director
Director of 
operations Male Yes Client colleague 09/11/2012
Participant 9 Deputy Director
Dep Director of 
emergency planning Male Yes Client colleague 09/11/2012
Participant 10 Manager
Decontamination 
manager Female Yes Client colleague 07/08/2012
Participant 11 Auditor / Facilitator
Governance 
facilitator Female Yes Client colleague 15/10/2012
Participant 12 Nurse
Dep director of 
nursing Female Yes Client colleague 23/10/2012
Participant 13 Nurse
Infection control 
advisor Female Yes Client colleague n/a
Participant 14 Director Director of Estates Male Yes Client colleague 23/10/2012
Participant 15 Chief Executive Chief Executive Female Yes Client colleague 21/03/2012




Professor of Health 
Economics Imperial College Male Yes
Friend/profession
al colleague 23/10/2012
It was even more important that they were the ‘right’ participants to ensure that they 
had at least an interest and hopefully a commitment to the realisation of the projects 
intentions. Table 4.0.2 shows the representative key participants recruited from the 
















The majority of the participants sit on the Medical Devices Committee. This was 
important because the committee is cross-sectional, representing all aspects of 
medical devices management’s operational needs. I decided to recruit from this 
committee, because it has the authority to approve purchases, and reviews 
governance arrangements for maintenance, training and regulations on a monthly 
basis. It also has the authority to approve revisions to the policy. 
In short, the participants are a representative sample from all staff groups involved in 
using or managing devices. They include people such as the Head of Procurement, 
Chair of the Medical Devices Committee, Deputy Director of Nursing, Medical 
Table 4.0.2: Profile of participants, and interview dates 
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Equipment Maintenance Manager, Medical Devices Manager, Central Alert System 
Coordinator, Infection Control Nurse, Governance Coordinator, Decontamination 
Manager, Operations Manager, and Estates Manager. With the recruitment process 
complete, the next cycle of research was to interview these participants but that posed 
the question of just what needed to be asked as well as the style and format of the 
interviews. 
Action (Informative) cycles (Four to Six) 
Cycle Four—Participant interviews  
The participants are key stakeholders and take part in semi-structured interviews with 
the objective of understanding how we can innovate, thereby improving and 
implementing medical devices policy.  
Through the interviews, the participants discuss procuring equipment, using equipment, 
maintaining equipment, corporate governance, and as a group these participants are 
essential for ensuring policy initiatives with regard to medical devices are delivered 
(see Figure 4-0-1). 
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The questions below were used as a guide for the interview. 
1. Have you read the organisational medical devices policy? 
If yes, take details of: 
I. Participants’ thoughts on current medical devices policy. 
II. Participants’ understanding of device management policy within the 
organisation. 
III. Participants’ understanding of the CQC and NHSLA impact on 
current policy. 
IV. How well the organisation communicates device management 
policy. 
If no, take details of: 
I. Participants’ thoughts on what Medical Devices policy is about. 
II. Participants’ understanding of device management within the 
organisation. 
III. How the organisation could better communicate device management 
policy. 
2. Level of awareness of the latest regulatory standards for medical 
devices? 
I. What is the Participants’ understanding of CQC and NHSLA 
regulations/standards for medical devices? 
II. How are Participants notified of changes in regulations/standards for 
medical devices?  
3. How can we improve policy to bring it in line with the latest 
regulations? 
I. Process for communication. 
a. Review period. 
II. Process for documentation. 
III. How to make policy happen. 
IV. What makes a policy sit on a shelf gathering dust/stagnate. 
I carried out a pilot interview with one of the participants to test my interview questions, 
participant approach and recording device. I subsequently made some minor amendments 
to the questions in the guide based on the responses from the participant that was 
interviewed. This practice interview delivered useful data, and I therefore decided to take 
this forward with the rest of the participants. As the practice interview lasted approximately 
an hour, I allocated one hour for the rest of the interviews. Transcribing the practice 
interview took around six hours. Having 17 participants, of whom 14 were interviewed, took 
up a large amount of my time but provided useful data for analysis.  
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Although I allocated one hour as the maximum time for an interview, on two occasions 
the discussion carried on with the permission of the participants because the 
discussion was interesting and innovative, bringing me some new relevant ideas. 
Therefore, although it is a good idea to have a set amount of time for an interview, the 
interview should not be stopped if the participant still wants to continue and I, as the 
researcher, feel that what they say is important to the case-study outcome. All the 
people interviewed knew me in a professional way, and took part as participants 
because they believed in the project, they believed in me, and there were pleased to be 
able to help. 
I created a template for the semi-structured interview that included questions covering 
the core constituents within the medical devices management policy, and also 
questions relating to the regulatory standards. It was important to understand the level 
of expertise that each participant had, and whether the expertise they had was superior 
to my own, or whether the ideas they had were different from my own and could be 
adopted within the new policy model going forward. When carrying out the interview, I 
tried to be as conversational as possible while using prompts to guide me through the 
interview. The interview was recorded using a digital voice recorder pen, which enabled 
me to make notes and record the conversation at the same time. The device also 
allowed for any part of the interview to be listened to by touching the pen tip on the 
written text. However, the interviews raised questions with regard to my relationships 
with the participants. 
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The researcher-participant relationship 
It is important to understand the relationship between the participants and myself, the 
researcher. Working in the Hospital since 2008, I have developed professional 
relationships with most of the participants. In Figure 4-0-2, I illustrate the methodology 
of how the Medical Devices Committee participants interacts with me through the 
Medical Devices Committee. 
 
 
This has benefits in that I am able to gain their confidence and get a deeper insight into 
how they really feel about the impact of policy on their professional practice. There is 
also a negative aspect to having such professional relationships within the Hospital, 
because the participants may not want to hurt my feelings, and therefore may avoid 
telling me certain aspects that frustrate them. I must take this into consideration during 
the analysis phase of this project. I believe that the benefits outweigh any negative 
impacts of being an insider–researcher. In particular, this issue of relationship was 
crucial in the case of the Medical Devices Committee participants because of their role 
in policy development and approval.  
However, whatever their status and role in the Hospital, my intention was that 
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Figure 4-0-2: Discussions with the Medical Devices Committee participants 
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project and able to have their say in how to make changes. This would give them a 
sense of empowerment because they had an improved understanding of the policy 
demands, therefore enabling them to identify the risks as well as the benefits involved. 
Another realisation may be that they do not understand, and are therefore not 
operating in accordance with, the organisational policy and regulatory requirements. 
This, then, motivates them to be involved and want to improve policy for the benefit of 
the patient, their own practice and improved organisational management. Clearly, this 
was a good intention, but would it be achieved when I met the participants? To prepare 
myself for this I needed to gain some appreciation of their current understanding the 
existing Hospital policy. 
Cycle Five—Meeting participants and understanding participant 
awareness 
In addition to the semi-structured interviews, I administered a participants’ awareness 
questionnaire to arrive at a baseline of the participants’ understanding of the policy and 
regulations. The questionnaire forms Appendix 2. I chose a multi-disciplinary 
participant team. It was important that they had influence within the Hospital to enable 
acceptance and approval of the changes and, as can be seen from Table 4.0.3, the 
participants are members of various high level committees. Communication is an 
important aspect of medical devices management policy and implementation. During 
my meetings with the participants I asked them about other meetings they attend within 
the Hospital.  
Table 4.0.3 shows the meetings that these participants attend. The Medical Devices 
Committee, Health and Safety Committee, and Governance Committee are all at the 
same management level within the organisation. All these committees report upwardly 
to the Risk Committee.  
The Risk Committee is attended by all the general managers, and is chaired by an 
executive director, normally the director of nursing. The Risk Committee then upwardly 
reports to the Board meeting. 
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Interview ID no MDC Health & Safety Governance Risk committee
Participant 1 x x
Participant 2 x x
Participant 3 x x
Participant 4 x
Participant 5 x x
Participant 6 x x
Participant 7 x x
Participant 8 x x
Participant 9 x x x
Participant 10 x x
Participant 11 x x
Participant 12 x
Participant 13 x
Participant 14 x x x
The purpose of the questionnaire was to ensure that the participants were impacted 
upon by device policy, had expertise in some specific area of device policy, were aware 
that my objective was to produce a best practice model for medical devices 
management policy, and that their objectives were based on continual improvement of 
the medical devices management policy at the Hospital. The results are given, 
analysed and discussed in the next chapter, but first I needed to manage the data I had 
collected in a form that could be discussed and decided on.  
 
Cycle Six—managing the data 
As discussed in earlier chapters, I had to obtain a large amount of data. This was kept 
electronically and saved into folders by data type. The organisational data, for example 
minutes of the Medical Devices Committee and transcriptions of interviews with 
participants, were initially kept in document format. These were later formatted into 
spreadsheets so that analytical word search tools could be used and any comments or 
text sorted into relevant categories. The main tool used in Microsoft Excel 
spreadsheets was a word search string:  
=IF(ISNUMBER(SEARCH("polic",B2)),"Policy", "NA") 
The above string uses the software to instruct that if any spreadsheet cell contains the 
following letters ‘polic’, it writes the word ‘Policy’ in a corresponding cell. If it is not 
there, then write ‘NA’. 
Table 4.0.3: Participant committee attendance 
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Pasting this string into a spreadsheet cell allows the easy searching of data. To try to 
do this manually would take a huge amount of time and would be frustrating. It was 
important to use this tool because it allowed me to search words within the texts from 
the semi-structured interviews that allowed me to focus on specific areas. The core 
word searches I carried out were for the following:  
 policy; purchase; training; maintain; regulations; CQC; standards; 
NHSLA; ownership; management; expect; fault 
It was useful to pull together groups of comments that discussed particular issues, 
because this allowed me to analyse those comments together and draw conclusions, 
whether they came from the minutes of the medical devices management committee or 
the transcribed texts of the participants. All participants were given a unique identifying 
number from P1 to P17. 
I created two spreadsheets, one for the medical devices management committee 
minutes comments, and one for the semi-structured interview text. Each comment was 
given a unique number to enable me to refer back to it within the text. Appendix 10 is 
an example from the analytical tool that I used. This particular example is based on 
searches for text relating to policy. As mentioned earlier, I also produced similar tables 
for all the core words of: policy; purchase; training; maintain; regulations; CQC; 
standards; NHSLA; ownership; management; expect; fault.  
 
The final tasks of the project were now obvious: I must report on the results of these 
exercises first to the participants and then to the decision-making Medical Devices 
Committee.  
  
No. Comment Policy Purchase Train Maintain Regulations CQC Standards NHSLA Ownership Management Expect fault Month yr
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Output (transformative) cycles (Seven to Nine) 
Cycle Seven—Discussing and recording the project activities with 
participants 
This part of the project involved organising meetings with participants and interviewing 
them in a research focused way to identify the issues impacting on medical devices 
management policy. Issues were discussed with a view to finding solutions to be 
included within the new best practice policy. These proposed solutions were 
subsequently brought up at the Medical Devices Committee meeting (see Appendix 9) 
and have been documented throughout the project, and also reported to more senior 
committees. I worked with the participants individually, and attended the Medical 
Devices Committee meetings with the participants on a monthly basis to set out some 
of the suggested changes.  
There was some disagreement between the Medical Devices Committee and one 
participant, who unfortunately did not attend because of having to attend a different 
committee at the same time. This created some issues because the participant held 
strong opinions about how the policy should be created and formatted, and there were 
disagreements on the side of the other participants.  
As the specialist, I had to listen to all of the arguments and decide which ones to put 
forward to the Medical Devices Committee for discussion, approval and upward 
reporting. It was important during all cycles to ensure agreement with the Committee, 
of which a large percentage of the committee members were participants in the case-
study project. I had good working relationships with all of the participants and, even 
when there were disagreements, we were able to come to an agreement eventually 
because of the respect that had been built up as part of the good working relationships.  
As each policy amendment needed to be agreed with the MDC, it was best not to take 
it immediately to all the other committees, but to wait until all of the amendments have 
been completed, and then approach the committees. For six months, the policy was 
presented to various stakeholders within the organisation for comment, and received 
approval from the Medical Devices Committee in March 2013. This was not the end, 
because we were on a journey with this policy and, as the insider–researcher, I 
understand that there must be a team of experts involved in continuing to drive the 
changes to a satisfactory conclusion. 
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Cycle Eight—Report, discuss, and approve all improvements at the 
Medical Devices Committee 
The MDC brings together participant practitioners from different departments and helps 
to reduce ‘silo mentality’ as members are responsible for reviewing and implementing 
the medical devices management policy throughout the Hospital. It is the responsibility 
of the MDC to approve the transformed policy during this cycle of the case study before 
it was sent to the executive committee for final sign off. The submission of the MDC's 
decision to the executive committee would constitute the final cycle of the research 
activities. 
Cycle Nine—Evaluation/reflection, review (refine); Executive 
agreement 
As part of the data gathering exercise, I wanted to ensure that I continually reviewed 
and reflected on the project, especially with regard to the new ideas coming directly 
from the participants. There was also a need to review and reflect on documentary 
evidence, minutes of the Medical Devices Management Committee, and discussions 
with my peers.  
It was my responsibility as the insider–researcher to reflect and review, with the 
participants, to find improvements and refinements to my current model, to ensure the 
Hospital can continue meeting its objectives strategically and operationally. Any 
changes that are agreed and implemented must be considered in an ethical and 
sensitive way. The success of the case study is vital to improving Hospital policy, which 
then impacts on improving practice.  
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Once all the participants and the Medical Devices Committee have agreed the new 
policy, it will be submitted for executive sign off and a future review date set to 
‘unfreeze’ the process and trigger a further action cycle. 
       PREPARATORY            INFORMATIVE             TRANSFORMATIVE 
 
Figure 4-0-3: Preparatory, Informative, and Transformative cycles of Action Research 
The AR cycles had the effect of altering previous policy by delivering changes due to 
the diagnosis of the issues with the participants, impacting on all cycles of the 
research, thus informing further refinements to the Hospital policy. As can be seen from 
Figure 4-0-3, there are three steps in my approach, namely: Preparatory, 2. 
Informative, and 3. Transformative. Within these three steps, there is a spiral of cycles 
within each step, starting with the ‘unfreezing’ of the policy at Step 1 through to the 
transformative at Step 3, where ‘re-freezing’ of the policy takes place after approval 
from the executive management team. This is not the end, because the cycle can 
restart at Cycle 1 to ‘unfreeze’ the policy model at agreed intervals.  
Thus, I was now in a position to analyse the results and establish the findings. This has 
enabled me to critically review my previous model and construct a best practice 
medical devices management policy model. Putting all the foregoing cycles into a 
timeframe, I prepared a Gantt chart as a guide for my activity and presented it within 
my project plan to the Hospital and University, as in Table 4.0.6, Case Study Timelines 
(below).  
CYCLE 1 


















DISCUSS AND RECORD 
PROJECT ACTIVITIES 
CYCLE 8 




EVALUATE, REFLECT & 
REVIEW ; EXECUTIVE 
AGREEMENT 
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Task Start date End Date
Project Agreed by Client 01/04/2012 15/04/2012
Project Agreed by EBME Limited 01/04/2012 15/04/2012
Project Agreed by Midx WBL 01/04/2012 15/04/2012
Identify Participants 01/04/2012 15/04/2012
Agree measurables and compliance areas 01/04/2012 15/04/2012
Sign off DProf project plan with Trust 01/04/2012 15/04/2012
Request documentation for review 01/04/2012 15/02/2013
Review policy needs with Participants 15/04/2012 15/02/2013
Agree changes with Participants 01/05/2012 01/12/2012
Review / Make changes with Participants 01/05/2012 15/02/2013
Attend medical device committee meetings 01/05/2012 15/02/2013
Policy
Review current policy 01/04/2012 01/12/2012
Revise current policy 01/05/2012 01/12/2012
Does the policy/project require ratification at other 
forums/meetings/committees? 01/11/2012 15/12/2012
Policy training requirements 01/05/2012 15/02/2013
Assess Risks (NHSLA/CQC/MHRA compliance) 01/07/2012 15/02/2013
Maintenance policy
Review of Maintenance requirements / Interview 
maintenance participant 01/04/2012 01/01/2013
Review 01/04/2012 01/01/2013
Procurement policy
Assess Purchase requirements 01/04/2012 01/01/2013
Review Purchase Metrics 15/05/2012 01/01/2013
Equipment Replacement Policy 01/07/2012 01/01/2013
Training policy
Review medical devices training needs 15/05/2012 01/01/2013
Review Intranet (Medical Devices Documentation) 15/05/2012 01/01/2013
Quality
Review Care Quality requirements 01/04/2012 15/02/2013
Submission
Draft introduction 15/08/2012 15/10/2012
Participant Interviews 15/08/2012 15/10/2012
Draft further sections 15/08/2012 01/12/2012
Consultant/advisor meeting 01/12/2012 15/12/2012
Draft Paper 01/12/2012 01/05/2013
Consultant/advisor meeting 15/04/2013 01/05/2013
Submit paper 01/05/2013 31/08/2013
In this chapter, I have described and discussed the case-study activity, and how I 
designed the participatory approach to collaborate with participants who are experts in 
specific areas of practice relating to this policy model.  
I will now go on to Chapter 5 to discuss the results, analysis and finding of the case 
study. 
  
Table 4.0.4: Case study timelines 
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Chapter 5: Results, Analysis and Findings 
My fieldwork, which includes questionnaires, interviews and regular discussions with 
participants, has given me information and views from the participants that have 
enabled me to critically review the areas of my previous policy model covering the 
areas of procurement, training, maintenance and governance.  
I have also identified some general factors critically affecting the model’s 
implementation and operation. I will therefore first explore my fieldwork in respect of the 
areas of the model and then the general factors impacting on it. I will now detail my 
fieldwork, starting with the questionnaire and semi-structured interviews.  
The questionnaire 
It is absolutely imperative to select key individuals, as in Table 5.0.1, with expertise in 
the medical device practices related to this policy. The participants selected can then 
use their knowledge in a positive way to impact on improving the model by working with 
me, using an AR approach. The participants will also assist in ensuring it is 
implemented, monitored and regularly updated.  
 
Project title: ‘Achieving a Best Practice Model for 
Medical Devices Management Policy’
My objectives are based on continual improvement of 
medical devices management policy. Please could you 
answer the following questions?
Question P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17
1. Have you been made aware of the medical devices 
management research project objectives? Yes/no Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
2. Have you read the organisational medical devices 
policy? Yes/no Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Please answer the following in relation to medical 
devices management in your organisation:
1 = Poor, 5 = Excellent 3.0 3.7 3.5 4.0 4.0 3.3 2.3 4.2 4.0 4.7 4.5 4.0 3.7 3.8 3.0 4.5 Average
3. What is your understanding of device management 
policy within your organisation? 4 5 4 4 4 4 4 4 4 5 5 4 3 4 4 5 4.2
4. What is your understanding of NHS Litigation Authority 
standards? 2 3 3 3 4 4 1 4 3 5 5 4 4 3 3 5 3.5
5. What is your understanding of CQC and NHSLA 
regulations/standards for medical devices? 2 3 3 5 4 4 1 4 4 5 5 4 4 4 3 5 3.8
6. What is your understanding of CQC and NHSLA impact 
on medical devices procurement policy? 3 3 3 3 4 3 1 5 4 5 3 4 4 3 2 4 3.4
7. What is your understanding of of CQC and NHSLA that 
impact on maintenance policy? 3 4 4 5 4 4 3 5 4 5 5 5 4 5 2 5 4.2
8. How well does the organisation communicate device 
management policy? 4 4 4 4 4 1 4 3 5 3 4 3 3 4 4 3 3.6
Table 5.0.1: Participants’ awareness questionnaire scores 
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Table 5.0.1 indicates that participants have a good level of understanding of policy, 
regulations and standards, and will be more likely to impact positively on improving the 
previous model. While there are weaknesses indicated with some participants, there 
are others who have indicated a strong understanding, highlighted in yellow.  
The participants have generally scored themselves ‘satisfactory’ to ‘excellent’, 
indicating that they consider themselves to have a good understanding of the policy 
areas, standards and regulations, justifying their selection as participants. 
Semi-structured interviews 
From my experience, and after subsequently interviewing them, I understand that 
participants have an expert understanding of the regulatory requirements relating 
specifically to their field of practice. The executives at the Hospital were relying on 
lower-tier management to deliver the services in accordance with regulatory standards. 
The lower-tier managers were getting the policy signed off, but not ensuring complete 
understanding. 
P17 commented: ‘Policy tends to… when it comes up for 
revision,.. it varies, sometimes it’s yearly, sometimes it’s 
every two years, but it’s probably better to revise it yearly, 
because more recently we've had things like the CQC 
coming in, in October 2010, and then we've had, also in 
the last two years, we've had two changes of the 
standards for the NHSLA. There have been slight 
adjustments to standards, but also importantly, the criteria 
numbers have changed, I don't know why, why would they 
do that when they haven't even changed the content?... 
Everywhere I have ever worked or managed I've insisted 
that the staff in my department read and sign for the 
policy, which they have,.. (pause) I'll be honest, I've 
never tested them, but they've all signed written 
statements that they've read and understood them.’ 
(My emphasis in bold—JS) 
It cannot be assumed that all the required expertise exists within the Hospital, therefore 
having guidelines or best practice model to work from will allow the Hospital 
continuously to review and improve its medical devices management policy. Although it 
can be difficult to carry out policy research in a hospital, it can be seen from this case 













study that there are potential benefits from this research that can lead to improvements 
in both policy and practice.  
P7 commented: ‘The procurement is there to deliver the 
outcome, so, it is the outcome you want in terms of quality 
and training, and in order to do that it's best to standardise. 
You don't have to have a standard for procurement, 
because there are all sorts of other rules and regulations 
around procurement anyway. It's how can procurement 
deliver the outcome, but procurement isn't standardisation, 
that’s the will of the Trust. It's not just down to procurement.’ 
In my previous model, I discussed individual purchases. This new model discusses 
purchasing devices in a planned way by technology group. This is a major shift from 
my previous model. The procurement process was subsequently redesigned to enable 
the purchase of standard equipment types, by technology group for each clinical 










Figure 5-0-1: Technology group life cycle 
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As discussed in my findings later in this chapter, the resulting best practice model is 
much more heavily focused on procurement. Better practice in procurement will 
inevitably assist in improving practice in the use and maintenance of equipment.  
The Hospital governance team must ensure that policies comply with local rules and 
external regulations. The governance participant agreed that the recommendations 
made in collaboration with all other participants could be applied to the policy and put 
forward to the Risk Committee for approval. The only issue that came back was 
ensuring the format was in line with other policy documents and all relevant 
committees, such as the Medical Devices Committee and Staff-Side Committee. 
Having achieved an improved best practice policy, it was finally approved by the 
Hospital Risk Committee in May 2013, and it is now the responsibility of the 
participants and Hospital to implement the improvements across all stakeholder 
groups. 
An important benefit from this research was improving cross-profession 
communication, thereby using the specialist knowledge of professional practitioners 
within the organisation to improve policy. This ultimately leads to the improved practice 
through improved ownership of the policy.  
This case study started out with an analysis of the previous policy model being used at 
the Hospital, then by working with the participants we identified a number of areas that 
could be improved. However, all these areas rely on improved standardisation, which 
can only come about through tightening up the procurement processes. As a result of 
the study and collaboration with the participants, we redesigned and improved a large 
section of the policy specifically related to procurement. There were other minor 
changes that related to user training, maintenance and governance. The reason why 
procurement became the most important area of policy is explained in more detail in 
the final chapter.  
In summary, good procurement reduces the variety of equipment types, enabling user 
training to be more effective, maintenance to be more effective and economies of scale 
to be achieved, thereby reducing costs. Another added benefit of the changes to the 
policy was that risks associated with the use of equipment can be reduced, making it a 
safer environment for patients. There are strengths and weaknesses to being an 
insider–consultant–researcher. The way that each of these three roles impact on my 
thinking and that of the participants is discussed in later chapters. The AR methodology 
involves participants at the Hospital who are closely involved in the management and 
delivery of procurement, training, maintenance and governance. This cooperation and 
collaboration with the participants to research ways of positively improving policy 
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involved many meetings, e-mails, telephone calls, interviews—including the 
transcription and analysis of the data.  
I carried out a literature search to review what data has been published in relation to 
this issue, and also to review methods used for addressing these issues. This search 
included academic, government, regulatory and internal data specifically related to 
areas of the study.  
The overall outcome of the project has been the improvement to my best practice 
model by carrying out an in-depth case study working closely with the participants. I 
have designed an improved and approved best practice policy model (see Figure 5-0-
2), for medical devices management within a governance framework that meets the 
needs of the external regulators, and the management of the organisation. More 
specifically, it was discovered that the use, maintenance and governance of medical 
equipment were reliant on a central issue, namely procurement practice. Procurement 
conduct was redefined within the Hospital policy and, when fully implemented, will 
make training, maintenance and governance easier to achieve, thereby reducing risk 
and cost.  
Moreover, it is anticipated that the model could be used at similar healthcare 
organisations, ultimately leading to a contribution to knowledge and practice that 
assists in patient safety and meeting budgets.  
 Participants’ involvement assisted in improving the previous best 
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Figure 5-0-2: The approved best practice policy model 
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 Procurement conduct must be clearly laid out within policy to 
ensure standardisation 
 Standardisation improves patient safety and reduces cost 
Exposing to scrutiny my practice and that of the participants involved with medical 
device management has resulted in an improved device management policy that can 
be promoted as a best practice model.  
In March 2013 I presented a paper at a conference published in Clinical Services 
Journal as ‘Promoting Best Practice in Medical Devices Policy’ (see Appendix 7). The 
general consensus was that this is still an issue in other hospitals that must be 
communicated at the highest levels if progress is to be made. 
As the insider–consultant–researcher and policy author, I conclude that participatory 
AR is an ideal method for assisting in systematic and collaborative change to medical 
devices management policy throughout this case study. Active participation has 
allowed me to develop relationships with the participants and really understand their 
problems. Hence, I would argue that a consultant–researcher can be an asset to any 
organisation wanting to solve a specific issue, where the consultant can show a high 
degree of knowledge and experience. 
Communication and collaboration 
I constantly strive to generate debate with the participants by discussing medical 
device policy, including journal articles (Sandham, 2012) and feedback from 
conferences (Frampton, 2012) about how we deal with policy failure and ensure patient 
safety.  
One area that comes up regularly is poor communication, often voiced by participants 
as ‘working in silos’. ‘Silo mentality’ means that each department works to its own set 
of rules and processes, resulting in departments that do not properly communicate with 
one another, as illustrated in Figure 5.0.3. This represents the way that many of the 
participants also see their departments operating in the Hospital.  
Communicating the policy requirements is key to getting departments working together, 
and understanding their impact on other areas of policy. Conduct in practice guided by 
the policy is the ultimate goal, but to achieve this requires cooperation and involvement 
in implementation.  
  





























As can be seen in Appendix 10, one participant stated, ‘if you're not communicating it 
with people, it's not going to work’. The policy is not yet part of everyday practice, 
therefore hinders improvements in practice. Improved communication is helping to 
bring about changes to this mind-set. The participants indicated that cross-disciplinary 
teamwork needs to be improved to enable stakeholders to understand responsibility 
not just in regard to their own department, but to the Hospital and the patient. When it 
comes to medical device policy and implementation, this improved understanding 
already delivers new ideas to improve implementation policy that ultimately guides 
practice.  
An objective from this study was to aid communication across professional boundaries, 
and to consider whether devolved budgets impact negatively on procurement practice. 
Improving collaboration across departments can benefit the Hospital in terms of 
economies of scale and patient safety.  
During this case study, I have found that it can be difficult for participants to find time 
for meetings. This leads to communication problems with regard to the case study, and 
by speaking to the participants it was found to be not only a problem of communication 
for the case study but an endemic problem of practitioners not being able to attend 
meetings or even answer e-mails because of workload or staffing problems. 










Figure 5-0-4: Overlapping demands 
Communication is vital if staff are to be aware of requirements within the policy. 
Communicating changes to the policy is normally undertaken at committee level but in 
this case, because it was part of a case study, there was much more contact with those 
involved. They all expressed concern that documentation with regard to policy can be 
difficult to understand due to the terminology used, but also difficult to find the time to 
read because of the length of the policy document, approximately sixty pages.  
It is important to the participants that I find a way to communicate the policy in a user-
friendly way, preferably through a summarised document supported by a short face-to-
face explanation. This is achievable with 14 participants, but there are approximately 
2500 medical device users. All of these users must understand their responsibilities 
with regard to the policy. It was suggested by one of the participants that the only way 
to achieve this is by cascading that information and making the policies available in a 
short format on the Hospital intranet. Following on from my discussions with the 
participants I made the policy document available on the intranet. Another issue is that 
participants say there are insufficient computers for all staff to access policy and 
training materials online.  
As depicted in Figure 5.0.4: Overlapping demands, regulations, medical device policy, 
the Hospital and individual practice are interrelated. Changes in any of these four areas 
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The policy model with regard to procurement 
Each time a medical device is purchased, it starts off a chain reaction involving clinical, 
purchasing and maintenance staff, and governance. That is, as individuals, equipment 
users will know what medical device they want to use and will speak to their business 
manager telling them what to buy. The question asked of the participants was, ‘Is this 
right?’ Should any equipment user unilaterally decide what to buy, or should the 
organisation speak to all the users of that technology group and make a decision that 
involves all stakeholders, thereby allowing standardisation within that technology 
group, thus reducing variety, improving economic efficiency, and making user training 
more achievable?  
Unfortunately, participant discussions revealed that users put pressure on 
management to have the devices they want. Their arguments can seem plausible to 
non-clinical staff, and the managers are concerned that they may lose the services of 
that equipment user, which could impact on the Hospital’s ability to deliver services. 
Rather than upset the consultant/nurse, the business manager may purchase the 
equipment that they prefer. Sometimes it is important to challenge the assumption that 
consultants or other practitioners using medical equipment should be allowed their 
choice. A far better way would be to invite those consultants to form a procurement 
committee that decides what is best for the organisation, the patient and the equipment 
user. 
During my semi-structured interview with the procurement manager, I asked the 
question: 
JS: Could you explain your understanding of the medical devices 
policy? 
P7 answered: I refer back to it as and when I need to, I haven't read it from 
cover to cover. 
Although this participant is an expert on policy relating to their area of practice, the 
participant was unaware of other aspects within the policy that do not directly impact on 
his area of responsibility.  
While carrying out this semi-structured interview I was led to the realisation that there 
will be many participant experts with whom I needed to work at the Hospital. To write a 
best practice policy that could be delivered using a best practice management model, I 
needed to ensure that I knew which experts should participate in this case study, and in 
that way ensure that no gaps in knowledge in the medical device management policy.  
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Although I have many years of experience, it was important to assess the current policy 
situation with the participants to understand what the plan might be, in future. 
Throughout this case study, I have worked with the participants to improve my 
understanding of their specific issues and have come to realise more and more that the 
procurement of devices has a major impact on the ability to carry out training of the 
users and the maintenance team. It has also led me to the realisation that good 
procurement reduces the variety of devices.  
Figure 5.0.5: Weighting for levels of importance in my old policy model, is indicative of 
my thinking prior to this case study. The size of the circles can be considered as the 


















In the box below are some direct quotes from the semi-structured interviews with two of 
the participants, specifically related to the importance of procuring standard equipment.  
P5 : ‘They are impacting because it may be, there is a requirement 
to keep the user training, user training records, and maintenance of 
those, that's an added function, that needs to happen, and can't be 
avoided, so if you standardise what you've got, it impacts on 
the admin function, and the training problem, because everyone 





Figure 5-0-5: Weighting for levels of importance in my previous model 
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Hospital) now have control of equipment that is going out into the 
workplace, whereas before it was very possible to use year-end 
funds through a particular department who could buy and bypass 
us, or it didn't quite make it onto the training passports, but I think 
now that we've got standardised processes for procurement, all 
equipment now comes through us, we’re notified of everything 
through the Medical Devices Committee, so anything that is going to 
have an impact on policy is picked up at the MDC committee, 
including procurement. So, if they (The MDC) manage the 
procurement, even on quite small medical devices... (pause) but 
because of the make-up of the MDC committee, everybody that 
needs to be involved around policy, sees what the procurement 
process is as well, and everything that is out of the ordinary has to 
be justified when the equipment comes into the service, with regard 
where it is registered, so we know where it is, we know they've got 
something there, and the medical devices management team 
understand it’s there, so there's no reason that it doesn't go into the 
training programme, so… (pause) and I think that also, and seeing 
more and more now that we are demanding suppliers, that they 
provide training at the point-of-sale. Whereas (before the policy 
changes) equipment could land and then suddenly you've got to buy 
the training, and that includes maintenance training as well. You 
know, it (the policy) has an impact because people understand now 
it has got to meet the requirements for NHSLA and CQC and 
actually it needs to start from the very point that the equipment 
comes into service.’ 
P7: ‘the procurement is there to deliver the outcome, so, it is 
the outcome you want in terms of quality and training, and in 
order to do that it's best to standardise. You don't have to have a 
standard for procurement, because there are all sorts of other rules 
and regulations around procurement anyway. It's how 
procurement delivers the outcome, but procurement isn't 
standardisation, that is ‘the will of the Trust’. It's not just down to 
procurement and the Medical Devices Committee, because it 
supports us as well, people can't browbeat us, particularly junior 
staff saying I want this, I want that tomorrow, but if people know 
there's a process, then they need to know it can take a month or two 
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months sometimes. I don't think we get that so much now, as soon as 
we get the requisitions we log it on a spreadsheet, and they get a 
standard e-mail saying this will go to the next Medical Devices 
Committee for approval, before it can go forward, it says, thank you 
for your acquisition, the meeting for the next Medical Devices 
Committee is whenever, and your requisitions will go forward with a 
statement of need, with the cost of consumables, and the likely 
maintenance costs required, and we've got to get the cleaning 
instructions, so there's a really strong and detailed process in 
place, and that has been driven by the Medical Devices 
Committee and their scrutiny’. (My emphasis in bold—JS) 
 
This case study has shifted my thinking to a position where procurement conduct 
described within the policy, as illustrated in Figure 5-0-6, must be weighted far more 
















   
100 
Multiple budget lines 
As illustrated in Figure 5-0-7, there are approximately a hundred wards and 
departments with their own budget lines for equipment (this number can change due to 
ward closures). I found that the current state of device procurement does not easily 
allow for equipment standardisation that can reduce costs and risks. Users of 
equipment at the Hospital have a great degree of choice when buying devices. This 
would be understandable if they were buying something for their personal use, but 
when it comes to thousands of devices being used across the hundreds of departments 







Discussions with many of the participants revealed that there was a feeling that the 
Hospital had moved towards standardisation, because all purchase requests are 
analysed and authorised by the Medical Devices Committee to improve 
standardisation. It was also felt that the Hospital was developing a strategy for filtering 
purchase requests; the preferred future state for device procurement should be a 
planned process in accordance with World Health Organisation guidance. This would 
mean that all wards and departments would have their budgets removed and put into a 
central budget that the MDC could use in a planned way to buy devices strategically for 










MDC authorised to buy 
devices. MDC carries 
out strategic healthcare 
technology planning. 
Finance takes away 
ward/dept responsibility 
for buying devices. 
Devices purchased in a 
standardised way to reduce 
cost, reduce risk, and 
simplify management. 
Figure 5-0-7: Current state of device procurement 
Figure 5-0-8: Preferred future state of device procurement 
Purchase requests analysed 
and authorised by MDC to 
improve standardisation. 
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Figure 5-0-9: Funding for equipment procurement 
According to Participant 7, standardisation impacts on patient safety:  
P7  The reasons for these things (policy), as we describe it to our staff, it's 
the safety, you can't just have stuff coming in willy-nilly, you 
standardise it for a reason. (My emphasis in bold—JS) 
All the participants seemed to understand the importance of standardisation. The 
following question and answer is typical of the thinking coming from the Medical 
Devices Committee and all participants. 
JS:  So with regard to the operational needs of your service, do you 
feel that the CQC and NHSLA regulations impact on your 
service, the delivery of your service, or the way you perform your 
service? 
P5 answered: I think they are having a bigger impact now, I think they're 
starting to impact, improve my service. I think where that 
manifests itself really is through provision of equipment, 
standardisation of equipment, standardisation of practice, to 
drive best practice. 
Multiple sources of funding 
I found that as well as multiple budgets from wards and departments, there are multiple 
sources of funding for equipment including Capital and Revenue Hospital funds, and 
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It became clear that there is a need to look at the way equipment is bought from the 
Hospital’s budgets and to question why the budget holders at ward and department 
level have direct access to equipment purchasing. Why do these users (budget 
holders) continue to have such a variety of choice? This seems to be historic and part 
of the culture within many healthcare organisations. Another question that arose is why 
staff in the Hospital still have a high degree of choice when it comes to buying medical 
equipment. This level of choice ultimately leads to higher costs and higher risks. 
Consequently, there is a need to query whether the current practice is right, or whether 
procurement and finance systems need to be redesigned? If one started with a clean 
sheet, what could be achieved? This will be discussed in greater detail in later 
chapters.  
Buying in a safe and sustainable way 
In order to have a compliant section within the policy, and to ensure that the Hospital 
acquires equipment in a safe and sustainable way, I recruited a participant with expert 
knowledge in procurement practice to this case study. The participant agreed to take 
part because they understood the importance of device acquisition and procurement 
processes. We discussed the policy issues specific to their area of expertise. This was 
enlightening for me, as their expertise in the area of procurement far surpassed my 
own. For instance, many equipment issues are apparent before devices even arrive. I 
asked the question, ‘How does medical equipment get into our organisations?’  
The participant explained: 
P7:  We are the gatekeepers... we support the 
people for finding the products that best meet 
their requirements… we don't tell people 
what they can have, we are the support 
service, what we are good at is buying, we 
are not medical devices specialists. 
JS (Researcher):  I like your expression... ‘gatekeeper’ 
P7:  Yes, but there are other people along the line 
and I will give you an example of that, for 
example, theatres phoned EBME up and said 
can you come and check this equipment so 
we can put it into use? So they came over, 
and they said, okay, so what's the purchasing 
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number, and they [Theatres] said there isn't 
one, so they [EBME] said, don't touch it, and 
then obviously, when we started digging 
around, we had the equipment removed, and 
we were able to do that because we worked 
together because there were processes in 
place [policy], and we were the gatekeepers. 
JS (Researcher):  So what you're saying is that there are a 
team of gatekeepers. 
P7:   Yes I think there are… 
JS (Researcher):  So where do you fit within this team, are you 
the goalie? 
P7: (laughs) No, I think we’re the back four. No, 
everybody plays their part, because if EBME 
just checked it out and said ‘you can use It’, 
they [Theatres] would have gone ahead and 
used it, so in terms of bringing things in that 
don't actually cost anything [demonstration/ 
loaned equipment], we've worked up a 
process in conjunction with [Director 
responsible] that he had to sign off, and so if 
everybody uses that now, everybody knows 
there are questions to ask, because there is 
a process [Policy] to ensure that things don't 
slip through. Siemens and EBME would still 
be saying, ‘Do you have a loan form?’ Do the 
people know what questions to ask, or do 
they just blindly do what they want?  
 (My emphasis in bold—JS) 
The answers from this participant raised many interesting questions. Does the policy 
ensure that the equipment coming into the Hospital has been requested? Does it meet 
the needs of the organisation and the needs of the patient, and can those responsible 
for maintaining it access spare parts and training?  
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It was important to understand what other researchers were saying about multiple 
acquisition routes and variation. According to the World Health Organisation, variation 
leads to higher risk to the patient: 
Variation in medical devices between hospitals (and even within 
the same hospital) is one of the causes of these accidents. 
(World Health Organisation, 2010, p. 14) 
New technologies are entering medical practice at an 
astounding pace. This is motivated in part by patients who 
request (and increasingly expect) minimally invasive procedures 
that result in minimal damage to healthy tissue. The ‘side 
effects’ resulting from the introduction of new, often-complex 
technology in health care, however, can be considerable—both 
for patients and health professionals. This paper has shown the 
consequences of the increased complexity of technology used 
for the treatment of patients. Three facts emerged: 1) the 
devices are often not well designed for the medical environment 
in which they are used; 2) the user is often not trained properly 
to use these devices; and 3) the (new) procedures often result 
in long learning curves for health professionals. These three 
facts influence outcome of care. It has been shown that it is 
valuable to develop a standardised methodology for the 
evaluation of the quality of medical devices and the analysis of 
complications resulting from their (mis)use. This can be done by 
introducing various methods, such as a video monitoring 
system. It is better that new equipment and instrumentation not 
be introduced without a thorough evaluation of its functionality 
(Technical Evaluation), followed by monitoring its use in clinical 
practice (Health Technology Assessment). These evaluations 
can be facilitated by a biomedical engineer or similar health 
care professional. If the benefit of an instrument or device 
cannot be proven through these assessments, it should not be 
introduced. Standardisation of equipment can solve many user 
problems; indeed this measure has been used effectively by 
aviation and industry. Training and (continuing) education are 
important components of standardisation, to ensure safety. Any 
programmes standardising medical practices and the use of 
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medical devices could include training curricula, including 
credentialing methods for the post-training period (e.g. every 
half year). Implementing such measures as part of an overall 
programme of standardisation will help to reduce errors and 
improve care. (World Health Organisation, 2010, p. 16) 
Multiple routes of acquisition 
During my research I found that there are multiple sources of funding as illustrated in 
Figure 5-0-10, but there are also other routes by which devices ‘appear’ in the Hospital. 
These include donations from charities and personal donations from patients, as in 
Figure 33. It is not uncommon for charities and patients to buy equipment for wards 
and departments as gifts. This is well-meaning but not necessarily beneficial unless the 
equipment is introduced as part of a planned process following the conduct described 
in the Medical Devices Management policy.  
 
•League of Friends 
•Other charities Charity funds 
•Capital funds 
•Revenue funds NHS Funds 
•As part of a consumables deal 
•As part of a clinical trial Supplied free 
•Occasional use 
•Insufficient equipment available Rentals 
•Patient arrives with their own device Patient owned 
•Patient arrives in an ambulance with devices from 
another Trust Patient transfer 
Figure 5-0-10: Device acquisition routes into the Hospital 
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Improving acquisition 
I decided to delve much deeper into the procurement section of the policy, as it 
impacted directly on cost and patient safety. I held further discussions with other 
participants about acquisition of equipment and raised the issue at the Medical Devices 
Committee. 
As a direct result of the participant discussions, a working group was set up by 
Participant 7 that also involved stakeholders who would be impacted upon by the 
revisions to policy. This consultation also included the suppliers of medical equipment. 
This resulted in many amendments to the device procurement part of the policy, and 
eventually a complete revision of the procurement section of the policy. The purpose of 
the new section in the policy was to ensure that consideration was given to the need for 
new technology, while ensuring that the suppliers to the Hospital were not introducing 
equipment that staff were not trained on. The purpose of the amendments was to 
ensure sound and professional working relationships between the Hospital and its 
current or potential suppliers. The amendment was offered to provide information on 
the Hospital’s expectations of company representatives’ behaviour when approaching 
the Hospital. There was also a need to ensure that the Hospital's indemnity procedures 
were adhered to (the Hospital had a policy of not buying from suppliers who did not 
have professional and product indemnity insurance to a value of £5 million). 
As the medical devices management specialist, and as the person responsible for this 
case study, I needed to ensure that the medical device management group understood 
the importance of the acquisition of medical devices.  
With regard to procurement and acquisition of medical equipment, the MHRA say that 
policy should include the need to: 
 Establish advisory groups to ensure that the agreed acquisition requirement 
takes account of the needs and preferences of all interested parties, 
including those involved in the use, commissioning, decontamination, 
maintenance and decommissioning. 
 Ensure that the selection process takes account of local and national 
acquisition policies, e.g. whole life costs, the method of acquisition, and the 
agreed acquisition requirement. (MHRA, 2006, p. 13) 
After speaking with the procurement participant I was able to improve the wording 
within the policy that was specific to practitioner and supplier conduct relating to 
acquisition. Therefore, a major finding is the critical impact that procurement has on the 
ability of the Hospital and practitioners to abide by the policy (See Figure 5-0-11). The 
















participants and I now consider good procurement to be the primary policy area, with 
user training and maintenance being the secondary policy areas. The content and 
layout of the policy has now been changed by working with the participants to give a 















Figure 5-0-11: Good acquisition policy 
Major findings that result from this case study with regard to 
acquisition 
There are many different types of equipment in use within the Hospital, but many of 
these can be put into technology groups related to the clinical use of the equipment. 
For example, an electrocardiograph (ECG) is used for monitoring the activity of the 
heart and is one type of technology group. There are approximately a hundred ECG 
machines of different makes, models, and age in use, all fulfilling the same function. 
The Medical Devices Committee now filters all requisitions for new equipment in an 
attempt to standardise devices within technology groups, linking each technology group 
to a specific clinical practice. There are approximately 500 technology groups, and 
within each group the ages of devices can vary from less than a year old to more than 
ten years. This device age variance makes standardisation more difficult to achieve 
because replacing a group of technology requires more expenditure than replacing one 
device, although, if a group of devices were replaced, economies of scale could be 
realised and thus bring down the cost of each device. 
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The organisational policy model at the participating Hospital works most effectively 
when the procurement of medical devices is carefully considered and enshrined within 
policy.  
o The policy can only work effectively, with regard to training and 
maintenance, if the procurement of devices is clearly laid out, and 
applied across all professional groups to ensure standardisation, and 
technology is bought that meets the business need of the Hospital, the 
clinical needs of the patient, and can be easily used and maintained.  
o Procurement mechanisms must be a priority of the policy because 
correct use, maintenance, and governance are all reliant on the initial 
procurement being right. 
I found out that the acquisition model must be addressed to reduce the variety of 
equipment and reduce cost. This should also have an impact on patient safety.  
The policy model with regard to training 
The participants, especially doctors and nurses, felt that too much variety of devices 
introduces another problem into the Hospital, because practitioners move around within 
and outside the organisation. New staff join the Hospital, and the Hospital also uses 
agency staff. With a variety of devices and staff turnover it becomes difficult to have 
any degree of quality training on medical devices. Therefore, historically, users of the 
equipment at the Hospital tend to learn in a cascade fashion from other users. Many of 
the people who are cascading training are self-taught and therefore the competency of 
the user and the training is questionable. Indeed, the medical equipment training in the 
Hospital was found to be weak, and is now slowly improving.  
This is an excerpt from a semi-structured interview with one of the participants: 
Researcher:  Trying to ensure nurses are trained correctly and using the 
equipment correctly is my ultimate goal… 
Participant: To be honest, the evidence on how up-to-date their training is, I 
think is lacking. I'm not saying that they've not ever been trained 
on something but I do think that on high-risk devices, there is a 
lot of self-certification… 
The above excerpt indicates that one of the participants, who has a good 
understanding of what goes on at general ward level, is not convinced that staff are 
adequately trained on high-risk medical equipment. As part of the improvements to this 
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policy, it is important to understand why users are not trained on devices they use on 
patients, and why they are willing to use devices on patients when they are not trained, 
even though they are aware that they have not been formally trained. This can lead, 
and has led, to serious incidents within the Hospital.  
To better understand the issues around training users on medical equipment, I had to 
speak to the users to obtain their perspectives and understand their views. This 
confirmed the importance of the selection of participants, to ensure that some were 
users of medical equipment and responsible for training users, or for the management 
of users of medical equipment. 
Self-certification and funding issues 
There are thousands of devices being used in the Hospital and, according to the 
participants, it is therefore difficult to carry out adequate training across all professional 
groups on all devices. This necessarily leads to self-taught, self-certified users. Even if 
the procurement of devices were perfect, the participants believe it would still be 
difficult to carry out training across all device groups because there is insufficient 
funding for training. The participants have also stated that it is difficult to release staff 
because of staff shortages and difficulties in recruiting staff. Therefore, the only way to 
improve training is to find more money to recruit more staff, thereby enabling staff to be 
released from their primary duties to be adequately trained to use the devices required 
for their particular practice.  
When it comes to enshrining training within policy, the participants were reticent to 
make competency-based device training compulsory, except on the highest risk 
devices. This is a common-sense approach, allowing staff to choose which devices that 
they feel safe and competent to use. This improvement has been made to the new 
ratified policy (in May 2013), identifying which devices are highest risk and most likely 
to cause harm if misused. This allows the Hospital to identify the highest risk devices 
and focus training on those types of devices, thereby implementing an improved 
strategy within the policy that develops a lower risk approach to device use.  
The impact of procurement on training 
As the policy has been changed to make procurement much tighter, the variety of 
technology will inevitably reduce over time as standardisation improves, and subject to 
the conduct of the policy actually guiding practice, which requires ongoing 
implementation of the changes. The average device life is seven to ten years, therefore 
it is likely to take this long to standardise all devices across all clinical disciplines, as it 
would be far too expensive to replace all devices within each technology group at once. 
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With improved procurement policy, there will be savings due to standardisation and 
economies of scale, and the management of the Hospital will have to make a decision 
whether to invest those savings in taking on more staff and paying for additional 
training, or whether to take those savings and use them to cut budgets. In the current 
financial climate, this will be a difficult decision for the Hospital executive. Doctor and 
nurse participants in this study all stated that some parts of the policy needed to allow 
flexibility in the decision-making process of whether they should or should not receive 
competency-based training. 
However, it is clear that lack of training is considered a high risk by government, and as 
a result of this it has introduced the regulations previously discussed. The World Health 
Organisation recognises the benefits of medical equipment in its paper, ‘Increasing 
complexity of medical technology and consequences for training’, but also points out 
the risk of underestimating the importance of training: 
The influence of the operator on the effective and safe application of medical 
technology is generally underestimated. In an investigation on incidents 
involving defibrillators in the US (2), it was concluded that the majority of the 
incidents were due to incorrect operation and maintenance. A study of 2000 
adverse incidents in operating theatres in Australia showed that only 9% were 
due to pure equipment failure (9). In two reports on the use of critical care 
equipment by nursing staff, 19% (10) and 12.3% (11) of nurses, respectively, 
indicated that they had used equipment improperly, which had consequently 
harmed a patient. (World Health Organisation, 2010, p. 5) 
Enabling effective training to take place requires changes to policy to ensure all 
purchasing of medical equipment is done in such a way as to include the users, but 
reduce variety. The reduction of the variety of devices within technology groups will 
lead to reduced costs, reduced risks and greater ease of training and maintenance. 
In December 2012 I presented the updated draft policy to the Medical Devices 
Committee. Although the statement below states that the policy will go to the 
Governance and Safety Committee for final sign off in December 2012, this did not 
happen at that time. Participant 11 is a member of the Governance and Safety 
Committee and has been involved throughout the case study. Even so, this participant 
came back to me and requested further changes, because the group wanted to ensure 
that the external NHSLA auditors would see the policy in the NHSLA expected format. 
The actual organisational sign-off was delayed by five months to May 2013 because of 
these amendments, as seen in the minutes of the December 2012 Medical Devices 
Committee: 
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7.1: JS presented the updated Medical Device Policy which has been amended 
to take into account feedback from the NHSLA pre-meeting and the agreement 
with the Medical Director to allow doctors to self-certify. It was agreed to allow 
committee members one further week to comment on the changes and any 
comments to be circulated to P9. Once completed, the Policy will go to the 
Governance and Safety Committee for final sign-off.  
The participants all agreed that these key operational issues can change over time. The 
participants have said training is made more difficult if there is a lack of standardisation. 
This increases the potential risk for staff to use equipment incorrectly, because they 
may not have been satisfactorily trained. It can also increase costs.  
The policy model with regard to maintenance 
One of the participants explained the impact on the maintenance department of 
medical equipment users who were not correctly trained. He explained the interaction 
between medical equipment users and medical equipment maintainers, implying that 
because staff have no mandatory training on medical equipment, practitioners 
maintaining the equipment are called out unnecessarily. This wastes their time, but 
also means equipment is unavailable for clinical care. It is interesting that this 
participant sees that the main impact of the policy is on maintenance calls, where 
equipment has ‘appeared to fail’. Each participant will have their own ‘take’ on what is 
most important. If nurses are properly trained to use the equipment, it will mean less 
work for his department. 
Participant 5 commented on the impact of training on maintenance: ‘It's 
quite an interesting probe, because as a maintenance department we 
generally get involved in equipment when it doesn't work, we deal with 
the preventative maintenance, and we deal with accepting equipment 
in, and disposing of equipment out of the system. Actually, the 
interaction with the staff happens when the equipment fails. Generally 
the equipment will fail for a number of reasons, it can fail because it 
has a catastrophic failure, it can fail because it has an issue with its 
peripherals, so, a cuff off a BP monitor, or something like that, it can 
fail, or it can appear to fail, because of something like that, and that's 
where the medical devices policy, maybe, can make the biggest 
impact, because I'm intrigued, in that, we put training requirements ‘in’ 
for equipment, but there is a very strange take on what mandatory 
training is in the NHS. Mandatory training, as I understand it, is only 
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The impact of training on maintenance 
If nurses were properly trained, and they cascade that training to their colleagues, there 
could be a benefit to the maintenance team. Moreover, there is an additional benefit 
that the knowledge gained by the participants can be cascaded to the different teams 
involved with different facets of medical devices management policy around the 
organisation, thereby improving practice amongst other stakeholders involved in 
medical devices management and policy.  
Hence, a major finding was that maintenance of devices is impacted upon by poor 
training, and training is impacted upon by increased variety. The maintenance 
participants involved explained the importance of standardisation to them as being a 
way for the technicians to gain more experience in repairing and maintaining devices. 
The maintenance manager participating in the study also explained that, if nurses and 
doctors are not trained on devices, this results in many reported faults that are 
subsequently proven to be user error. This wastes the time of the maintenance team, 
but also means diagnostic and therapeutic equipment is not applied to the patient when 
it should have been and in the right way. This can lead to incidents ultimately involving 
harm to patients. Another impact of poor procurement is that devices can turn up that 
the maintenance team have no technical training in, no technical manual and no spare 
parts. This can also result in long delays repairing equipment when it breaks down and 
additional costs, either because the maintenance manager must buy additional spare 
parts or because the maintenance manager has to call in the original equipment 
manufacturer or send the equipment away for repair. 
From March 2012 Medical Devices Committee minutes: 
4.2 Maintenance Management of Loan Equipment: 
Participant 7 stressed that a Policy must be put in place for 
the maintenance of loan equipment and that this should be 
mirrored across both sites. [MDC Stakeholder] advised 
that he would speak with [non-MDC stakeholder].  
concerned with an item that every single person will use, but it could be 
every single piece of equipment that a midwife might use, or every 
single piece of equipment that a group might use, and I wonder 
whether making equipment part of mandatory training will help?’ (My 
emphasis in bold—JS) 
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The policy model with regard to management and governance  
The executive management team has a corporate governance responsibility for every 
policy within the organisation and a team of corporate management (governance) 
experts who assist members to ensure that policies are applied across the 
organisation. The participants involved in the governance of devices are responsible for 
monitoring and assisting with regulatory compliance and have an expectation that all 
practitioners who buy, use, or maintaining devices do so in accordance with the 
Hospital policy, and in accordance with the regulatory requirements.  
The governance participant explained that the regulators have specific requirements 
and, as the governance team, it is their job to ensure that the policy meets all of their 
requirements. Sitting down with the governance participant and writing a policy that 
meets the requirements of the regulators is quite prescriptive, because all policies must 
follow a specific governance format. The difficulty with policy is ensuring it is written in 
such a way that it not only meets the requirements of the governance lead for that 
policy, but it is realistic for the procurement team, the maintenance team and the users 
of the devices. All of the participants understood the importance of ensuring the policy 
meets the requirements of the regulators, but achieving full compliance with every 
aspect of the policy is extremely difficult unless concessions are made to allow an 
acceptable element of risk.  
Hospital culture towards compliance 
There is a culture within the Hospital of sometimes waiting until an inspection is 
announced for the management team gradually to escalate pressure upon operational 
staff to try to achieve compliance by the time the auditors arrive. This only works if it is 
known when the auditors are coming and you have the resources to ramp up the 
operational activity.  
Even then, the Hospital is not certain to deliver compliance. One of the participants 
described this process: 
Participant 15 commented: ‘What happens with most policies 
is, they go through the long route, they get approved, that ticks 
the box, and that's the end of it. Then when we get inspected, 
by the CQC or NHSLA, they will ask for the policy, and we will 
show it to them and try to demonstrate compliance.’ 
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It would be far better to have a policy and a best practice model that kept the policy 
operational and compliant at all times. Even within the last six months there is still a 
perception by most of the research participants that other ‘non-participant’ stakeholders 
from within the organisation do not own the policy in the same way that they 
themselves do. For example, the following statements are taken from participants 
during the semi-structured interviews: 
Participant 15 commented: ’The problem is top-down, 
senior managers need to take ownership’. 
‘without ownership we ain't going anywhere! I know, like, I'll 
get problems with cleaning, and medical equipment is not 
down for us to clean.’ (My emphasis in bold—JS) 
This leads me to observe that participants are far more willing to immerse themselves 
in policy development as part of a team effort to improve. I believe that the attitudes to 
the new policy model have improved, especially with regard to the participants 
involved. It is now important to cascade this new model across the organisation, 
involving all stakeholders. 
Management and practitioner responsibility 
Management responsibility, especially ownership of ensuring compliance with the 
policy, involved considerable finger-pointing at other managers and professional 
practitioners for not ‘doing their bit’.  
Participant 5 commented: ‘What do they need, what do I need 
to do, if I need a bed from the ward, I need to take that bed 
make sure it's un-plugged, clean it. If I don't do it, the impact is 
on patient safety. There needs to be a lead back to say “it's in 
the policy”. We do it this way because… If they can't explain 
why they're doing it, they're probably going wrong and not in 
accordance with the policy, I think that transposes everywhere 
so it's almost like this [The director responsible] leads on 
ownership of the policy, quite right, but I think the 
departmental managers need ownership of their elements, 
I really do, I think I should be able to have a reasoned 
discussion with a matron about why I don't want dirty equipment 
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turning up in my department and it shouldn't be a squawking 
rage, it should be a reasoned adult discussion about, “no I don't 
want it because actually you're not complying with the policy”, 
so there you go. And that's what we're trying to promote good 
practice with the incident reports, but unless they have an 
understanding…’ (My emphasis in bold—JS) 
The participants agreed that weak management and lack of ownership were 
considered to be contributory factors in non-compliance with policies and regulations.  
The policy model with regard to senior management 
There were preconceived ideas from the senior management team about the objective 
of this case study being to enhance managerial control.  
Some of the senior management felt threatened by the project because it exposed 
weaknesses within their area of responsibility, and at the start of the project this 
required sensitive handling and reassurance for the managers involved. When working 
with one particular manager who had concerns about the validity and need for the 
project, I was able to convince her that there would be eventual benefits from of the 
project, and even if they, or other managers, were found to have weaknesses, the fact 
that they recognised those weaknesses and were willing to work to improve their 
processes and remove those weaknesses was empowering for them and for their 
teams.  
There were also some sensitivities around my motives for carrying out this case study, 
especially with regards to my commercial interests. It should be clear to the participants 
that this research would benefit the policy of the organisation, and ultimately the 
practice of the organisation, but in doing so it will inevitably benefit my business. This is 
a consideration, but I can clearly explain that although there may be a benefit to my 
business, the outcome of the research will also benefit the Hospital, staff, and patients, 
through improvement in the model for device management policy and implementation. 
Participant 15 commented: ‘He knows he's responsible [for the 
policy], but he doesn't do anything with it. It's the same with every 
policy, he don't really do anything, only when something happens, 
then he’ll want to know more.’ 
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Participants becoming allies 
As the case study, now focused on medical devices management policy, gained 
momentum it led to other stakeholders wanting to become more involved and have a 
better understanding about the project. It was clear to me that the participants, once 
recruited, became strong allies because it was in their interests and would impact on 
their reputation once the project was successful. It would also not look good for those 
participants if the project was unsuccessful, and therefore they acted as advocates for 
the case study. Having these participants as allies was extremely important in gaining 
organisational approval through all the management committees, as many of the 
participants sit on these various committees. 
Participant 17 commented: ‘Firstly one of the problems is that 
Trusts have too many policies and a lot of them policies are 
40, 50, 60 pages, the medical devices policy is, I've seen 
them 50 to 60 pages, and ten pages of that is about 
procurement and standing financial instructions, and to be 
honest they’re boring, and I don't know how to make 
people read it. One thing that we have toyed with 
previously, is that we've extracted the best bits, the most 
important bits out of the policy, so rather than the regulation 
bits which do bore people, we've extracted out of the policy 
the operational parts that people need to do is, what do I do if 
it breaks? What do I do if I need a new one? What do I do if 
it's at the end of its life?, and I try to summarise that in a 
practical way, which is maybe four pages, with what do I do 
if…, First not dealing with the regulations side of things, what 
do I do with using the equipment, or if it fails, etc. Maybe that 
is the best way, to summarise the policy, which is 40 to 50 
pages, how you focus on the regulation aspects of it, is a 
difficult one, but I don't know if people need to know Outcome 
11 Regulation 16, they just need to know, it’s law.’ (My 
emphasis in bold—JS) 
This case study has allowed me to carry out an in-depth research project to understand 
the professional practice difficulties that impact on the creation of policy, the 
implementation of policy, and the subsequent ongoing management and governance of 
all the professional practice areas that are encapsulated within the policy. There are 
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experts within the organisation with the knowledge for each of the core activities 
described within the policy. It must be the responsibility of the researcher to find out 
who those individuals are with the expertise that can be tapped into to ensure that the 
policy meets the needs of the organisation and is in line with the organisational culture, 
and that the researcher also has the buy-in of the participants involved. It is also 
important to understand whether the participants have the knowledge and skills that the 
researcher is reliant upon to deliver an improved policy, and an improved best practice 
model that meets the goals described in Chapter 2. When speaking to the participants, 
policy is described in many ways, but the majority recognise that it is a management 
tool for governing a specific area of management within the Hospital. It is the 
authoritative document that managers can use as a guideline for practice, as a 
disciplinary tool and also as a reference for decision-making. 
Management expectations 
Although agendas may vary between the executive management, the operational 
management, and the operational practitioners such as doctors and nurses, it is 
important for the researcher to work with all these groups to ensure there is a common 
goal. In the following quote from a participant during their semi-structured interview, 
after discussing the impact of regulations this participant implies that new regulations 
add new functionality to policy that can be used to impact on procurement and training 
practice: 
Participant 5 commented: ‘They [regulations] are 
impacting because it may be… there is a requirement to 
keep the user training, user training records, and 
maintenance of those, that's an added function, that 
needs to happen, and can't be avoided, so if you 
standardise what you've got it impacts on the admin 
function, and the training problem, because everyone is 
using standardised equipment. The other issue is that we 
now have control of equipment that is going out into the 
workplace, whereas before it was very possible to use 
year-end funds through a particular department who 
could buy and bypass us, or it didn't quite make it onto 
the training passports, but I think now that we've got 
standardised processes for procurement, all equipment 
now comes through us. We’re notified of everything 
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through the Medical Devices Committee, so anything that 
is going to have an impact on policy is picked up at the 
MDC committee, including procurement. So... they minute 
methodology for procurement, even on quite small 
medical devices, but because of the make-up of the MDC 
committee, everybody that needs to be involved around 
policy, sees what the procurement process is as well, and 
everything that is out of the ordinary has to be 
justified when the equipment comes into the service, with 
regard to where it is registered, so we know where it is, we 
know they've got something there, and the medical 
devices management team understand it’s there, so 
there's no reason that it doesn't go into the training 
programme, so,.. and I think also that and seeing more 
and more now that we are demanding suppliers, that they 
provide training at the point-of-sale. Whereas, equipment 
could land and then suddenly you've got to buy the 
training, and that includes maintenance training as well. 
You know, it has an impact because people 
understand now it has got to meet the requirements 
for NHSLA and CQC and actually it needs to start from 
the very point that the equipment comes into service.’ 
(My emphasis in bold—JS) 
Convergent interests—Patient safety and operating within defined 
budgets 
The interests of the management and the operational practitioners converge on the 
patient in this instance. All the stakeholders and participants have a central focus: the 
patient. Although there are many other factors that come into play such as budgetary 
pressures, training, maintenance, and governance, which are all needed to ensure the 
organisation meets the regulations, even in these areas there is a convergence 
towards that central goal. The doctors and nurses want equipment that is safe to use 
and has been maintained. Management wants doctors and nurses to use equipment 
safely, and to be trained to use it safely. The finance team wants the doctors and 
nurses, and management, to have everything they want, but within a defined budget.  
The Hospital must establish corporate objectives with regard to the regulatory 
standards and internal business needs before it can redesign policy. A policy 
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improvement research project must indicate to all the participants exactly what the 
organisation will and will not do in pursuance of its overall purpose and objectives. This 
policy project must reflect the organisation's culture and belief systems, while 
incorporating external demands from regulators. The findings coming from this case 
study closely relate to the findings from the World Health Organisation in Appendix 11.  
It is apparent from meetings with the participants that, although the Hospital has a 
policy considered compliant, there are still difficulties when it comes to implementation. 
I found that these difficulties can be triggered externally and internally. Triggers that 
impact on policy may also impact on patient care. If the Hospital budget is cut, the 
temptation might be to buy cheaper equipment, but the long-term impact could be 
worse clinical outcomes or higher expense due to poor reliability. 
In Appendix 12, Medical Equipment in the News, it can be seen that risk associated 
with medical devices is a nationwide concern, and therefore this case study will have a 
wide impact on healthcare organisations. There are two core concerns in medical 
device management policy that lead to non-compliance, firstly training in the safe use 
of medical devices, and secondly maintaining and calibrating devices. This is a serious 
issue, as can be seen from the numerous negative news stories, and many NHS 
organisations are increasingly finding it difficult to manage medical devices. As the 
Health Select Committee points out, there is evidence from case note reviews that 10 
per cent of patients admitted to Hospital suffer some form of avoidable harm. 
According to the Health Select Committee (2009): 
The evidence, particularly from case note reviews both in England and 
internationally, indicates that the extent of medical harm is substantial, even on 
a conservative estimate, and that much is avoidable. International studies 
suggest that about 10% of all patients who are admitted to hospital suffer some 
form of harm. Judging how far patient safety policy has been successful 
requires more reliable data regarding how much harm is done to patients. 
Unfortunately, neither the NPSA nor the DH was able to provide us with that. 
Government estimates of avoidable harm and the attendant financial costs are 
extrapolations from old, very limited, data; and no attempt has been made to 
produce reliable up-to-date figures. (Health Select Committee, 2009)  
Improving the understanding and expertise of participants 
In medical devices management it is often commented my professional peers that 
fellow practitioners involved with the implementation of policy do not sufficiently 
understand the regulatory standards that impact on their practice.  
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During this case study, I have worked with participants from varying professional 
groups. I have recognised the importance of working with these practitioners to 
improve my previous model by accessing their knowledge of the issues to improve 
practice linked to policy. My work with these participants has also improved their 
knowledge of the issues, and allowed them to become part of the solution. This has 
resulted in an improvement to my previous model through collaborative processes, and 
the use of participatory AR methods.  
Through attending meetings with the Medical Devices Committee, and also 
interviewing active participants, I have come to recognise that writing policy is of little 
value unless the policy is actively implemented and managed. Many of the participants 
had not read the medical devices management policy until they became part of this 
project. This in itself was an issue, because the policy is meant to be followed to 
ensure expediency in the specific activities detailed within the document.  
The medical device management policy defines a course of action agreed by the 
Medical Devices Committee participants, signed off by other executive committees. 
The importance of this policy cannot be overstated, as it is directly linked to regulatory 
standards that must be adhered to. 
To ensure actions are in line with policy, practitioners responsible for adherence to the 
policy must understand what their course of action should be in relation to their 
professional practice. From working with the participant practitioners during this case 
study research project, I have learnt that they all felt that the medical devices 
management policy was too long, difficult to understand, and with too many policies to 
make it realistic to really find a way to read and understand the parts of the policies 
impacting on their own professional practice. 
Participant 16: ‘One of the problems is that the Trust has 
too many policies and a lot of them policies are 40, 50, 60 
pages.’ 
In reality, I found that I was needed to translate the policy and explain the requirements 
impacting on that particular participant and directly related to their own needs. All the 
participants had a common complaint about my policy relating to the number of pages 
and the complexity involved. 
Participant 6 commented: ‘Policies are all right, but policies 
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are pages and pages long, and not what they need to know’. 
All the participants had their own professional knowledge and expertise that they used 
in their day-to-day practice. The policy itself does not stop them from being able to 
practice, and therefore holds less importance for them. For example, doctors can move 
from organisation to organisation and still be able to practise, based on their 
professional knowledge and previous experience. In each organisation they work in, 
the policies are written in different ways and are generally ignored. It is only in the 
event of something going wrong that a doctor may refer to policy. As Participant 5 
states below, practitioners rely on prior knowledge, whether right or wrong, because it 
does not stop them from doing their job. 
Participant 5 commented: ‘There is an element though, of real-
time planning, so you've got to, you've got to go on prior 
knowledge, of policy, you could go on prior knowledge of site, 
if there was anything in there that was particularly contentious 
I would have talked to you. A lot of it, because our systems are 
developing on site, we are changing systems around slightly, 
and fudging things, and moving things, fudging things is the 
wrong word, our systems, although they are robust, they are 
not mature yet, so the policy has to develop with the systems, 
so I was happy to take on the policy that you had written, have 
a look at it and see if there was anything contentious in there, 
and know that through the MDC I had somewhere where I 
could affect a change to the policy, so it seems silly to get too 
much involved at the beginning, because I’ve taken over a 
service where a policy had been developed anyway, and as I 
develop the policy, I can let the MDC know, policy should 
guide what I do, but should not stop me doing what I do, 
as long as I'm correct.’ (My emphasis in bold—JS) 
This statement from Participant 5, who had only been in post for approximately nine 
months, starts from the point of view of using prior knowledge from his previous jobs. 
He feels that there is no need to get too involved at the start, and states that if there 
was anything contentious he would speak to me. He goes on to say that policy should 
guide him, but not stop him doing his job, so long as he is correct. Within this 
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statement, he contradicts himself slightly, because at the start he states that he has to 
go on prior knowledge, and at the end he states that policy should guide what he does. 
This indicates that there is a breakdown in communication between the organisation 
and the practitioner. The Hospital has a responsibility to ensure that anyone buying, 
using, or maintaining a device does so in accordance with the policy. During the 
research phase of this project, I have interviewed 14 participants across different 
professional groups to find out how much they know about medical devices policy. In 
most instances, they had some knowledge of the policy, because I have been working 
in the Hospital for the last five years and have been constantly promoting good practice 
in medical device management across all professional groups. This did not mean that 
they had read the policy; quite the opposite, they had relied on me to translate the 
policy and assist them in understanding it, and how it impacted on them and their 
professional colleagues. 
Over the past five years I have written four versions of the medical device management 
policy for the Hospital. Every time I have written this policy I have sent it out to key 
stakeholders around the Hospital for comment. Even when I e-mailed this policy 
directly to people, they admitted that they still did not read it, either because they did 
not have the time or they entrusted the policy to me. 
Participant 14 commented: ‘There are so many policies, 
most people are busy, and they’re never going to go through 
every policy. Even if you read it, you may think, do I ever get 
any further with this?’ 
There was a definite gap in their knowledge with regard to the policy. The participants 
did not see the policy as a document that gave them a course of action. They only saw 
the policy as a bureaucratic need because the organisation must adhere to regulatory 
standards. 
Managers must take more responsibility for policy implementation if it is to be widely 
accepted by the Hospital. Over-reliance on specialists such as myself will lead to 
further risks within the Hospital. These risks could be financial, reputational or practice 
related. 
When I spoke to the participants about gaps in their knowledge with regard to medical 
devices policy they did not really seem concerned, because they were still able to 
practise by virtue of their knowledge and skills acquired as a result of academic studies 
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and experience. Interestingly, even though all these professional practitioners were not 
fully aware of the requirements of the policy, this did not affect the running of the 
business of the Hospital. Even when interviewing the Board level participants it was 
apparent that, for them, the importance of this policy was low and the level of 
knowledge of this policy was low. After discussing the policy with Participant 15 (a 
senior director), the level of knowledge was improved and the importance of the policy 
to risk and cost within the organisation was raised, giving Participant 15 a different 
perspective and more interest in the policy. 
What has emerged from speaking to all the participants is a lack of in-depth knowledge 
and a lack of understanding of the impact of what ’not having this knowledge’ has on 
the organisation, on the patient and on them as a professional practitioner, should they 
do something against the guidelines of the policy. 
Once they understand the risks to patients, to costs and to themselves, they are far 
more interested in using the policy as a guideline on how to conduct specific activities. 
They then understand that this makes practice safer and cheaper, and in line with 
regulatory standards. 
Participant 7: ‘You do have to have policies, because you 
can't rely on everybody to be an expert, or be operating best 
practice, so the organisation must set the standards. They 
need to make sure that they’re being adhered to, I think 
more problems occur when we don't have a policy to refer to 
(especially when different people have different approaches, 
policy aligns culture and practice).’ 
One of the issues that has arisen from this case study is an over-reliance on myself as 
the insider–consultant to manage all aspects of the policy. As a specialist consultant, I 
was originally brought in to author and implement the device management policy. As a 
researcher, I needed to involve those responsible for specific aspects of policy. 
Ownership of those responsibilities has come up during the participant interviews, and I 
believe that through this process ownership has been improving yet still has a long way 
to go. I now believe that the responsibilities of managers with regard to understanding 
and implementing policy cannot be set aside by them because they believe that there 
is a specialist consultant employed by the Hospital to do that job. It is extremely 
important that they all understand their specific responsibilities with regard to the policy 
to enable the organisation to adhere to the requirements of the policy to ultimately 
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benefit the organisation, the practitioners, and the patients. I have also discovered the 
benefits of a collaborative research approach in changing my perspective and 
approach to listen more and learn from ‘insider–experts’. 
The importance of medical devices management policy 
The importance of medical devices management policy cannot be understated. Even 
since starting on this DProf journey, I have investigated incidents where patients have 
been harmed or died while connected to medical devices. All of these incidents could 
have been avoided if the professional practitioners involved had been fully aware of 
their responsibilities, and had operated in accordance with the definite course of action 
described in the medical device management policy. These actions in the policy are a 
legal requirement, and yet all participants were not fully engaged and did not fully 
appreciate the importance of applying the policy to their practice. 
It is important to me that this research project delivers a best practice model for 
delivery of medical devices management policy. I feel concerned that many 
organisations may be in the same position as this Hospital, and it is therefore 
imperative that I complete this project in a way that can be easily understood, 
impacting on best practice in this Hospital and setting an example to other hospitals. 
As a specialist in device management policy and practice, my insights into the 
problems faced help the design, implementation and analysis of this medical device 
management policy case study. Robson discusses practitioner–researchers and 
suggests that extending their abilities by allowing them time to carry out insider–
research is a worthwhile enterprise. Most busy professionals do not have the time to 
carry out an in-depth research project. If the insider–researcher carries out a research 
project within their own workplace it requires less time commitment, therefore is an 
economical approach to enquiry: 
If the extended professional is a better professional, then the time should be 
found for this extension to take place. Alternatively, the time commitment 
needed to carry out worthwhile studies could be decreased, that is, we look for 
an economical approach to enquiry, such that it is feasible at the same time as 
managing a substantial practitioner workload. (Robson, 2002, p. 536) 
Allowing time for the study 
It is important not to underestimate how much time is required to carry out a project of 
this nature. Although the project is a work-based and will lead to work-based learning, 
this does not mean that the research project can be completed only within work hours. 
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For this project, the time commitment must take into account the weekends, evenings 
and even holidays. In breaking down the allocation of time, it is important to ensure that 
every participant has time to meet the researcher.  
Focus and motivation for the study 
The focus of this study is important to me because I can see at first-hand, as an insider 
in the Hospital, the risk associated with poor policy and its impact on practice, and 
ultimately on patients. This has been the main motivating factor for this case study. 
Having investigated many incidents involving harm to, and the death of patients, I was 
intent on producing a piece of work that was research-based and acceptable from an 
academic standpoint. Having reached this point, I can now use this piece of work to 
create political debate in the hope that policy, and implementation of policy that can 
benefit patients, and ultimately also Hospital practice, reputation and finances. 
The importance of my relationships with participants 
Many pertinent issues came up during this research, and because I had been working 
in the organisation for five years my relationship with the participants was based on 
mutual trust, reputation and respect. This trust was very important and I believe these 
personal relationships gave me a better insight into their problems, and gave them a 
better insight into my problems, allowing us to come up with solutions that helped us 
both.  
The participants were willing to admit problems and always had reasons that enabled 
us to consider solutions. As a result of this research, my knowledge and understanding 
has improved in terms of both the organisational and the practitioner requirements, 
leading to an overall improvement in my knowledge and a broadening of my impact on 
the organisation through the participants involved.  
It is not only important to explain and make issues visible within the organisation, but to 
ensure that those who must act upon those issues have the knowledge and ability to 
do so. For example, where issues are identified through changes in regulations, it is not 
sufficient to update the policy because, as my research shows, most practitioners do 
not necessarily read or understand policies. It is therefore important to ensure that the 
expert has a way of imparting their knowledge of the policy to the practitioners who are 
expected to work in accordance with those specific activities described in the policy. 
Systems must be in place to ensure that practitioners are able to amend their practice 
in accordance with changes in policy. If systems are not put in place, staff will become 
entrenched in practice based purely on their own knowledge and skills, and if those 
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knowledge and skills are subsequently found to be inadequate, as a result of the 
organisation not adhering to its own policy, the organisation is as much at fault as the 
practitioner for not providing suitable support. 
This project has enabled me to develop a deeper level of understanding of the 
problems facing the Hospital, and also to understand the benefits from the solutions 
that are the reasons for this case study and this doctoral programme. This improved 
medical device management policy and practice model is the natural culmination of 
many years of work. In concluding this study, I have placed an emphasis on 
procurement and acquisition because, as one of the participants stated, ‘the 
procurement team [members] are the gatekeepers of the policy’.  
The acquisition of the equipment has become the main area of change within the policy 
as a direct result of this research. The participants agreed that to ensure users have 
the right equipment, and that they can use it safely; this must be a process that starts 
long before the equipment arrives on the ward. The business need must be identified 
and the funding must be agreed. The governance should be evaluated, not just for the 
requesting ward or department but against organisational need, thus enabling 
standardisation. The participants were in agreement that standardisation is a vital 
component that helps to make training easier, maintenance easier, governance easier, 
reduces the investment required in the medical technology, and ultimately improves 
patient safety and care. 
I have recommended significant changes to the new Hospital policy from the original 
policy model. It places much greater focus on procurement (see Figure 5-0-12) to 
deliver economies of scale, patient safety, improved skills and compliance with 
regulations. This is especially with regard to creating a medical devices replacement 
plan and procuring devices by technology group, rather than by individual devices.  
This is the significant improvement that can deliver real and lasting benefits, but is 
likely to take many years to achieve because most devices last up to ten years, and it 
would not be economically or operationally viable to replace them over a shorter period 
of time. 
There were five revisions made to the policy from June 2006 to May 2012. In contrast, 
as a direct result of the case study, there were six revisions made to the policy from 
June 2012 to December 2012, with the most significant impact being on the tightening 
up of procurement mechanisms. The six revisions to the policy resulting from this 
project can be seen in Appendix 5, Title page of medical devices management policy. 




Figure 5-0-12: The impact of improved procurement policy 
 
Improvements to the policy model  
The findings of this case study clearly define the risks associated with medical device 
management. I now understand that these risks can be described in order of priority as: 
procurement, training, maintenance and governance. These findings were supported 
by the literature from various government and research organisations as described in 
Chapter 2. I went on to outline my methodology in Chapter 3, and used that research 
methodology to discover the findings described in Chapter 4. The findings in Chapter 4 
verified the issues identified in the literature. The key objective was to have an 
improved policy that met the requirements of the CQC and the NHSLA, as well as the 
requirements of the Hospital, the participants and the wider stakeholders that the policy 
would impact upon. 
I worked with a wide range of participants across the four core practice areas to 
produce an improved policy. The participants have been closely involved in the 
development of the new policy that allows them to understand it in greater depth; 
moreover, because they have been involved in its formation, they have ownership. 
As an experienced specialist with a history of working in this Hospital, it was still 
challenging to agree the project with the senior management. I do not believe that the 
sensitivities involved in this type of project would win the approval of the organisation 
unless it completely trusted the individual carrying out the research. As a specialist 
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relationships with senior managers to achieve a case study ultimately approved and 
signed off by the executive management in the Hospital.  
Even when it was signed off, I still had to identify willing participants to take part in the 
study. To do this required the use of my relationships with many individuals who sat on 
relevant senior management committees. It was important to select these participants 
because they were instrumental in influencing the core areas of the policy. Going back 
to the research question, it was important not only to consider the individuals who 
would be best suited to the case study from within the organisation, but also the 
literature available outside the organisation that described the responsibilities and 
conduct required by the regulatory organisations. 
Summary 
The intention of this case study was to research improvements in medical device 
management policy, and the practices impacted upon by that policy, that entailed a 
modifying of the original model to create a best practice model. As the insider–
consultant–researcher in this Hospital, I have worked with participants and focused on 
the problem of improving and implementing medical device management policy, 
coming to terms with the reasons why some practitioners find it difficult to adhere to 
policy.  
I used a participatory approach and AR methods to gather the relevant data, and then 
specifically to analyse medical device management policy, while involving participants 
in the research and reviewing the relevant literature.  The AR cycle in this study, as 
shown in Figure 3-0-5, had an output objective of an improved policy. This has been 
achieved with a refined Hospital-approved policy and is therefore the point at which 
‘refreezing’ and implementation of the improved policy takes place, and therefore the 
end of this current AR cycle.  
I will now go on to summarise in Chapter 6 the arguments presented, how these relate 
to the research question, re-stating the main point of view presented in the introduction, 
an overview of the improved policy model and the implications of what has happened 
as a result of this research.  
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Chapter 6: Conclusions and Recommendations  
Introduction 
I started this research project with the intention to examine critically my original model 
for medical device management policy with a view to creating a best practice model. To 
this end, this research adopted action research to develop and improve policy by 
involving participants in everyday practice at the Hospital.  
I have discussed three core areas of investigation, as in Figure 6-0-1, that led to the 
policy improvements: 
 Firstly, I reviewed external and internal documentary data to ensure I was up to 
date with the latest regulations and also fully understood the position of the 
Hospital.  
 Secondly, I used a questionnaire to review the understanding, with regard to 
device policy, of the participants’ knowledge and expertise. 
 Thirdly, I interviewed them to understand their problems and gain deeper 
positive insights into their ideas for improvements to the previous policy model.  
 
The data was then analysed and discussed with the participants, creating the improved 
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Revising the former policy model 
This study has resulted in an improved policy model for device management. This 
revised model then needed to be organisationally approved through all the relevant 
committees, resulting in a significant impact on improving procurement and training as 
shown in Figure 6-0-2. Red text indicates significant improvements to the former RAL 8 
model shown in Figure 3-0-1. (The application of this improved policy model can be 
seen in Appendix 13, p.173). Indeed, as will be shown, it led to identifying procurement 
as the central activity. Hence, the improved model had to be reconfigured (see Figure 
6-0-4). 
Figure 6-0-2: Revision of the former policy model  







Figure 6-0-3: Procurement policy at the centre of the model 
As can be seen from the revised policy model in Figure 6-0-2, the main changes to the 
policy are in relation to procurement and training, but I would go so far as to say that it 
is imperative to put procurement at the centre of this policy model, if the model is 
genuinely to succeed in the other policy areas of training, maintenance, management 
















As a consequence of this research project, it is clear, therefore, that not only do 
participants have to be trained in their particular areas of practice, they also need to be 
trained in procurement practice. Managers must ensure that effective training 
programmes are provided to ensure budget holders understand the revised policy 
model, especially with regard to procurement, so that they become more familiar with 
the conduct required by the policy.  
In addition, all stakeholders who use devices need to be made aware of the importance 
of device standardisation and its impact on other areas of policy. Stakeholders must be 
provided with clear summarised guidelines about the Hospital device management 
policy because this research has shown that, due to the number of policies and the 
length of those polices, most stakeholders tend not to read them. Above all, we need to 
address communication problems and to maintain an atmosphere of tolerance, 
understanding and cooperation amongst device buyers, users, maintainers and 
managers.  
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Improving the previous model 
Building on my previous work as a consultant in the field of medical devices 
management, where I constructed the previous model described in my RAL 8, this 
research sought to improve that model.  
There is a genuine need for further improvement to medical device management 
policy, and to continue the consultative process that has been implemented throughout 
this case study. Hospital management had to establish a common purpose with the 
participants. It was important to go to the Hospital management and participant 
meetings with sufficient evidence to explain why this would be good for the Hospital. 
Preparation of suitable material, and also having allies inside and outside the 
organisation to back up the reasoning, was important in gaining permission to carry out 
the research. It was then necessary to agree a leadership and support structure, which, 
in my opinion, must include the project sponsor at the Hospital as one of the 
participants.  
It is important to understand how vital it was to ensure that the right participants were 
selected with expertise in one or more of the four core policy areas of procurement, 
training, maintenance and governance. I not only needed the knowledge of the 
participants, I also needed their influence to ensure a successful outcome. In other 
words, once they had signed up as a participant to the project their influence impacted 
on stakeholders outside the project scope. The knowledge they gained as part of the 
project was cascaded to their colleagues. Therefore, I found that when recruiting 
participants it was important to understand that I needed both their knowledge and their 
ability to cascade their learning to their professional peers within the Hospital. 
Throughout the case study, it became more and more apparent that procurement 
policy must sit at the centre of device management policy. The issues discussed with 
participants around procurement impacted on the other areas of policy, such as training 
and maintenance. Procurement of devices was found to be the most important factor in 
reducing the variety, improving standardisation, and impacting in a positive way on 
reducing cost, making user training easier to implement, and maintenance easier and 
cheaper. The impact of procurement cannot be underestimated because, if the conduct 
of managers does not adhere to the policy, the Hospital may procure equipment that 
poses risks to patients because users are not trained to use the equipment or because 
the maintenance team is not trained to maintain or repair the equipment, and 
potentially financial risks because the life costs of the equipment have not been 
properly considered.  
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reduces costs  
In summary, this project has resulted in an improved model that can only be effective if 
the new procurement conduct described within the improved policy model is adhered 
to. Once fully implemented, it will impact on Hospital costs, and knowledge, time, effort, 
and morale. This collaborative approach has resulted in participants willing to think 
about, and change the model for policy to deliver benefits in relation to of the Hospital, 
the staff, and the patients. Managers must have an effective understanding of the 
policy, especially with regard to procurement, if they are to cascade that knowledge to 
their teams. The Improved policy model has procurement combines figures 6-0-2 and 
6-0-3 resulting in The Improved Policy Model, Figure 6-0-4 with procurement at the 
















Figure 6-0-4:The Improved  Policy Model 
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Many of the practices currently in place have been poorly cascaded and this affects 
beliefs about what stakeholders can and should be doing with regards to device policy. 
It is important firstly to train managers on the improved model, then to cascade this to 
other stakeholders. The policy may never be a ‘best practice’ model, however further 
studies to identify improvements and solutions, as well as better training for managers 
and other stakeholders, should result in a much more understanding and cooperative 
Hospital that can lead to the policy improvements discussed.  
As a specialist consultant–researcher, I used an action research approach, whilst 
working as an insider, with operational participants to understand their point of view 
and utilise their expertise, ultimately leading to improvements in the medical devices 
management policy after intervention, monitoring and revisions to the old model.  
The research was conducted at a single NHS hospital in London. It took the form of a 
case study specifically exploring the overarching medical device management policy, in 
collaboration with participants with expertise in one or more of the four interrelated 
medical devices policy areas of procurement, training, maintenance, and governance.  
In contrast to the original model, this collaboration involved a literature review analysing 
the external demands from regulatory agencies such as the NHSLA and CQC. It also 
involved a review of internal documents such as policies and minutes to understand the 
demands of the organisation and to identify the policy issues. The internal demands 
highlighted procurement and budgetary issues. The AR informed changes in Hospital 
policy, especially around procurement, that led to improvements in practice. The 
internal politics and culture of the Hospital were found to be both a help when starting 
up the case study, and a hindrance when it came to achieving agreement and approval 
to change the policy content, because of multiple committees and competing interests.  
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Fundamental questions of patient safety 
I found that this Hospital, like many others, faces fundamental questions of patient 
safety, budgetary limits, and the ever-increasing availability of medical technology. 
Throughout this study I have not only looked at the internal aspects of medical devices 
management policy but have researched the available literature. Medical device 
management policy and implementation is a serious issue recognised by research 
undertaken worldwide. The literature discussed forms part of the framework for this 
study, from the National Audit Office, the National Patient Safety Agency, the 
Medicines and Healthcare Products Regulatory Agency and the World Health 
Organisation. 
Medical device management policy is an extremely complex area within the Hospital 
covering the procurement, training, maintenance and governance of medical devices 
ranging from a magnetic resonance imager (MRI) to a simple thermometer. 
Working as a consultant–researcher, I identified the importance of selecting 
participants from many different professional areas within the Hospital who had a good 
knowledge of their particular responsibility with regard to devices, whether from 
procurement department buying devices, from clinical departments using devices, from 
maintenance departments repairing and maintaining the devices, or the governance 
department ensuring compliance with internal policies and external regulations. 
Medical devices are used in the Hospital for diagnostic and therapeutic purposes. It is 
important that these devices are used correctly to ensure the safety of the patient; 
indeed, there is evidence that patients are sometimes harmed or die because devices 
are not used correctly. Even during this study these types of incidents have happened 
within this Hospital. Discussing the reasons for these incidents with the clinicians and 
nurses involved led me to the conclusion that there is too wide a variety of devices that 
do the same job. This variety makes it difficult to ensure user training is carried out on 
all devices. Therefore, the Hospital has taken the decision only to train on the highest 
risk devices that can harm or kill in the event of misuse, and allow self-certification on 
all other devices. This risk-based approach is the only one that the participants 
considered feasible in the short term. 
Consequently, I have concluded from this case study that the only way to improve 
training, and thereby reduce the risk of harm to patients, is to standardise devices to a 
single equipment type from a single supplier for each technology group. This is difficult 
to achieve at the moment because I found that the purchasing mechanisms, although 
moving towards standardisation of devices, still have a long way to go. Mainly, this is 
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because the Hospital has approximately 600 different technology groups in use for 
different diagnostic and therapeutic purposes. It therefore makes it extremely difficult to 
find agreement from users within each technology group, when there can be hundreds 
of device users across multiple wards and departments who all want to have a say in 
what they use on patients. 
Another conclusion from this study is that the age profile of medical devices can be 
wide, from the newest to the oldest devices within each of the 600 technology groups, 
which leads to some devices being less than a year old while others in the same 
technology group are more than ten years old and already past their useful life. This is 
as a result of multiple budgets, and multiple purchases by different budget holders. As 
long as there are multiple budgets and device users continue to have individual choice, 
the risks will remain. I worked closely with the procurement participants to understand 
this issue. Not only does this impact on patient safety, it also affects cost because the 
procurement manager cannot access the same level of discount when devices are 
bought individually.  
When speaking to the participants who are device users, their main concern is having 
equipment that they are able to use safely and that functions well.  
When speaking to the maintenance participants, it was clear that they wanted 
standardisation, and they wanted users to be trained because with standardisation they 
could carry less spare parts and become more expert in repairing devices, thereby 
reducing down-time. Moreover, with trained users there would be fewer callouts to 
equipment that is not at fault. The maintenance participants expressed concern at the 
number of calls they receive because users do not know how to use the equipment 
correctly and therefore ‘think it is faulty’.  
The governance participants were mainly concerned about meeting inspection 
standards from the CQC and the NHSLA. To achieve this, I had to work with them to 
ensure the policy was inclusive not only of the internal requirements of the Trust, but 
the regulatory requirements from the CQC and NHSLA. 
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The outstanding finding of this study 
As discussed earlier, poor policy design leads to systemic organisational problems. 
During this project poor design related to equipment procurement policy within the 
Hospital device management policy was found to impact on the Hospital’s ability to 
improve in other areas of practice such as training, maintenance and governance.  
Therefore, the outstanding finding of this study has been the effect that redesigning 
device procurement policy has on all other aspects of device management policy. 
Clearly, if the procurement part of the policy is poorly designed, or well-designed but 
not implemented, all other areas of policy will also be negatively affected. The 
importance of this finding cannot be underestimated, because it impacts on patient 
safety and the operational costs of the Hospital.  
There is a strong likelihood that this could be mirrored in other NHS Trusts. If my 
improved policy model, redesigned as a result of this case study, is adopted in other 
hospitals it has the potential to make an important contribution to knowledge for 
healthcare organisations.  
My client Hospital has learnt from this study; the next cycle for the Hospital is to 
implement the redesigned policy, which is likely to take many years to complete 
because of the investment in new equipment required to standardise all groups of 
equipment. This is the next challenge, but the Hospital now understands the policy 
issues and has redesigned the policy to be a workable solution for the future. 
I have personally learnt from this study, and it is my intention to test this model further 
in other healthcare organisations. I can see that my methods are in line with the 
‘learning organisation’ concepts discussed earlier in Chapter 2. If these new ways of 
addressing improvements to policy were more widely adopted, I believe healthcare 
organisations could ‘tap into people’s commitment and capacity to learn at all levels in 
an organisation’ (Senge, 2006, p. 91). 
I believe that this research, in time, could have a considerable public benefit if more 
widely adopted. There is also an opportunity for other researchers to test my improved 
model in other hospitals. 
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Recommendations based on the findings 
It is recommended that: 
 The Hospital Medical Devices Committee should review and update the policy 
in actual time so that it informs conduct for practitioners on how to procure, use, 
maintain and manage devices.  
 This current updated version needs to be supported by continual policy training 
with key stakeholders, followed up through the Medical Devices Committee to 
ensure implementation is in accordance with specific activities relating to 
practitioner areas of responsibility.  
 Once implemented, it must be monitored for compliance, and then reviewed at 
every MDC meeting to ensure it is always in line with current regulations.  
 
 The case study’s main area of change within the policy is procurement conduct, 
as described earlier in Chapter 4. Uncontrolled procurement of devices impacts 
on all other aspects of policy, making it much more difficult to meet the 
regulatory requirements and adding unnecessary risk that can cause harm to 
patients. It was also identified as a cost-saving measure, because with 
improved procurement comes the ability to buy devices in bulk.  
The Hospital is currently on a journey, implementing the new improved policy model. 
My previous model focused on the areas of purchase, training, maintenance and 
governance, but did not go far enough with regard to identification of specific 
technology groups and inclusion of key participants to bring fresh ideas and support. 
My recommendations have been accepted and approved by the Hospital committees 
and include: 
 The MDC ensures implementation of, and monitors the new policy model, 
especially with regard to procurement. 
 The MDC is responsible for identifying each technology group and carrying out 
a clinical needs analysis of each technology group with each group of users, 
with the objective being the selection of an individual make and model of 
equipment for that technology group. 
 The MDC reviews the age profile of each technology group and sets in motion a 
medical devices technology replacement plan across every technology group. 
 The MDC discusses implementation and progress of policy each month. 
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A summary of the improved procurement recommendations is expressed in Figure 6-0-5 
below: 
 
Figure 6-0-5: Technology group purchasing 
If the Hospital is successful in adopting all aspects of policy, especially the revised 
procurement section, there will be cost savings that could be reinvested into training 
clinical users in the correct use of devices, and technicians in the correct maintenance 
of devices, ultimately leading to improvements in practice. 
The revised policy that has resulted from this work has been ratified through the 
Hospital committees and is now in the process of being implemented. As described 
earlier, because equipment has a ten-year life, this is likely to be the length of time it 
will take to implement and embed the policy into the culture of the organisation. It is 
imperative that, throughout this ten-year cycle, the Hospital MDC implements the policy 
and replacement plan. 
Transformative findings 
This study has had a significant impact on my thinking with regard to my approach to 
change management within the context of this Hospital policy study. I now understand 
that achieving real change that will be subsequently implemented by practitioners not 
only requires knowledge of change management, regulations and standards, but for 
the researcher to have specialist knowledge in the policy area and experience of the 
organisation and the people within it. Participant involvement was imperative in the 
context of this case study. The participants had to approve and take part in the case 
study. 
Medical devices  
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I also could not have undertaken this case study without my specialist knowledge and 
experience in the area of medical device management policy and regulations. I have 
approached the changes to policy in a different way, moving from a process-driven 
methodology that impacted upon the way the participants behaved to working with the 
participants to develop the policy that impacts upon stakeholder conduct, ultimately 
enabling practitioner-based improvements to policy. 
The use of AR methods has allowed me to consider the literature, my own specialist 
knowledge and knowledge of the participants involved. This context-specific AR model 
has been used for this case study because I considered it the most appropriate 
method, due to my position as a consultant–researcher within the Hospital.  
Using these AR methods allows me to use relationships already developed to access 
different participants from different levels within the organisation. Due to the complexity 
of the Hospital and the relationships, values and beliefs between different professional 
practices that are impacted upon by device management policy, it was important that 
participants understood their role within the case study and trusted my role as the 
consultant–researcher. As a specialist in this area of knowledge, I was able to use my 
analytical skills to work with participants, and thereby design a new improved model.  
This research model must be underpinned by current regulatory standards and cannot 
therefore be applied without first having a detailed knowledge of the subject area. This 
is an up-to-date means for transformation of policy and is therefore a context-bound 
model that hinges on the specialist knowledge of the consultant–researcher and the 
relationships, values and beliefs between the researcher and the participants from 
different professional practices within the Hospital. 
This project has been transformative for (i) me, (ii) my business, and (iii) the Hospital, 
ultimately delivering transformative improvements. My motives for engaging in this 
project were to deliver benefits such as:  
 Work creation 
o I am already in discussions with other Healthcare establishments to roll 
out this model, thereby growing my business. 
 Contributions to knowledge  
o I have shown that the model has been improved, especially with regard 
to procurement. 
 Support for educational institutions 
o I have opened up this model to my own staff and encouraged them to 
carry out their own studies. 
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 New paradigms for policy  
o I have shown that although the current focus from government and 
regulators is training and maintenance, the actual issue is procurement. 
 Supporting further research 
o This leaves the door open for other researchers to test this model. 
I will now go on to Chapter 7 to critically reflect on the case study and discuss the 
impact on those involved, especially myself, as the insider–consultant–researcher.  
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Chapter 7: Reflexive Account 
Introduction 
I have recognised that my relationship with the University, my supervisors, my 
consultants, and the participants involved in the case study, has allowed me to critically 
reflect on all aspects of my work, and allow me to help the participants to also reflect on 
their work, to collaboratively produce a much improved policy model. Policy production 
and implementation in the context of this case study must be a collective action 
because it crosses professional practice boundaries. 
Colebatch describes policy as an elusive concept; 
perhaps partly because it is used by practitioners (for whom ambiguity about 
definitions can be useful) as much as it is by social scientists. A satisfactory 
definition would have to recognise the tension between the model and the way 
it is used, e.g.’policy is a term used to refer to the structuring of collective 
action by the mobilisation of a model of governing as authoritative 
decision-making’. This is an awkward approach to the definition, but it does 
focus attention on the essential elements. (Colebatch, 2009, p. 142) 
The consultant–researcher 
I am struck by the significance of the consultant–researcher role. The original model 
was constructed by me as a consultant. My approach before this case study was 
involved with embedding my policy model within the Hospital. My previous way of 
working was process-driven, whereby I trained the staff within the Hospital to work in 
accordance with the policy model and processes I had designed and was based on my 
knowledge and experience, with limited input from stakeholders. During this project, I 
have changed the methodology by working critically with the participants to develop the 
new policy and processes for the Hospital, and then continuing to work with those 
participants to impart the new policy and processes to stakeholders within the Hospital. 
The researcher role has not only provided new data, but also a new dispassionate 
mind-set, criticality, to expose the strengths and weaknesses of the old model and to 
produce a more effective version and how it may be implemented. 
I have worked with the participants to create an improved medical device management 
policy model that has hurdles to overcome. I have been able to critically reflect on 
current practice and I now realise and understand that up to this point I have been 
allowing external and organisational constraints to limit my thinking to my own pre-set 
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boundaries. I have put those constraints to one side to allow me more flexibility in my 
thinking.  
Once the case study had initial agreement, it was important to use the participants 
(insider–experts) to my advantage, creating and communicating the vision and using 
them to help me recruit other participants as collaborators on the project.  
Once these participants were on board with the project, I had to ensure that they 
understood their role within the project, and then to allow them to innovate and come 
back to me with ideas and information leading to empowering those participants, 
allowing me to improve my knowledge and expertise by sharing their vision of the 
future. 
This has also allowed me to think about the relationship between my academic study 
and my commercial interests. The academic studies have brought about new policies 
and methods for learning. I can now use these tools commercially to create further 
momentum in device management. Criticality has brought real benefits to me 
personally, to the Hospital and to my business. I now have new competencies that 
enable me to recognise issues and deal with them in a constructive way. I have also 
recognised the problems around being an insider–consultant–researcher, which bring 
ethical and relationship dilemmas that need to be understood in order to be managed 
effectively.  
I believe in this type of research project; as long as the values and interests of the 
researcher are aligned with the values and interests of the organisation, then a 
participatory AR approach is justified. My knowledge of the organisation, and my 
knowledge of medical devices management policy and regulations, allowed me to 
analyse the problem from different viewpoints and to use my specialist knowledge to 
work with participants, identifying problems and solutions. The data gathered from 
attending meetings, from reading internal minutes of meetings and carrying out semi-
structured interviews with the participants, allowed me to widen my knowledge of the 
problems faced by practitioners trying to implement policy. It also allowed me to share 
my knowledge and my understanding of the problems faced by practitioners with 
participants from different fields of expertise within the organisation, and from different 
ranks within the organisation. 
I would recommend that if another researcher wanted to carry out a similar case study, 
they should be a specialist in the particular policy area they are researching. This 
would enable them to critically examine the feedback from the participants in an 
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analytical and meaningful way that enables them to make recommendations that 
ultimately improve policy and practice.  
During this DProf process I have learnt to be more empathetic, to be more 
understanding, to be more deeply reflective, and this has led me to a new 
understanding thereby allowing me to open my mind to new solutions. It would be easy 
to blame the users of my management systems when poor practice is identified, but 
there are structural reasons within the Hospital management procurement processes 
that make it difficult for all practitioners to deliver their practice in accordance with 
governmental requirements and local policy requirements.  
I now see that device management policy is impacted upon by many different sources, 
and is therefore nonlinear in nature and needs to be continuously managed. In 
Organisational Innovation in Health Services (Gabbay, et al., 2011, p. 107) ‘The 
Innovation Journey’ shows a case study journey that took place over 17 years, 
following the path of 14 different innovations in different organisations. It can be clearly 
seen that these journeys involving continuous improvement can change direction along 
the way for many different reasons. The point of this particular case study, carried out 
by Andrew Van De Ven, is to show that there can be many different reasons why 
organisational change is nonlinear and needs to be guided by management.  
Through my knowledge of the Hospital, the regulations, the participants, I can go on 
the journey with the organisation and assist participants to make the policy changes. 
This allows me to see what is needed in real time, to refine my methods in a real 
situation, and to develop a useful tool that can then be tested in other NHS 
organisations. 
This research was always intended to leave a lasting legacy, namely improved policy, 
improved implementation and monitoring solutions to ensure the policy stays on track. 
This DProf project will lead to conference papers, training programmes and 
presentations to my professional peers. It has allowed me to improve my analytical 
approach, enhancing medical devices management policy through implementation of 
revised relevant policies and processes.  
Perhaps, as already intimated, the most important outcome of the study is that it has 
made me consider deeply the complex role of being an insider–consultant–researcher. 
For instance, I now see that my specialist knowledge as a medical devices 
management consultant might be seen as a benefit and a hindrance; a benefit because 
it allows me to use my experience to compare any new ideas with those that have gone 
before, and a hindrance because I may already consider my methods for policy 
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development and implementation to be good. Therefore, I may be unknowingly ‘set in 
my ways’ and need to be mindful of these factors, critically reflecting on my methods, 
thereby taking myself out of my comfort zone.  
However, with hindsight, I would recommend this insider–consultant–researcher 
approach to anyone starting this type of project. It gave me, and all the participants, 
time to ‘bed in’ the process for the case study and the AR cycle that was developing 
through one-to-one meetings, and through the Medical Devices Committee meetings.  
I found that as a consultant–researcher specialising in this subject matter, I was able to 
work constructively with these participants to enhance policy and methods further for 
adoption and implementation. During the case study we learnt more about each other, 
and this enabled me to build stronger working relationships, benefiting the overall 
study.  
Also, to fulfil this role. I found I had to delve more deeply and more widely than I have 
before. In the past, there were regulations and standards from external agencies that I 
never questioned but always included in my policy. There were also the internal 
management structures of the Hospital that I had never questioned. My policy model 
had always been confined to these rigid management structures. I had to question the 
validity of these regulations and structures that impact upon the medical device policy.  
Undoubtedly, through this study I have gained new knowledge that has found 
expression in a new medical device management policy model. My only 
disappointment is that, although the policy has now been agreed, it will take years for 
the model to be embedded in Hospital culture, but I am encouraged that I am still 
involved in making that happen. 
Postscript 
I have recently met a number of private and public healthcare directors and discussed 
some of the aspects of this project with them. This has resulted in three opportunities to 
take this concept into other organisations. 
One of these organisations has approved a project starting in September 2013 to work 
with me in an attempt to make this concept work across 31 hospitals for a single 
technology group: infusion pumps. This is an exciting move forward, and has come 
about as a direct result of my learning and understanding that has come from this case 
study, and my DProf journey. This project has a potential contract value of £2.5M over 
5 years.  
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Appendices 




Mr John Sandham IEng MIET MIHEEM 
School: WL; Campus: WBL; Site: Hendon 
Student number: M00290705 
 
(To be read by interviewer before the beginning of the interview.  One copy of this form should be left 
with the respondent, and one copy should be signed by the respondent and kept by the interviewer.) 
My name is John Sandham, I am the researcher on a project entitled: ‘Achieving a Best Practice 
Model for Medical Devices Management Policy’     
 
This project is being sponsored by EBME Ltd, Wrest Park House, Silsoe, Beds, MK45 4HR  
I am the contact person in charge of this project and I may be contacted at this phone number 07870 
682097 should you have any questions. This doctoral project will use information provided by the 
participants, and Chase Farm Hospital Medical Devices Committee, to improve the Trust policy for 
Medical Devices Management. The aim is also to analyse information from project no. GPI 000012; 
OJEU REF: 2010/S 95-143993; Medical Device Management Services [provided by EBME Ltd]. The 
objective of this doctoral project is to improve medical devices policy with an outcome of improved 
regulatory compliance.  
 
Thank you for your willingness to participate in this research project.  Your participation is very much 
appreciated.  Before we start the interview, I would like reassure you that as a participant in this 
project you have several very definite rights. The following information outlines your rights in the 
interview.  Please feel free to discuss anything you do not fully understand. 
 
1. First, your participation in this interview is entirely voluntary.  
You have the right: 
2. To be fully informed of the purpose of the research. 
3. To be able to terminate the interview at any stage. 
4. To anonymity. 
5. To ask for information to be changed or recalled to you as the interview progresses. 
6. To know who the audience will be, i.e. who will be receiving my research project. 
7. To have your comments and any information safeguarded. 
8. To have your views objectively reflected. 
9. To express your opinions on the research. 
10. To discontinue the recordings at any stage of the interview. 
11. To negotiate the content of the interview.  
12. To refuse to answer any question at any time. 
This interview will be kept strictly confidential and will be available only me. Excerpts of this interview 
may be made part of the final research report, but under no circumstances will your name or 
identifying characteristics be included in this report. I would be grateful if you would sign this form to 








Please send me a report on the results of this research project (circle one) 
 
YES    NO 
 





(Interviewer: keep signed copy; leave unsigned copy with respondent) 
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Appendix 2: Participant questionnaire 
Student: Mr John Sandham IEng MIET MIHEEM 
Student number: M00290705 
School: Work Based Learning 
Campus: Hendon 
 
Project title: ‘Achieving a Best Practice Model for Medical Devices Management Policy’ 
 
My objectives are based on continual improvement of medical devices management policy. Please could you answer 
the following questions? 
 
1. Have you been made aware of the medical devices management research project objectives?  Yes/no 
 
2. Have you read the organisational medical devices policy?     Yes/no 
 
Please answer the following in relation to medical devices management in your organisation:   
           
                     1 = Poor, 5 = Excellent 
                                                                                                                                              1     2      3      4     5 
3. What is your understanding of device management policy within your organisation?   
    
 
4. What is your understanding of NHS Litigation Authority standards?    
                
 
5. What is your understanding of CQC and NHSLA regulations/standards for medical devices?  
                          
 
6. What is your understanding of CQC and NHSLA impact on medical devices procurement policy? 
               
 
7. What is your understanding of CQC and NHSLA that impact on maintenance policy? 
  
8. How well does the organisation communicate device management policy? 
 




Participant Name: ………………………………..…… Title: ………………………………………….. 
 
Participant Signature: ………………………………… Date: ………………………………………………. 
 
Feedback to participant?   Yes / No  
(circle one) 
  
   
152 
Appendix 3: Clinical Services Journal, May 2012 
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JOHN SANDHAM discusses the impact on medical devices 
management policy of both CQC and NHSLA regulations. 
 
is described later in this article. 
The NHSLA sets risk management 
standards and operates an insurance 
scheme for member organisations. The 
objective of these risk management 
 
The term ‘medical device’  
encompasses medical devices as legally 
defined in the Medical Devices 
Regulations. This refers to an instrument, 
apparatus, appliance, material or other 
article, whether used alone or in 
combination, together with any software 
necessary for its proper application, which 
is intended by the manufacturer to be  
used for the purposes of: 
• Diagnosis, prevention, monitoring, 
treatment or alleviation of disease. 
• Diagnosis, monitoring, treatment, 
alleviation of, or compensation for, an 
injury or physical impairment. 
• Investigation, replacement, or 
modification of the anatomy or of a 
physiological process. 
• Control of conception. 
 
A medical device does not achieve its 
principal intended action in or on the 
human body by pharmacological, 
immunological or metabolic means.  
This definition includes devices intended 
to administer a medicinal product, such 
as a syringe driver, or which incorporate a 
substance defined as a medicinal product, 
such as a drug-eluting stent. 
The delivery of safe and effective 
treatment in healthcare settings is 
dependent on the correct use of medical 
equipment in a range of applications. 
Interventions using medical equipment 
can optimise treatment, reduce length 
of stay and improve the patient experience 
of care. However, when used 
inappropriately, medical equipment 
carries the associated risk of causing  
harm to patients. It is, therefore, essential 
that all organisations have an overarching 
medical equipment policy and training 
programmes to minimise the risk of errors 
occurring. 
 
Pressure to improve services 
Healthcare organisations are constantly 
under pressure to improve processes and 
enshrine those processes within their 
organisational policies. The importance of 
policies to the individual, the department, 
and the organisation cannot be 
understated. 
The two core bodies that healthcare 
organisations in the UK are most 
concerned with are the National Health 
Service Litigation Authority (NHSLA) 
and the Care Quality Commission 
(CQC). 
The CQC audits against regulations 
approved by the UK Government. A 
summary of the regulations that impact  
on medical equipment management policy 
standards is to make the patient 
environment safer. If organisations are 
members of the NHSLA scheme (all 
NHS organisations must be members) 
the goal must be to reduce risk by 
providing evidence to the auditors that 
they are complying with the standards. 
Both the NHSLA and CQC base 
much of their audit criteria on 
information provided by the Medicines 
and Healthcare Products Regulatory 
Agency (MHRA). 
Many organisations struggle with 
changes in regulatory standards. Some 
organisations do not have systems in 
place that enable them to quickly change 
and implement policy. Therefore, 
changes made by Government may never 
actually get down to organisational level 
policy, in a reasonable timeframe. 
If an organisation does not have a 
professionally qualified person that is 
able to interpret the changes in 
regulatory standards and then update the 
organisational policy, then the changes 
required by Government will not be 
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Appendix 4: Project map 
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Appendix 5: Title page for medical devices management policy 
Title of policy  Medical Devices Management Policy 
Policy version number  CG05 
Status  Approved 
Policy author/s  John Sandham 
Policy consultees  Lead for Clinical Risk 
Health and Safety Team 
Medical Devices Committee 
Negotiated through  Risk Committee 
Accountable Director  Director of Operations – Planned Care 
Approved by: Medical Devices Management Committee 
Ratified by Clinical Governance & Risk Representatives 
Date of ratification and implementation:  
Review date: December 2013 




Document location  Trust Intranet 
Distribution and dissemination  All Clinical Areas via Intranet 
Principal target audience  All Clinical Staff 
Responsibility for dissemination of policy to 
new staff  
Departmental Equipment Controller 
NHSLA/Healthcare Commission/ALE impact  Compliance with requirements 
 
LITERATURE SEARCH AND EVALUATION (Details in Section 9)  
REVISION HISTORY 
Version  Date  Summary of Changes  
01  June 2006 Initial version of Policy 
02 November 2007 Review and amend document: 
Changes to directorate structure, 
roles and responsibilities included, 
process for monitoring, replaces 
previous Medical Devices strategy, 
additions to training strategy 
03 November 2008 Review and addition to document: 
Links to other policies and 
procedures such as Equipment 
library procedure, Decontamination 
policy, and introduction of Medical 
Devices policy training, and 
monitoring schedules  
04 June 2009 Review and addition to document: 
Section 5.8 concession added for 
CPAP patient owned equipment, 
subject to the conditions in Appendix 
11. Inclusion of Pre-Purchase 
Questionnaire Appendix 12 
05 December 2010 Inclusion of new sample DEC forms 
Appendixes 1(a) to 1(b) – removal of 
old style DEC forms 1 (a) to 1 (d) 
  





06 June 2012 Inclusion of revised sample DEC 
forms (passport) Appendixes 1(a) to 
1(b) – removal of old style DEC 
forms 1 (a) to 1 (b) 
07 July 2012 Inclusion of revised procurement 
processes: 
Flowchart p.8 updated  
08 July 2012 section 7 updated (Removal of 7.3 & 
7.4 Rewrite of 7.5 – Purchase of 
medical equipment; Rewrite of 7.7 - 
loan equipment 
09 July 2012 Section 7.26 – Rewrite of Company 
representatives procedure 
10 August 2012 Section 9 - Update of References for 
NHSLA Risk management standards 
and CQC compliance assessment. 
11 December 2012 4.16– Ward/Department 
Staff/Doctors/Junior Doctors are 
responsible for ensuring their own 
competence prior to operating an 
item of equipment. 
RATIFICATION HISTORY 
Ratifying body Date of ratification  Version 
Risk Committee June 2007 01 
Risk Committee November 2007 02 
Risk Committee November 2008 03 
Risk Committee June 2009 04 
Risk committee December 2010 05 
Risk committee December 2012 06 
This policy has been ratified by [Hospital] Hospitals NHS Trust Risk Committee. Circumstances may 
arise or there may be a change in guidance or legislation that requires the policy to be updated 
between now and the review date. The responsibility to ensure the policy review process is activated 
lies with the Medical Devices Manager. All policies remain in force until notification of an amended 
policy is circulated and posted on the Trust intranet.  
MONITORING THE EFFECTIVENESS OF POLICY IMPLEMENTATION 
 
Key Performance Indicators: Medical Devices Policy Training Status  
Date of Audit Report: Monthly and Annual Reports presented to Medical Devices Management 
Committee.  
Location of Audit Report: Corporate Services & Redevelopment 
Appendix 5 continued: Title page for medical devices management policy 
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Appendix 6: NHSLA factsheet 
The NHS Litigation Authority 
 




This factsheet provides information about the expenditure of the NHS Litigation Authority, a Special 
Health Authority responsible for handling both clinical and non-clinical negligence cases on behalf of the 
NHS in England. Information about other aspects of the NHSLA’s activities is contained in further 
factsheets in this series, available on our website at www.nhsla.com. Our recent Annual Reports are also 
available on our website. 
 
 
The schemes managed by the NHSLA 
 
The NHS LA handles negligence claims on behalf of the NHS under a number of different schemes. 
 
 The Clinical Negligence Scheme for Trusts (CNST) is a voluntary risk-pooling scheme for clinical 
negligence claims arising out of incidents occurring after 1 April 1995, funded out of members’ 
contributions. Currently all NHS Trusts, Foundation Trusts and PCTs in England choose to belong.  
 
 The Existing Liabilities Scheme (ELS) covers clinical negligence claims arising out of incidents 
which occurred before April 1995. It is not a contributory scheme: the costs of funding settlements 
made under ELS are covered centrally by the Department of Health. 
 
 The Ex-RHAs Scheme covers any clinical liabilities incurred by the Regional Health Authorities 
before their abolition in April 1996 with the NHSLA itself acting as defendant. 
 
 The Liabilities to Third Parties Scheme covers non-clinical ‘third party’ liabilities such as public and 
employer’s liability claims. Like CNST, it is a voluntary scheme funded through members’ 
contributions. 
 
 The Property Expenses Scheme covers ‘first-party’ losses by NHS bodies such as property loss or 
damage. Again it is a voluntary scheme, funded through members’ contributions. 
 
 
Expenditure under each Scheme  
 
In 2011/12, the NHS LA made payments totalling £1,330 million in respect of all five schemes. A 
breakdown of these payments between schemes, together with comparable data for previous years, is 
given overleaf. It should be noted that these figures relate only to expenditure incurred by the 
NHSLA itself.  
 
Until April 2000, when all outstanding ELS claims were ‘called in’ to the Authority, NHS organisations 
handled (and funded) lower value ELS claims themselves, and paid ‘excesses’ on the higher value claims 
handled on their behalf by the NHS LA. Similarly, until the call-in of CNST claims in April 2002, 
member organisations paid part of the cost of claims made under CNST. Excesses are still payable on the 
non-clinical schemes (LTPS and PES). The cost of these excesses, being carried by individual NHS 
organisations, is not included in the NHS LA’s figures.  
 
It should also be noted that when the NHS LA called in claims under ELS (April 2000) and CNST (April 
2002), as part of the process it reimbursed the above-excess costs already incurred by member trusts on 
these claims. Thus the apparent ‘bulges’ in these years do not reflect an increase in overall claims 
expenditure, but rather one-off reimbursements of expenditure already incurred (and accounted for) by 
member trusts. The value of these reimbursements is identified separately in the table, accounted for in 
2000/01 for ELS repayments and in 2001/02 for CNST repayments. 
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Payments made by NHS LA in respect of negligence claims against the NHS 
 
 Payments made in the financial years 06/07 to 11/12 
 
  11/12 10/11 09/10 08/09 07/08 06/07      
Scheme  £’000 £’000 £’000 £’000 £’000 £’000      
             
CNST  1,095,302 729,072 650,973 614,342 456,301 424,351      
ELS  179,112 132,700 135,064 150,806 171,562 153,246      
Ex-RHA  2,957 1,626 954 4,078 5,462 1,794      
             
TOTAL  1,277,371 863,398 786,991 769,226 633,325 579,391      
             
             
LTPS  48,128 42,435 33,952 33,975 24,986 29,697      
PES  4,262 5,546 6,424 3,914 2,730 4,186      
             
TOTAL  52,390 47,981 40,376 37,889 27,716 33,883      
             
             
GRAND 
TOTAL 
 1,329,761 911,379 827,367 807,115 661,041 613,274      
      
 
         
Payments made in the financial years 00/01 to 05/06          
   05/06  04/05 03/04  02/03 01/02 00/01       
Scheme   £’000  £’000 £'000  £'000 £'000 £'000       
                 
CNST   384,390  329,412 293,384  175,277 *201,869 22,521       
ELS   168,203  169,414 128,071  269,345 343,242 *842,093       
Ex-RHA   7,716  4,068 1,059  1,562 3,832 7,372       
                 
TOTAL   560,309  502,894 422,514  446,184 548,943 871,986       
         *£119,000 *£612,000       
                 
LTPS   26,692  21,280 7,395  14,480 3,112 551       
PES   4,586  3,839 2,735  6,866 1,931 429       
                 
TOTAL   31,278  25,119 10,130  21,346 5,043 980       
                 
                 
GRAND 
TOTAL 
  591,587  528,013 432,644  467,530 553,986 872,966       
        *£119,000 *£612,000    
 
         
Expenditure relates to paid and accrued but excludes reserves 
* £612,000 in 2000/01 and £119,000 in 2001/02 reflects the amounts reimbursed to trusts  
 as part of the ‘call-in’ and included within ELS/CNST payments. 
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Outstanding liabilities 
As at 31 March 2012, the NHSLA estimates that it has potential liabilities of £18.9 billion, of which 
£18.6 billion relate to clinical negligence claims (the remainder being liabilities under PES and LTPS). 
This figure represents the estimated value of all known claims, together with an actuarial estimate of 
those incurred but not yet reported (IBNR), which may settle or be withdrawn over future years.  
Legal costs 
The following table sets out the amounts paid out by the NHS LA for legal costs relating to clinical 
negligence claims closed in 2011/12 with damages paid. The figures are broken down into costs incurred 
by the NHS and by claimants: however they relate only to costs paid by the NHS LA and hence do not 
include costs met by claimants themselves or by the Legal Services Commission. 
Legal costs incurred in connection with claims closed in 2011/12 
 Claimant costs Defence costs Total 
CNST 171,543,654 43,007,435 214,551,088 
ELS 11,191,207 5,173,518 16,364,726 
       
Grand total 182,734,861 48,180,953 230,915,814 
 
Unlike in previous years, the above table does not include those claims where damages were not paid to 
the claimant, i.e. where no liability was established. In 2011/12, 3,175 clinical claims were closed without 

























Promoting best practice 






JOHN SANDHAM IEng MIHEEM MIET highlights the risks 
associated with poor medical device management policy 
and argues the need for Trusts to be more actively involved 
in setting policy and systems to improve practice. 
‘In a typical NHS Trust 
there can be 200 wards 
and department with their 
own budget lines for 
The NHS Litigation Authority (NHSLA) 
estimated that, as at 31 March 2012, it 
had potential liabilities of £18.9 billion, of 
which £18.6 billion related to clinical 
negligence claims. This figure represents 
the estimated value of all known claims, 
which may settle or be withdrawn over 
future years (NHSLA Factsheet 2 – 
published 2012). 
The NHS is carrying significant risk in 
terms of patient safety and expenditure. 
This is a serious issue because of the high 
percentage of high-risk medical devices 
that are being used without evidence of 
adequate training or maintenance. 
This is resulting in serious injuries and 
even death. 
Two core issues are impacting on 
medical devices management policy that 
leads to non-compliance. Firstly, training 
in the safe use of medical devices, and 
secondly maintaining and calibrating 
devices. This is a serious issue, as can be 
seen from the numerous negative news 
stories of which just a few examples are 
shown in Panel 1. 
NHS procurement systems and budget 
management processes are currently set up 
in a way that allows managers of individual 
wards and departments choice to buy 
medical equipment, as can be seen from 
the budget statement example in Figure 1, 
(from the Audit Commission) showing 
local equipment and consumable purchase 
ability. 
In a typical NHS Trust there can be  
200 wards and departments with their own 
budget lines for equipment. This does not 
allow for easy equipment standardisation 
that can reduce costs and risks. 
 
equipment. This does not 
allow for easy equipment 
standardisation that can 
reduce costs and risks.’ 
 
The risks of poor device 
management 
The proper management of medical 
equipment has become an issue in the 
healthcare sector due to the multitude of 
devices in use, changes in technology, 
changes in regulatory requirements, and 
the need to manage all these issues. 
Government approved legislation for 
device management in 2010 relates to 
providers meeting the care quality 
standards described in the 
regulations. The Department of 
Health is assuring legal compliance 
through the Care Quality 
Commission (CQC). The CQC is 
monitoring healthcare providers to 
ensure they are adhering to the new 
legislation which relates to quality 
provision. 
The law should play an important, 
though not dominant, role in 
regulating the relationships between 
Trusts and various stakeholders, 
including patients and commercial 
suppliers. So, for example, there are 
laws specifically designed to protect 
patients with regard to the use of 
medical devices, and there are laws 
specifically designed to ensure 
suppliers provide services within an 
Figure 1: An example of an expenditure budget statement for a ward. agreed legal terms of reference. 
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Panel 1: News stories 
The Times on-line stated: ‘The critical 
research conducted by Dr Foster, a 
consultancy that collates independent 
league tables on NHS Trusts, also 
identified 27 Trusts with unusually high 
death rates involving the deaths of 
5,000 more patients in the past year 
than had been expected. A CQC spot 
check last month had uncovered soiled 
mattresses, poor clinical practices, 
mould growing in suction machines  
and out-of-date medical equipment’. 
(29 November 2009). 
 
According to the Health Select 
Committee: ‘The evidence, particularly 
that from case note reviews, both in 
England and internationally, indicates 
that the extent of medical harm is 
substantial, even on a conservative 
estimate, and that much is avoidable. 
International studies suggest that 
about 10% of all patients who are 
admitted to hospital suffer some form 
of harm. Judging how far patient safety 
policy has been successful requires 
more reliable data regarding how much 
harm is done to patients.  
Unfortunately, neither the NPSA nor  
the DH was able to provide us with 
that. Government estimates of 
avoidable harm and the attendant 
financial costs are extrapolations from 
old, very limited, data; and no attempt 
has been made to produce reliable 
up-to-date figures’. 
(29 July 2009). 
 
Medical equipment in the news: 
A report demonstrated the fact that 
risks associated with medical devices 
management is a nationwide concern, 
stating: “CQC inspectors also found 
medical equipment in a state of 
disrepair, staff training inadequate  
and medicine managed unsafely.” 
(14 January 2012, BBC). 
 
There is, however, a question as to 
whether the CQC understands device 
management issues, and is really able to 
get to the heart of the problem. Device 
management is a burning public issue 
because it has now been enshrined in law 
through The Health and Social Care Act. 
This Act is in an area that is politically 
significant, impacting on levels of risk to 
patients, and NHS organisational 
reputation. The CQC has made medical 
devices management a priority (under 
regulation 16, outcome 11) and listed 
device management as one of the poorest 
performing areas of NHS management in 
its 2010 report. (Care Quality 
Commission, 2010) 
NHS Trusts must adhere to the CQC 
regulations and NHSLA standards. Over 
the last 30 years there have been many 
attempts by Government and healthcare 
agencies to address the policy issues faced 
when managing medical technology. In 
broad terms, these policy issues have 
always involved procurement, use, 
maintenance, and governance, in 
accordance with regulatory standards of 
medical technology. 
A 2011 Government report shows that 
the medical technology market will 
continue to grow year-on-year. Over the 
next five years, medical technology is 
expected to grow at 10% per year. The 
report states that: “The medical 
technology market is estimated to be 
worth £150-£170 bn worldwide with 
growth rates forecast at 10% per annum 
over the next five to six years and a 
market size approaching £300 bn by 
2015. This growth is driven by the ageing 
of the world’s population and the per 
capita income increases in healthcare 
expenditure across developed countries.” 
The NHS is struggling to manage 
devices it owns due to their variety and 
complexity, changes in regulations, and 
new devices coming onto the market, 
resulting in more demands from nurses 
and doctors to have access to new 
devices. 
Government policy is produced as a 
result of analysis of many factors affecting 
patient care. This will include cost, new 
devices, new drugs, new techniques, and 
pressure from manufacturers and service 
providers to open up the NHS market to 
external providers. The demand for new 
technology is insatiable, and this can 
result in unnecessary cost, additional risk, 
and practical constraints of how to 
procure equipment, how to train staff to 
use the equipment, and how to maintain 
such a wide variety of equipment. 
Alongside these internal demands, are 
the demands of the Government, through 
regulators, to ensure that equipment is 
managed to the highest standards for the 
well-being and safety of the patient. 
Although a great deal of technology is 
available for patient care, the quantity and 
variety of devices available can introduce 
risks of misuse, risks of overspend, and 
risks when equipment is unavailable due 
to lack of maintenance. The Government 
has, therefore, decided to regulate in 
order to mitigate these risks. There 
are many other areas which impact 
on the organisation’s policy for 
managing medical devices. These 
are a mixture of external influences, 
and internal influences. Some of 
these external influences are shown 
in Figure 2. 
The NHSLA sets the risk 






















Professor Nick Bosanquet presented 















Figure 2: External governance and 
regulatory demands. 
 
National Health Service. (NHSLA, 
2010). The Medicines and Healthcare 
products Regulatory Agency (MHRA) 
regulates specific medicines and 
healthcare products (MHRA, Managing 
Medical Devices: Guidance for healthcare 
and social services organisations, 2006). 
The European Union (EU) regulates the 
manufacture of medical devices (EU 
Commission, 1993). These are the four 
key external governance and regulatory 
areas that influence the hospital’s medical 
devices policy. 
A 2004 project paper from the  
National Patient Safety Agency (NPSA) 
shows that many organisations were 
operating inefficient device management 
policies, as can be seen from the following 
extract. Many organisations are still facing 
similar problems today. 
 
 
‘Policy in isolation is very 
ineffectual, and does not really 
benefit patients, practitioners, 
or the organisation.’ 
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‘These audits established the following 
averages across the six pilot sites: 
• 65% of available stock in each site was 
under-utilised; 
• The range of infusion devices available 
for use was 31; 
• Infusion device stock was 1065; 
• The cost of this stock was £1.6 m. 
 
‘Staff requiring training at a Hospitals NHS Trust normally find it 
very difficult to leave their posts because there is insufficient 
funding to backfill them while they go through training.’ 
These findings reflected an inefficient 
system in which infusion devices are 
purchased, managed and used. This is 
probably a national issue supported by the 
fact that 93 Trusts initially expressed an 
interest in participating in this pilot work 
(implying that they needed help).’ 
 
Procurement 
Good procurement of medical technology 
can reduce the size of the inventory, 
reducing the value of the inventory, and 
thereby reducing the annual spend on 
replacing assets. It can also result in 
improved utilisation of assets, resulting in 
improved outcomes for patients, and 
improved throughput of patients, resulting 
in improved revenues for the Trust. 
The procurement policy for medical 
technology has an impact on the 
organisation in terms of cost, availability, 
and suitability, and strategic needs. 
Uncontrolled purchasing was 
discussed in a NPSA project report, 
Standardising and centralising infusion 
devices – a project to develop safety 
solutions for NHS Trusts (National Patient 
Safety Agency, 2004, p2) which said: 
‘The project identified that uncontrolled 
purchasing and device management, in 
the absence of competency-based 
training, were contributing factors in 
causing incidents.’ 
especially when there was limited 
standardisation across many groups 
of medical devices. 
 
Funding training 
To meet the key requirements of the 
regulations and standards funding is 
required to: 
• Employ qualified staff who are able to 
implement the regulations and 
standards. 
• Carry out training on the actual 
changes to the regulations and 
standards with the relevant 
management teams. 
• Carry out training on the actual medical 
devices. 
 
Staff who require training often find it 
very difficult to leave their posts because 
there is insufficient funding to backfill 
them while they go through training.  
For example, if 2,500 staff require 
training on five pieces of medical 
equipment, each equipment training 
course taking one hour each, this requires 
12,500 hours of replacement staff time. 
The average NHS Trust will have 
thousands of different equipment types. 
Maintenance policy for medical 
technology is important to the efficient 
running of the organisation, aiding 
therapeutic and diagnostic care of 
patients, and also to the volume of 
equipment required by the organisation. 
 
Governance 
Governance policy for medical technology 
is carried out in accordance with the 
requirements of Trust policy for medical 
devices management, which must meet 
the requirements of the regulators. 
There is a serious lack of professional 
knowledge with regard to device 
management, and a lack of understanding 
of the impact of what ‘not having this 
knowledge’ can have on the organisation, on 
the patient, and on them as a professional 
practitioner should they do something 
against the guidelines of the policy. 
 
Training 
Training is considered a high-risk area by 
Government, which has resulted in the 
introduction of the regulations previously 
discussed. Policymakers at a Government 
level may not understand the practical 
difficulties of implementing training 
































   
Appendix 7 continued - Clinical Services Journal, March 2013 
Appendix 7 continued - Clinical Services Journal, March 2013 







‘Systems must be put 
in place to ensure that 
practitioners are able to 
amend their practice in 
accordance with changes 
in policy.’ 
 
The importance of medical devices 
management must not be understated. 
There have been many reported incidents 
where patients have been harmed or have 
died while connected to medical devices. 
Most of these incidents could have been 
avoided if the professional practitioners 
involved had been fully aware of their 
responsibilities, and had been operating in 
accordance with the definite course of 
action. 
Best practice in medical devices 
management policy should be promoted 
to ensure risks to patients are minimised, 
and unnecessary inefficiencies in NHS 
organisations are avoided, thereby 
reducing costs. 
At the Electronic and Biomedical 





2012 – Professor Nick Bosanquet, 
professor of health policy at Imperial 
College, said:  “This new model for 
healthcare has a technological basis and 
biomedical engineers will be the key 
drivers – they are the people that can 
deliver better utilisation and better access. 
They will have to learn to meet new 
challenges in terms of quality.” 
In reality, practitioners have a difficult 
job to do, and are under a constant 
workload. Finding time to sift through 
policies and recognise areas that impact 
on their professional practice is difficult. 
Even if they do find time to sift through 
the policies, how do they then implement 
those policies unless they have sufficient 
support from the organisation? Policy in 
isolation is very ineffectual, and does not 
really benefit patients, practitioners, or the 
organisation. It is important to  
understand the reasons why policies sit on 
shelves gathering dust. 
Trusts need to be more actively 
involved in making changes that improve 
their practice. Systems must be put in 
place to ensure that practitioners are able 
to amend their practice in accordance 
with changes in policy. If systems are not 
put in place, staff will become entrenched 
in practice based purely on their own 
knowledge and skills, and if those 





found to be inadequate as a result of the 
organisation not adhering to its own 
policy, the organisation is as much at fault 
as the practitioner for not providing 
suitable support. 
The EBME Conference 
(www.ebmeassociates.com) on the 
1 May 2013 will address these issues and 
propose solutions based on best practice. 
The 4th EBME conference will also focus 
on innovations that deliver risk and cost 
benefits to healthcare organisations. ✚ 
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Appendix 8: Participant descriptions, agreements, and 




Interview ID no Professional Role Gender
Participant 
agreement 





Anaesthetist Male Yes Client colleague 23/10/2012 Semi structured
Participant 2 Nurse Female Yes Client colleague 25/10/2012 Semi structured
Participant 3
Senior Auditor / 
Facilitator Male Yes
Employee 
colleague na Semi structured
Participant 4 Auditor / Facilitator Male Yes
Employee 
colleague 23/10/2012 Semi structured
Participant 5 Inventory Manager Male Yes
Employee 
colleague 23/10/2012 Semi structured
Participant 6 Administrator Female Yes
Employee 
colleague 23/10/2012 Semi structured
Participant 7 Manager Female Yes Client colleague 23/10/2012 Semi structured
Participant 8 Director Male Yes Client colleague 09/11/2012 Semi structured
Participant 9 Deputy Director Male Yes Client colleague 09/11/2012 Semi structured
Participant 10 Manager Female Yes Client colleague 07/08/2012 Semi structured
Participant 11 Auditor / Facilitator Female Yes Client colleague 15/10/2012 Semi structured
Participant 12 Nurse Female Yes Client colleague 23/10/2012 Semi structured
Participant 13 Nurse Yes Client colleague n/a Semi structured
Participant 14 Director Male Yes Client colleague 23/10/2012 Semi structured
Participant 15 Chief Executive Female Yes Client colleague 21/03/2012 Semi structured
Participant 16 Quality Director Male Yes
Employee 
colleague 22/10/2012 Semi structured
Participant 17
Professor of Health 
Economics Male Yes
Friend/profession
al colleague 23/10/2012 Semi structured
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Appendix 9: Medical Devices Management Committee searches 
No. Medical Devices Management Committee comment Policy 
327 
8.4 Equipment Condemnation: ‘P10’ advised that the process for 
condemning equipment was different at [the Hospital] and this would need 
to be standardised across both sites. JS advised that users will occasionally 
dispose of equipment without informing anyone and suggested that staff 
should be reminded of the Policies.  Policy 
471 
4.1 JS advised that he was re-writing the Policy and would have it ready to 
present at the next meeting. The Trust are close to obtaining level three 
status however there are improvements to be made around action plans. 
The Trust must demonstrate their ability to monitor, audit and complete 
action plans. Policy 
987 
JS advised that the Policy was due to be reviewed in June and ratified by the 
end of December. The revised Policy will be reviewed and discussed by each 
committee member and then brought to the October committee for final 
Policy Update' so that this can be reported on each month.  Policy 
1227 
6.1 JS had previously advised that the Policy was due to be reviewed in June 
and ratified by the end of December. The revised Policy will be reviewed and 
discussed by each committee member and then brought to the October 
committee for final approval.  Policy 
This is an example of text extracted from Medical Devices Committee minutes, using 
the software tools to search for ‘policy’. As can be seen, each comment has a unique 
identifying number. 
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Appendix 10: Semi-structured interview searches 
No. Semi-structured Interview text Policy 
3 
‘P14’ - I think it's not only ticking the box on that policy, it's all policies. They 
don't drive it forward or take responsibility. Policy 
5 
‘P14’ - yes ‘P8’ knows he's responsible, but doesn't do anything with it. It's 
the same with every policy, he don't really do anything, only when something 
happens, then he’ll want to know more. Policy 
7 
‘P14’ - I think that's pretty much the same with all policies. The problem with 
this Trust is that all policies tend to be a tick box. So, it isn't only this policy, 
I’m talking about all policies. Policy 
201 
‘P16’ – yes, I think there are people, no disrespect to them, some of the lower 
staff, they are not privy to policies, they probably don't know about the 
policies, so they might not even know where to look for them. Policy 
255 
‘P16’ - and that's when people tend to refer to policies, when something goes 
wrong, or if there's a particular interest, like I need to order something, and it 
costs £6000, what do I need to do? Then they may go and look for the medical 
devices policy.  Policy 
265 
‘P16’ - those that have to live by the policy, the medical devices policy, I would 
say, that I would be an expert in it, but I wouldn't be at a higher level within 
the Trust, sort of more middle management within the Trust. Policy 
319 
‘P16’ - I think the chief exec needs to know that we have a policy for medical 
devices management, she needs to be able to sit there in front of somebody if 
asked and categorically state ‘yes’ we have a policy for medical devices 
management. Policy 
327 
‘P16’ - it's how much you need to know as an expert, or not. A cleaner 
probably doesn't even need to know that there is a medical devices policy, but 
they're not an expert. Policy 
349 
‘P16’ - as an expert, you can have the best policy and could tick every box 
imaginable in the world, but if you're not communicating it with people, it's 
not going to work. Policy 
446 
‘P5’ – in fairness to ‘P8’, I know that you've been dealing with the policy, and 
you deal with ‘P8’, so I’ve kind of gone with what I get on with. Policy 
454 
‘P5’ – could we work off summary documents and leave the policy alone to 
meet the requirements in the same way that ISO does? Policy 
456 
‘P5’ – I would use the policy as the highway code because the CQC and NHSLA 
is ‘The Act’. Policy 
556 
‘P6’ – well that's okay, policies are all right, but policies are pages and pages 
long, and not what they need to know. This is what you need to do, this is 
how you need to do it, simple information. Policy 
This is an example of comments extracted from transcripts using the software tools to 
search for ‘policy’. As can be seen, each comment has a unique identifying number.  
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Appendix 11: Problems that effective health technology 
management could avoid 
This evidence supports the finding from my case study that the issues discussed can 
be dealt with by effective healthcare technology management, which then improves 
utilisation of medical equipment and reduces cost.  
Problems that effective 
HTM could avoid 
Resulting waste you could save 
Policy/planning: 
 lack of standardization 
 purchase of sophisticated equipment 
for which operating and maintenance 
staff have no skills 
 30–50% additional cost for extra 
spare parts and extra maintenance 
workload 
 20–40% of equipment remains 
underutilised or unused 
Procurement: 
 impact on equipment and buildings 
during installation, unforeseen at the 
initial tender stage 
 inability to correctly specify and 
foresee total needs when tendering 
and procuring equipment 
 
 extra modifications or additions 
required for 10–30% of equipment 
 10–30% additional unplanned costs 
Training: 
 improper use of equipment by 
operating and maintenance staff 
 loss of 30–80% of the potential 
lifetime of equipment 
Operation and 
maintenance: 
 excessive equipment due to absence 
of preventative maintenance, inability 
to repair, and lack of spare parts 
 
 25–35% of equipment out of service 
Table copied from How to Organize a System of Healthcare Technology Management 
(Lenel, et al., 2005, p. 31) 
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(Accessed 29 December 2012) 
NHS Wales' medical negligence payout doubles to £38m. The cost of care has increased 
dramatically, as well as the cost of specialist equipment. http://www.bbc.co.uk/news/uk-
wales-19324996 
CQC inspectors also found medical equipment in a state of disrepair, staff training 
inadequate and medicine managed unsafely. http://www.bbc.co.uk/news/uk-england-bristol-
16560550 
To deal with the fixed budget, the Trust said savings will have to be made to pay for rising 
energy bills, pay increments and the increased cost of drugs and medical equipment. 
http://www.bbc.co.uk/news/uk-england-tees-15544693 
The old Kent and Sussex Hospital site has been earmarked for housing and will be sold to a 
developer, with the funds used to buy medical equipment for the new hospital, the NHS 
Trust said. http://www.bbc.co.uk/news/uk-england-kent-15511517 
The cycle response units use adapted bicycles that carry medical equipment in panniers and 
are designed to navigate quickly through pedestrianised and built-up areas. 
http://www.bbc.co.uk/news/uk-england-14460687 
"If anyone has any medical equipment they have borrowed and it is no longer needed or 
used, please return it so that another patient can benefit. Returning the equipment will also 
help the NHS save money." http://www.bbc.co.uk/news/uk-england-beds-bucks-herts-
14183965 
"I have been told by individual health boards that the items taken from NHS premises include 
laptops, which may hold sensitive patient information, along with valuable medical 
equipment and even hospital furniture” http://www.bbc.co.uk/news/uk-scotland-12552888 
Too many Trusts are still not responding to patient safety alerts in England, campaigners say. 
Alerts are issued when potentially harmful situations are identified in health settings, such as 
the risk of overdoses or using medical equipment. http://www.bbc.co.uk/news/health-
12527071 
High-risk medical technology has been found to be infected by computer viruses and 
malware, health and security experts have said. They fear that the virus infections could 
become so severe that a patient may end up getting harmed. 
http://www.bbc.co.uk/news/technology-19979936 
Parents have been warned about the sale on the internet of dangerous fake digital 
thermometers…. The MHRA warned they could give inaccurate readings, posing a serious 
threat to children with potentially fatal illnesses such as meningitis. 
http://www.bbc.co.uk/news/health-18456550 
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Appendix 13: Application of Medical Devices Management Policy Model 
Xxxx Hospitals NHS Trust 
 
Title of policy  Medical Devices Management Policy 
Policy version number   
Status   
Policy author/s  John Sandham  
Policy consultees   
Negotiated through    
Accountable Director    
Approved by:  
Ratified by  
Date of ratification and implementation:  
Review date:  
Equality impact assessment completed 
and impact   
 
 
Document location    
Distribution and dissemination     
Principal target audience    
Responsibility for dissemination of policy 
to new staff   
 
NHSLA/Healthcare Commission/ALE 
impact   
 
 
LITERATURE SEARCH AND EVALUATION (Details in Section 9)  
 
REVISION HISTORY 
Version  Date  Summary of Changes  
   
   
   
   
   
06 June 2012 Inclusion of revised sample DEC forms 
(passport) Appendixes 1(a) to 1(b) – removal 
of old style DEC forms 1 (a) to 1 (b) 
07 July 2012 Inclusion of revised procurement processes: 
Flowchart p.8 updated  
08 July 2012 section 7 updated (Removal of 7.3 & 7.4 Re-
write of 7.5 – Purchase of medical equipment; 
Rewrite of 7.7 - loan equipment 
09 July 2012 Section 7.26  – Re-write of Company 
representatives procedure 
10 Aug 2012 Section 9 - Update of References for NHSLA 
Risk management standards and CQC 
compliance assessment. 
11 Dec 2012 4.16.Ward/Department Staff/Doctors/Junior 
Doctors are responsible for ensuring their own 
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Ratifying body Date of ratification  Version 
   
   
   
   
   
This policy has been ratified by Xxxx Hospitals NHS Trust Risk Committee. Circumstances may arise 
or there may be a change in guidance or legislation that requires the policy to be updated between 
now and the review date. The responsibility to ensure the policy review process is activated lies with 
the Medical Devices Manager. All policies remain in force until notification of an amended policy is 
circulated and posted on the Trust intranet.  
MONITORING THE EFFECTIVENESS OF POLICY IMPLEMENTATION 
Key Performance Indicators: Medical Devices Policy Training Status  
Date of Audit Report: Monthly and Annual Reports presented to Medical Devices Management 
Committee.  
Location of Audit Report: Corporate Services & Redevelopment 
 
Approval and Authorisation  
Completion of the following detail signifies the review and approval of this document, as 
minuted in the senior management group meeting(s) shown.  
 
 
APPROVAL RECORD (approval cannot take place until checklist is complete) 
 
Evidence Base validated and policy / 
guideline agreed by Specialist Group: 
Medical Devices Management 
Committee 
Date:  
Checked for NHSLA requirements by 
and proof read by:  
Clinical Governance & Risk 
representatives 
Date:  
Ratified by the Risk Committee: Committee Members Date:  
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1. POLICY STATEMENT 
1.1. Xxxx & Xxxx NHS Trust is responsible for ensuring that all Medical Devices and 
Equipment are managed correctly to ensure safety and cost efficiency. Any person 
prescribing or using a Medical Device accepts that they are competent to do so. 
 
2. SCOPE 
2.1. The scope of this policy applies to all staff that use or loan Medical Devices either on 
or off Trust Premises. This includes homecare devices.  
2.2. Diagram 1 below summarises the key policy relationships between 1. Procurement, 2. 
Training, 3. Maintenance and 4. Governance (Quality).  
 
Diagram 1 – Key policy relationships 
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3.1. The aim of this policy is: 
 To maximising safety, performance, efficiency, competency and quality through 





4.1. The Trust Board is responsible for nominating a lead director for Medical Devices. 
 
Chief Executive 
4.2. The Chief Executive has overall responsibility to ensure safe working with Medical 
Devices. These duties are delegated to the General, Medical, and Nursing Managers. 
 
Director of Nursing & Clinical/Medical Directors 
4.2 Director of Nursing & Clinical/Medical Directors should: 
 Ensure this policy is implemented. 
 
Medical Devices Management Committee 




4.3. To ensure full implementation of this policy in their areas. 
 
Risk Management System 
4.4. Medical device management is within the remit of the Trust Risk Management 
System.  
 
Medical Devices Manager 
4.5. The Medical Devices Manager is responsible for working with key stakeholders to 
enable them to implement and maintain this policy in their areas. 
 Reporting device policy issues to the relevant managers, the medical devices 
committee, and the Risk Committee. 
 Coordinate training needs analysis 
 Ensuring assistance on the policy is available for the Departmental Equipment 
Controllers 
 Ensuring training records are being maintained and audited.  
 Recording and alerting appropriate managers of any non-compliance. 
 
Ward/Dept Managers  
4.6. Ward/Department Managers are responsible for understanding and implementing this 
policy. These duties may be delegated under a locally agreed system, however, the 
responsibility for policy remains with the Ward/Departmental Managers.  
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Matrons  
4.7. Ensure nominated Departmental Equipment Controller (DEC) are responsible for 
identified equipment. 
4.8. Ensure that DEC’s receive training by attending a Medical Devices Policy 
Implementation Training. DEC refresher training is required every three years. 
4.9. Ensure that all relevant staff attend training on the equipment that requires mandatory 
training (i.e. high risk and specialist equipment). 
4.10. Decontamination lead to ensure the correct advice is obtained implemented and 
monitored, with regards to decontamination, cleaning and sterilisation of devices. 
 
Purchasing & Supplies Department 
4.11. The Purchasing and Supplies Department are responsible for providing information to 
staff on the correct process for selecting and procurement of Medical Devices.  
4.12. Any purchase of a Medical Device must have the required purchasing system 
documentation, including a pre-purchase questionnaire (PPQ). 
4.13. The Head of Procurement or a nominated deputy must attend the Medical Devices 
Committee. 
 
EBME/MES Departments (Contractor Run)  
4.14. The EBME/MES Departments are responsible: 
 To provide either direct servicing (Planned Preventative Maintenance (PPM) or 
repair) or external servicing of Medical Devices specified in the contract.  
 To authorise pre-purchase questionnaires prior to official orders being placed 
 To test equipment prior to first use (Acceptance Testing), ensuring electrical 
safety and correct operational functionality.  
 To condemn Medical Devices in accordance with the Trust policy. 
 To assist Wards and Departments with inventory management. Staff should 
comply with the Medical Devices Policy and have certificates of competency. 
 To keep records of all spare part purchases, testing, maintenance, faults, 
acceptance and disposal for each item of equipment. This includes technician 
who carried out the maintenance. 
 To maintain an accurate and current information database, regarding items of 
equipment, user manuals/ instructions and contract details. 
 To maintain a Medical Device Asset Register. 
 Ensure equipment must be labelled with electrical safety test date, date of last 
service and date of service due. 
 
All Healthcare Professionals  
4.15. Healthcare Professionals are responsible for: 
 Ensuring that they are competent in the use of any Medical Device used in the 
prevention, diagnosis or treatment of patients. 
 Educating End users (patients) in the use of any Medical Device required for 
their care and treatment. 
 All incidents involving Medical Devices are promptly reported in line with the 
incident reporting policy. 
 
Ward/Department Staff/Doctors/Junior Doctors 
4.16. Ward/Department Staff/Doctors/Junior Doctors are responsible for: 
 Ensuring their own competence prior to operating an item of equipment. 
 Seeking training to use the equipment when necessary (always asking for 
advice if unsure). 
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 Always visually checking the Medical Device for signs of damage and in service 
date labels are present before each use. 
 Reporting any broken or un-labelled Medical Device to EBME/MES as both are 
to be considered as unserviceable. 
 
Trust’s Manual Handling/Ergonomics Advisor 
4.17. The trust’s Manual Handling/Ergonomics Advisor: 
 Is responsible for coordinating training, identifying and the recording of all 
equipment used for lifting/lowering patients. 
 
Point of Care Testing Committee (POCT) 
4.18. The POCT Committee will have overall responsibility for advising the Board of 
arrangements needed to ensure safe working with all Pathology near patient testing 
and monitoring the progress of this policy. 
 
Point of Care Testing Pathology 
4.19. The Point of Care Testing Pathology are responsible for: 
 Providing either direct servicing (PPM or repair) or external servicing of Near 
Patient testing equipment specified in the contract  
 Authorising pre-purchase questionnaires prior to official orders being placed. 
 Testing equipment prior to first use (Acceptance Testing) 
 Assisting Wards and Departments with inventory management. Staff should 
comply with the Point of Care testing policy and have certificates of competency 
 Keeping records of all spare part purchases, testing, maintenance, faults, 
acceptance and disposal for each item of equipment. This includes who carried 
out the maintenance. 
 Maintaining an accurate and current information database, regarding items of 
equipment, user manuals/ instructions and contract details. 
 
 
Patient owned CPAP equipment  
4.20. A concession can be made for CPAP patient owned equipment, subject to the 
conditions in Appendix 2 and signing of waiver. 
 
5. DEFINITIONS  
 
Medical Device 
5.1. A Medical Device (or Medical Equipment, Diagnostic and Therapeutic) is any 
apparatus intended by the manufacturer to be used on human beings for the purpose 
of: 
 Diagnosis, prevention, monitoring, treatment or alleviation of disease 
 Diagnosis, monitoring, treatment of, or compensation for an injury or handicap 
 Investigation, replacement or modification of the anatomy or physiological 
process 
 Control of conception. 
 
And which does not achieve its intended action by pharmacological, immunological or 
metabolic means, but it may assist the human body in its function by such means. 
Examples and risk levels of Medical Devices can be found in Appendix 3.  For the 
purposes of this policy, a medical device does not include the following devices: 
 
 X-Ray devices that are covered by Ionising Radiation and Medical 
Equipment Regulations (IRMR). 
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 Pathology devices that are covered by Clinical Pathology accreditation. 
 
Electro-Biomedical Engineering (EBME) 
5.2 This department carry out the service and maintenance of medical devices at Xxxx 
Hospital. 
 
Managed Equipment Services (MES) 
5.3 This department carry out the service and maintenance of medical devices at Xxxx 
and Xxxx Hospitals. 
 
Point of Care Testing (POCT) 
5.4 Point of Care Testing team is service provided by the Trust Pathology department to 
manage all Pathology equipment used for near patient testing within the Trust. 
 
MHRA 
5.5 Medicines and Healthcare products Regulatory Agency. 
 
Medical Devices Management Committee 
5.6 This is the operational group that steers the development and implementation of the 
Medical Devices management policy and associated work streams.  
 
MDM 
5.7 Medical Devices Manager. 
 
MAINTENANCE 
5.8 This is the correction or prevention of faults by a programme of planned inspection, 
calibration and replacement of parts in order to keep the Medical Device performing as 
intended by the manufacturer.  ‘PPM’ means Planned Preventative Maintenance. 
 
DEC 
5.9 Departmental Equipment Controller. 
 
Off Label Use 
5.10 Off label use refers to the use of a device outside of the purpose intended by the 
manufacturer and for which it has been CE-marked.  
 
6 POLICY DEVELOPMENT 
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Identification & Consultation with Stakeholders 
6.1 The Policy is a ‘live’ document and can continue to change however any 
developments must involve consultation with the Medical Devices Committee, Risk 
Management Committee, Health & Safety Committee and Risk Governance 
representatives prior to being ratified by the Clinical Governance Committee 
 
Equality and Diversity Impact Assessment 
6.2 These guidelines have been considered in terms of the seven strands of equity and 
diversity, human rights, age, gender, race, sexual orientation, religion and disability 
and have been assessed as having no impact. 
7 MEDICAL DEVICES MANAGEMENT 
 
Inventory Management 
7.1 All Ward/Department Managers must:  
Have access to an inventory list, this information will be held by the Ward/Dept DEC, 
or be able to access the information through the on-site Medical Device Service 
Supplier (EBME/MES), or via the intranet. Continuous monitoring of the Medical 
Device asset is carried out as part of the EBME/MES preventive maintenance 
program. The master records will be held on an electronic database by EBME/MES, 
and equipment lists made available upon request in either electronic or paper format.  
 
 Check the asset list for their department is accurate with the relevant 
EBME/MES departments and to adjust any insertions/deletions of medical 
devices as required.  
 Liaise with the members of the Supplies Materials Management staff visiting 
the ward regularly to check stock levels, for regularly used consumable items 
and place orders on your behalf (where such a service is provided, although 
this is not available throughout the Trust). 
 Purchase new/replacement devices through the Supplies Department.  
 Forward all copies of third party/manufacturers service sheets to EBME/MES 
for them to record on their database.   
 
Fault Reporting 
7.2 Timely reporting of faulty medical devices is required in order to prevent the following: 
 To prevent incorrect readings and misdiagnosis. 
 To prevent the fault from getting worse. 
 Reduces cost owing to requiring less spare parts. 
 The faulty medical device is repaired faster and back in the hands of the 
operator. 
Faults should be reported by phone to the site EBME/MES service provider. 
Purchase of new Medical Devices 
7.3 Ward/Department/Team leaders and service managers must take a planned approach 
to the purchase of Medical Devices in accordance with the Policy. 
7.4 Purchase of all Pathology near patient testing equipment must first be approved by the 
Point of Care Testing Committee. 
7.5 The need for medical equipment should be identified and prioritised within the 
Directorate and the means of funding identified.  The procurement process is the 
same, regardless of the source of funding. 
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7.6 All equipment must meet the Trust’s device standardisation, where such 
standardisation has been agreed, information can be obtained from Supplies or the 
Medical Devices Manager. 
7.7 A Pre-Purchase Questionnaire (PPQ Form) must be provided for all equipment and be 
provided to the on-site equipment management and maintenance providers for 
approval. 
7.8 The requirement for and means of cleaning and decontamination of the medical 
device must be considered as part of the selection process. Approval must be given 
by the Infection Control Team, Decontamination Manager and Sterile Services 
Manager prior to purchase. 
7.9 If an item of medical equipment requires consumables the suitability of these items 
and their costs must be considered as part of the selection process. 
 
7.10 Where applicable, a service contract should be taken out with the on-site equipment 
management and maintenance provider or the original equipment supplier (or 
acceptable alternative) allowing for on-going maintenance and repairs. This cost must 
be identified as part of the selection process. 
7.11 All equipment requests must have budget holder approval and be accompanied by a 
statement of need.  If equipment is being replaced, a condemning note for the current 
equipment must accompany the request. If additional equipment is being requested, 
full details of what has necessitated this must be provided. 
7.12 All requisitions for medical equipment will be referred to the monthly meeting of the 
Medical Devices Management Committee for approval, regardless of the source of 
funding.  
7.13 All purchases must be processed via the Supplies Department. Staff may not place 
orders directly with company representatives or make any commitment to purchase.   
7.14 All procurement will be managed by the Supplies Department and will be undertaken 
in accordance with the Trust’s Standing Financial Instructions.  For full details contact 
the Supplies Department. 
Commissioning/Acceptance procedures 
7.15 All Medical Devices (equipment), on first (and subsequent returns, in the case of 
Loan/Demo units) arrival on site, must be delivered to the Goods Receipt and 
Distribution Area of the Supplies Department  
7.16 The Medical Device will then pass to EBME/MES/POCT who will: 
 Log the device into the appropriate Asset Database (Trust /Loan /Demo 
equipment) 
 Issue an asset ID for each new Trust Medical Device 
 Check to see that it conforms to specification 
 Undertake an Electrical Safety test as needed, to ensure unit is safe to use 
 Note service contract details and update the service calendar 
 Liaise with Supplies /Manufacturer/Medical Devices Manager, for Training on 
the unit and inform users about the day-to-day checks and operation 
 Notify Supplies on completion of process, so that approval to issue unit to User 
can be given 
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7.17 When a Medical Device is issued to a User, staff must ensure that: 
 All Medical Devices have been acceptance tested or in the case of radiological 
or pathology equipment that a pro-active risk assessment and critical 
examination have been performed 
 They take part in suitable training, with the manufacturer, or local authorised 
trainer, on the correct use and clinical limitations of the product, prior to use 
 They receive instructions on how to use the device safely, including storage and 
handling 
 Ensure that the equipment is always used and stored according to the 
manufacturer’s instructions 
 That the device is locally maintained and cleaned appropriately, in accordance 
with instructions detailed in the CRAFT FOLDER 
7.18 After training, trainers will enter staff training details on the training database in the 
Education and Training Department. 
7.19 Local records must be held by the area manager or supervisor, which must be kept up 
to date and available on request, without prior notice. 
 
Indemnity Process  
7.20 Loan of Equipment Free of Charge and Free Issue of Consumables 
7.21 The Trust’s Indemnity Process must be followed when the Trust wishes to make 
arrangements for a supplier to provide equipment or consumables free of charge, i.e. 
items that are not covered by an official purchase order of the Trust. Such items may 
typically be provided on loan, or for a trial or be free issue.  
7.22 The signed indemnity documentation creates a contract between the Trust and the 
supplier.  It lays out the responsibilities of both the Trust and the supplier.  The 
equipment becomes the responsibility of the Trust and must be returned in the 
condition it was provided.  It protects the users of the equipment and the Trust, 
provided that the goods are used for the correct purpose, in the correct manner, by 
competent and appropriately trained persons, should the goods cause harm, injury or 
death to staff, patients or other persons or cause damage to the Trust’s premises. 
7.23 Anyone not following the Indemnity Process may be held personally liable for any loss 
or damage to the goods/equipment or the Trust’s premises and for any harm that may 
be caused to patients, staff or any other parties. 
7.24 The Supplies Department administers this process on behalf of the Trust and must be 
notified in the first instance and prior to any supply arrangements being made.  Under 
no circumstances are free of charge items to be left on the Trust’s premises until the 
Indemnity Process has been fully completed.  
7.25 A minimum of 14 calendar days’ notice is required for the completion of this process.  
The Supplies Department will confirm when approval has been given, thus enabling 
the items to be accepted on site. 
7.26 If approval is rejected the items will not be allowed on site and this matter will be 
discussed and dealt with as appropriate.  Until approval confirmation has been 
received from the Supplies Department the items must not be allowed onto the Trust’s 
premises. 
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Devices manufactured in-house 
7.27 Where applicable, Medical Devices manufactured in-house, must comply with and 
satisfy where appropriate, all procedures set out in this policy. 
7.28 Clinical investigations involving non-CE-marked medical devices 
7.29 If the Trust agrees with a medical device manufacturer to take part in a pre-CE 
marking Clinical Investigation of a new medical device. The following must be taken 
into consideration: 
 Has the MHRA issued the manufacturer with a letter of no objection? 
 Has the relevant ethics committee given approval for the study?  
 Have the relevant healthcare professionals received adequate training? 
 Are there arrangements in place to segregate the investigational devices from 
other CE-marked medical devices and to ensure that the only healthcare 
professionals to use the investigational device are those named as clinical 
investigators in the application to the MHRA?  
 
Safety and Incident reporting 
7.30 Managers should ensure that all team members understand their responsibility 
regarding faulty equipment. 
7.31 Act immediately on Hazard and Safety Notices, taking appropriate action and provide 
required feedback to the Medical Devices Manager. 
 
7.32 All staff must report any adverse incident involving Medical Devices on the IR1 
(Incident Reporting Form). The product along with disposables must be quarantined 
and the Medical Devices Manager must be informed immediately. 
7.33 Ensure that any equipment sent for repair is cleaned/decontaminated and 
appropriately labelled, with the fault details recorded along with any facts known as to 
the malfunction. 
 
Training for healthcare professionals 
7.34 The manufacturer must provide suitable training on the correct use and clinical 
limitations of the product prior to use. 
7.35 All staff must ensure they are competent in the use of Medical Device before use. 
7.36 Managers are responsible for monitoring the training and competency assessment of 
Ward/Departmental staff in the equipment they use. Notify Medical Devices Manager 
of training requirements and keep a training log of all staff training (Appendix 4 and 5).  
7.37 Each clinical area will have easy access to user manuals kept in electronic or in 
hardcopy format. 
 
Training for end users 
7.38 Patients/carers (End users) must be given clear guidance on how to use Medical 
Devices loaned or given to them to use at home. Trust staff issuing Medical Devices to 
patients are professionally accountable and must not issue any device unless they are 
competent to do so. Training will be given (if necessary) when the device is issued to 
the end user. The most commonly issued devices include Nebulisers, feeding pumps, 
Zimmer frames, etc. 
7.39 Staff providing Medical Devices to Patients/Carers must pass on the manufacturer’s 
instructions about the safe use of the product when the end user is the patient. This 
will minimise any legal liability in the case of an accident. 
7.40 The Patient/Carer should receive training in the use of the equipment prior to its use. 
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7.41 Staff must document that the Patient/Carer has received instructions and that the 
Patient/Carer is fully aware of the instructions importance.  Both parties are to 
document training, the patient and the end user/patient. 
7.42 The Patient/Carer must be given clear instructions about who to contact in the event of 
equipment failure. 
7.43 All locally produced instructions, (whether verbal or written), supplied to the user 
(patient/carer, [home use devices]) must be evaluated for their adequacy by the 
professional prescribing the device for home use. 
 
Servicing, Maintenance, Repair, Replacement 
7.44 Any reusable medical device must have a maintenance regime. This will be either 
provided by EBME/MES on site or by contracted engineer if the device requires 
specialised maintenance. 
7.45 All Equipment requiring servicing must be identified, coded and entered on the 
equipment database. 
7.46 Where applicable, ensure a service contract is made with the company supplying the 
equipment and allow for any on-going costs of servicing, maintenance or repairs. 
7.47 All equipment must be serviced, maintained and repaired in accordance with the 
manufacturer’s recommendations and service dates recorded on an asset database, 
managed by the EBME/MES managers.  Medical devices are to have a dated 
serviceable label attached. 
 
7.48 All copies of third party manufacturers service reports left with the user must be 
forwarded to EBME/MES Department for recording. 
7.49 All new and replacement equipment should be identified as part of the business 
planning process. 
7.50 Ensure any daily/weekly user maintenance checks are performed and documented as 
required, as per manufactures instructions. 
 
Decontamination of Medical Devices 
7.51 Single use devices should not be reprocessed or reused under any circumstances 
7.52 Medical Devices must be cleaned/decontaminated between patient uses in 
accordance with the Decontamination policy. 
7.53 Ensure that equipment sent for repair (external or internal) has been cleaned and 
transported in accordance with Trust Decontamination Policy. Equipment for Repair 
Label (Appendix 6) is to be completed and attached to each item sent for repair. 
7.54 All Medical Devices must be decontaminated, and stored correctly when not in use. 
For example, equipment that has an internal battery, should be kept plugged in, to 
keep the battery charged. 
 
Decommissioning of Medical Devices 
7.55 Electronic or mechanical Medical Devices for condemning must be returned to the 
EBME/MES Department for condemning.  Disposal of these devices will be completed 
in accordance with the Trust disposal procedure. 
7.56 Contact the Supplies Department to obtain the necessary form and guidance 
(Appendix 7). 
7.57 Any non-reusable devices must be disposed of either through the yellow bag waste 
system or be disposed of following the special waste procedure. 
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Medical Device Training 
7.58 The purpose of this guidance is to ensure that professional users are competent to 
prescribe and use medical equipment in a safe and effective manner.  Appendix 3 
gives examples of high, medium and low risk Medical Devices. 
7.59 This guidance covers all medical equipment at Xxxx Hospitals NHS Trust. The 
designation ‘Medical Device’ covers a wide range of products used every day across 
the Trust.  
7.60 The Medical Devices Manager will provide advice and support for any medical device 
training. Training will be provided by any of the following: 
 Self-Certification 
 In-house training (One professional user to another). 
 The supplier. 
 Policy training (e.g. Resuscitation or Training Officer) 
7.61 Training records will be kept within the Dept/Ward’s DEC Folder and a training needs 
analysis will be carried out using this folder. 
7.62 Training for all Pathology Point of care equipment will be provided/coordinated by the 
Point of Care Testing Team for all areas. 
 
Medical Devices Training Inventory 
7.63 The medical devices training inventory will be updated on department passports, by 
the following method: 
 
7.64 All purchases by the Trust are agreed at the Medical Devices Committee.  A list of 
these devices and the receiving department are to be given to Medical Devices 
Management in order that:  
 The Medical Devices Passports on the S-Drive are updated 
 The DEC are notified of the changes to their Medical Devices Passports and 
training can be arranged for the relevant clinical staff that are authorised to use 
the device 
 
Authorised users of medical devices 
7.65 The method used by the organisation to identify which staff are authorised to use the 
equipment listed on the inventory is:  
 The DEC will decide if the staff member is an authorised user and document it 
in column (e) of the training form in Appendix 5.  The DEC will issue a Medical 
Device Passport to all new clinical staff members.  This should be documented 
on the Employee Induction Checklist for Local Induction.   
 
Frequency of Training 
7.66 The method that the Trust decides the training and how the Trust decides the 
frequency of updates required is as follows:  
Registered Nurses: 
 Low risk medical devices - Self-certification on these devices may take 
place provided that there is not a policy that dictates that specialised 
training is required.  Staff should self-certify every five years. 
 Medium risk devices - Self-certification on these devices may take place 
provided that there is not a policy that dictates that specialised training is 
required and appendix 8 is completed.  Staff must self-certify every five 
years.   
 High-risk devices - Training must take place on these devices and 
refresher training to take place every three years.  (Training can be in-
  Appendix 13 
Medical_Devices_Policy_Sept_13_ xxxx Trust  185 
house training or by the manufacturer, however it must be documented 
training) 
 Health Care Support Workers, Theatre Support workers, Rehab Assistants, 
Community Nursery Nurse, etc. are not permitted to self-certify on low, medium 
or high-risk medical devices.  They must have documented training either in 
house or from the manufacturer.  Refresher training is to take place every three 
years.   
 
Qualified Doctors, Surgeons and Anaesthetists 
7.67 Qualified doctors can self-certify in all risk areas, but are accountable and must ensure 
they are able to use devices safely. The following are risk categories apply: 
 
 Low risk medical devices - Self-certification on these devices may take 
place provided that there is not a policy that dictates that specialised 
training is required.  Staff should self-certify every five years. 
 Medium risk devices - Self-certification on these devices may take place 
provided that there is not a policy that dictates that specialised training is 
required.  Staff must self-certify every five years. 
 High-risk devices – Self Assessment for training needs should take place 
on these devices and refresher training/assessments should take place 
every three years.  Doctors must make the organisation aware of their 
training needs and must not use high-risk devices unless they are trained 
and competent to do so. 
 
How the Trust records that all permanent staff complete training  
7.68 Recording of all permanent staff that have completed training is to be recorded on the 
Medical Devices Training Passport (Appendix 5), or via an electronic passport on the 
Trust server. 
 
How the organisation follows up those who do not complete training 
7.69 Medical device audits of the Medical Devices Passports will take place at least 
quarterly.  Wards/depts. that require training for their staff will be identified in an audit 
report.  This audit report is an agenda item at the: 
 Risk Committee 
 Medical Devices committee 
 
Action to be taken in the event of persistent non-attendance. 
7.70 Staff that do not attend training (when they have been booked on training) are not to use 
the medical device.  This is to be discussed during their annual appraisal and 
documented on the Medical Devices Training Form. (Appendix 5). 
 
Records of training 
7.71 Formal equipment training records must be maintained at departmental level. Policy 
training will be provided for DEC’s and records will be retained by each department, 
either in paper or electronic format. Equipment training records (Appendix 4 and 5) will 
also be held by each department DEC.  A record of all trained DEC’s is kept by the 
MDM. 
 
Training of bank staff 
7.72 Equipment training for bank staff will be provided as part of the bank nurse induction 
training. However, each department must ensure that bank staff and agency staff 
receive local induction and are safe to use equipment using the same procedures as 
trust staff. 
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Managers’ and Supervisors’ responsibilities 
7.73 All managers and supervisors must ensure that their staff have received adequate 
training and instruction, and be competent to use a Medical Device prior to its use on 
a patient. 
7.74 The onus is on the manager/supervisor to be able to prove that staff or people they 
have instructed to use a medical device are competent to do so. Training will be 
discussed at induction and will be monitored on an on-going basis to ensure training 
needs are met. 
 
Healthcare Staff 
7.75 All staff members must have the necessary training and instruction on a Medical 
Device and be passed as competent by their manager before using a Medical Device 
on a patient or providing equipment on loan to a patient. 
 
Users and Carers 
7.76 Users should ensure that they have received adequate instruction and training, and 
feel competent to use a Medical Device that they have been requested to use. 
 
EBME/MES Department training 
7.77 The contractor must ensure that their engineers have the required training and 
competency to repair as well as to give advice on Medical Devices.  NB: Equipment 
Competency Training Records (Core Competencies).  These records must be 
completed for each piece of equipment as evidence of the practitioner’s competence 
using assessment and performance criteria. 
7.78 Professional users are expected to understand the following policies: 
 Medical Devices Management Policy 
 Infection Control Policy (including the Decontamination section) 
 Incident Reporting Policy 
 Risk Management Strategy and Policy, Health and Safety Policy 
 Point of Care Testing Policy 
 
Adverse Incidents 
7.79 Adverse incidents where a patient has been or may have been injured as a result of a 
Medical Device failure must be reported on: 
 The Trust Incident Reporting system Incidents should be reported by the 
individual who first notices the incident, who should then follow trust guidelines 
on reporting 
 Escalate on the management system dependent on the severity 
 Complete an MHRA adverse incident report (if applicable) – as found on the 
website: www.mhra.gov.uk 
 User may complete an adverse incident form for their professional institute as 
appropriate 
 Inform the EBME Manager 
7.80 Any incident involving a Medical Device failure or misuse should be reported on the 
incident reporting system (DATIX), and/or when believed serious should follow the 
serious untoward Incident Policy. 
7.81 Any equipment involved in an incident that has been reported to EBME/MES/POCT 
immediately. They must be made aware that the device has been involved in an 
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incident. It is then the task of the EBME/MES provider to investigate whether the 
equipment has malfunctioned. The equipment should be quarantined with any 
consumable items used and all settings to be left as they were. 
7.82 EBME/MES are to report their findings to the clinical governance department as soon 
as possible. 
Company Representatives Procedure 
7.83 Xxxx Hospitals NHS Trust recognises the role that suppliers play in supporting health 
practitioners and other staff members in providing safe, effective and economic 
products and services to our patients. 
7.84 It is also recognised that representatives are present to promote and sell their 
products and services. This function should not contravene Trust, NHS or government 
policies and should be carried out in a proper and ethical manner. 
7.85 The purpose of this procedure is: 
 To ensure sound and professional working relationship between the Xxxx NHS 
Trust and its current and potential suppliers 
 To supply information on how the Trust expects company representatives to 
behave and the behaviour they can expect from the Trust’s staff 
 To ensure the Trust’s Indemnity Procedure is adhered to 
7.86 The procedure will be available to suppliers through the Supplies Department. Copies 
will also be made available to staff. 
7.87 Representatives promoting pharmaceutical products must first contact the pharmacy 
to make an appointment. The first point of contact for pharmaceutical representatives 
is the Principal Pharmacist Medicines Management, via the Chief Pharmacist.  The 
content of this procedure applies to all visits to the Pharmacy Departments.  The 
Principal Pharmacist Medicines Management will explain any additional requirements. 
7.88 Representatives promoting pathology products must first contact the Pathology 
Department and make an appointment. 
7.89 Representatives for resuscitation products / training equipment must first contact the 
Senior Resuscitation Officer to make an appointment.  
7.90 To make an appointment to see a member of the Supplies staff please contact the 
Supplies Department on 1234at Xxxx or 1234 at Xxxx. 
7.91 To make an appointment to see Consultants or other senior medical staff please 
contact the appropriate secretary. Junior medical staff may only be seen by 
arrangement with the relevant consultant.  
7.92 Company representatives arriving for an appointment on the Trust’s sites must visibly 
display their company identification badge containing their photograph, name, position 
and the name of the company they are representing.  
7.93 Immediately upon entering the Trust’s sites, company representatives are required to 
visit the Supplies Department to register and obtain a Trust’s company representative 
authorisation badge for the purpose of their visit. 
7.94 Visits that have not been pre-arranged with a named senior member of Trust staff are 
not permitted. Supplies will telephone ahead to let the member of staff know of your 
arrival and confirm that this is still convenient. Additional restrictions apply to certain 
areas such as ITU, Paediatrics and Maternity Units. This will be explained upon 
signing in.  Company representatives must not visit clinical areas if they feel unwell; or 
have any infection; or within 48 hours of experiencing vomiting and/or diarrhoea; or in 
the event that a ward is closed due to infection. 
7.95 No more than two representatives from one company may attend an appointment. 
Exceptions to this will be considered by prior arrangement with the senior member of 
staff of the area involved.  
7.96 Repeated visits should not be made to the same member of staff unless specifically 
requested by that individual. 
7.97 The wearing of nursing apparel or garments similar to doctors or other Trust uniforms 
is prohibited unless specifically requested to do so by a senior member of Trust staff. 
7.98 When on site, representatives must comply with instructions given by an authorized 
member of Trust staff in the event of an emergency situation, for example in the event 
of fire, and comply with Trust site instructions, for example restrictions on smoking and 
parking.  
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7.99 The Trust has an incident reporting procedure.  If a company representative is 
involved or affected by any untoward or adverse incident whilst on site they are 
required to report this to the senior member of staff of the area which they are visiting, 
who will take appropriate action. 
7.100 Following completion of meetings, the Trust’s authorisation badge must be returned to 
the Supplies Department and the representative is then required to sign out.  
7.101 On no account should a Trust’s authorisation badge be taken from the premises and 
used for repeated visits. Failure to comply with this rule will be construed as a 
deliberate attempt to contravene the Trust’s procedure. 
7.102 Company representatives should be well informed about the products they are 
promoting. Standard, technical, and where appropriate clinical data should be made 
available. Information on product effectiveness should be included. Price comparisons 
should not be used, unless they are approved by the Trust’s Supplies Department. 
7.103 Leaflets and posters produced by suppliers must not be distributed or displayed in 
clinical areas unless approved in advance by the Trust. 
7.104 Company representatives are not permitted to use the Trust’s policies for the 
promotion of their products or services without written permission from the Trust. 
7.105 Under the Bribery Act 2010, it is a criminal offence for an employee to offer, promise 
or give a bribe; request, agree to receive or accept a bribe; bribe a foreign public 
official to obtain or retain business 
7.106 Business gifts, other than items of very small intrinsic value such as diaries or 
calendars may not be accepted by Trust staff, therefore should not be offered. 
7.107 When Trust staff make visits to inspect equipment or sites with a view to make a 
possible purchase, the Trust will meet the cost of travel, accommodation and meals 
7.108 Commercial sponsorship relating to conferences or courses may be acceptable if 
approved in advance by the individual’s line manager and if the line manager is 
satisfied that acceptance will not compromise purchasing decisions in any way. 
7.109 Sponsorship for meetings of an educational, training or developmental nature, may be 
accepted, providing that the level of hospitality is that which the NHS would normally 
provide. Hospitality provided should be secondary to the purpose of the meeting. 
7.110 The implications of any sponsorship will be carefully explored before any    agreement 
is reached. 
7.111 The Trust’s Indemnity Process must be followed when the Trust wishes to make 
arrangements for a supplier to provide equipment or consumables free of charge, i.e. 
items that are not covered by an official purchase order of the Trust.  Such items may 
typically be provided on loan, or for a trial or be a gift. Guidance on the Indemnity 
Process is available through the Supplies Department who administer the process. 
7.112 Companies must be registered on the Department of Health’s ‘NHS Master    
Indemnity Agreement Register of Suppliers’ prior to any discussion in relation to free 





7.113 Company representatives must not enter into any agreement in relation to free of 
charge goods or equipment on loan, trial, test or free issue e.g. products trials etc. 
without prior approval from the Trust’s Supplies Department. 
7.114 No free of charge goods or equipment are to be left on the Trust’s premises until the 
Indemnity Process has been fully completed.  A minimum of 14 calendar days’ notice 
is required for the completion of this process. 
7.115 Drug samples are not permitted to be left in any area of the Trust for any reason. 
7.116 Trials must be arranged through the Supplies Department to ensure that: 
 Trials are carried out in accordance with the Medical and Surgical Consumables 
User Group 
 Trials are carried out on a controlled basis 
 The product in question meets the appropriate safety standards 
 Trials are not duplicated 
 Separate arrangements apply for trials involving medicines.  All such trials 
require Ethics Committee approval.  In the first instance please contact the 
Trust Chief Pharmacist. 
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Equipment Library 
7.117 An equipment loan service has been established on the Xxxx NHS Trust Sites. The 
loan service is available to the general wards and departments for Short Term & 
Courtesy Loans. For example: 
 Infusion pumps  
 Syringe drivers 
 Nebulisers 
 Monitors 
7.118 Further information is available in Appendix 9, and on the intranet under the 
‘Equipment Library’ section. 
 
8 MONITORING COMPLIANCE 
 
Medical device Asset/Inventory 
8.1 Process for monitoring - The medical equipment asset is carried out annually as part 
of the PPM program. The master records will be held on an electronic database by 
EBME/MES, and equipment lists made available upon request in electronic or paper 
format.  
8.2 Annually additions and deletions to the database will be agreed at the EBME/MES 
Contract review group. 
8.3 DECs are to contact the EBME/MES every 6 months to confirm the accuracy of the 
database on the intranet.  It is to be documented that the departments DECs have 
confirmed the accuracy of the asset database by the relevant EBME/MES department.  
This is to be discussed at the Medical Devices Committee 
8.4 All new medical devices purchased by the Trust should be acceptance tested, during 
this process all medical devices will be given a unique asset number and this, along 
with the details of the medical device are entered onto a medical devices database. – 
How is this audited Should it be by the Trust. 
 
Adverse Incidents 
8.5 Incidents, involving Medical Devices, will be monitored by the EBME Manager and 
significant trends will be reported to the Clinical Governance Committee in accordance 
with their reporting schedule. 
 
Medical Devices Training 
8.6 The Medical Device Manager will monitor completions of the training needs analysis 
and report to the Medical Device Management Committee. Uptake of training will be 
monitored and systems improvements will be reported to the: 
 Medical Device Management Committee 
 Risk Committee 
 
How the organisation monitors compliance of medical devices training 
8.7 As part of the monitoring an audit is carried out at least quarterly.  This consists of: 
 Medical Devices Management visiting departments 
 Reviewing the Medical Devices Policy Folder 
 Advising on areas of the policy that are not being met. 
 Collecting information on any areas of concern with regards Medical Devices 
 Completing a Medical Devices Training report 
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8.8 Medical Devices Management will audit the completion of the Medical Devices 
Passports at least quarterly.  A report is completed that documents each department’s 
compliance with the relevant assessment.  This will also highlight the next stage for 
completion of Medical Devices Training.   Departments will be audited against the 
following criteria: 
 Department Equipment Controller (DEC) is identified. 
 DEC receives training. 
 Training is recorded. 
 The DEC informs their department of the ‘Management of Medical Devices 
Training Folder and The Medical Devices policy. 
 The DEC categorises staff levels. 
 The DEC identifies risk levels of all medical devices. 
 The DEC identifies the training needs analysis for all staff from the completed 
Medical Devices Training Passports. 
 The DEC ensures that training is completed. 
 
8.9 Where monitoring identifies any deficiencies this is to be reported monthly to the: 
 Risk Committee 
 Medical Devices Committee 
 
8.10 Where compliance is less than 95% completion of training, action plans are to be 
completed in accordance auditing process and reported to the: 
 Risk Committee 
 Medical Devices Committee 
 
8.11 The Medical Device Management Committee and Risk Committee will monitor 
implementation of this policy.   
Fault reporting 
8.12 Audits of the fault reporting system is to be carried out by EBME/MES technicians and 
deviations from the process are to be reported to the: 
 Risk Committee 
 Medical Devices Committee 
 
Maintenance and Repair 
8.13 Auditing of the maintenance and repair of medical devices is to be carried out twice a 
year ensuring that Medical Devices have an: 
 Asset Label 
 In date serviceability sticker 
 Manufacturer’s Technical literature is available to the technician 
 Technicians are trained to repair and maintain the device 
8.14 This should be reported to the: 
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10. ASSOCIATED DOCUMENTATION 
 
Adverse Event Policy 
Infection Control Policy 
Decontamination Policy 
Point of Care Policy 
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Appendix 2 - CPAP Patient Owned Equipment 
Conditions of use: 
1. When patients bring in their own Constant Positive Airway Pressure (CPAP) device, 
indemnity will not be required, but the patient must sign a ‘Patient Waiver Form’. Note: 
normally, Indemnity insurance is required for an item of loan equipment. 
 
2. Patients must be trained to use their device safely. The device is not to be used if their 
device is normally set up for them by a community nurse/carer and they are not suitably 
trained in the operation of the device. 
 
3. If Nursing or Clinical staff are not trained to use the CPAP device, they must inform the 
patient. 
 
4. In the event of a device failure, the patient will be placed onto a Trust owned CPAP 
device. 
Note:  
 Staff must document that the Patient is fully aware that they are not able to adjust / set 
up the patient owned device.      
 The Patient must give clear instructions to the Trust about who to contact in the event of 
equipment failure. 
 All instructions, (whether verbal or written), supplied to the user (patient [home use 
devices]) must be evaluated for their adequacy by the professional prescribing the 
device for use. 
 
Patient Waiver Form 
Date......................................   Ward/Dept................................................ 
 
I wish to use my own CPAP equipment and accept responsibility for the clinical settings and 
maintenance of the device. 
 
Patient Name........................................................    
 
Signature...................................................   (Block capitals) 
 




Is equipment faulty?     Yes      ⁪         No   ⁪ 
 
Device decontaminated? (As per manufacture’s guidelines) 
                          
Cleaned/decontaminated     Yes      ⁪         No   ⁪ 
 
Is equipment serviced and functional?        Yes      ⁪         No   ⁪ 
 
Please ensure all faults are reported immediately to the EBME Department on: 
  
Xxxx Ext. 2216     
Xxxx Ext. 4123 
  Appendix 13 
Medical_Devices_Policy_Sept_13_ xxxx Trust  194 
Appendix 3 - Common Categories of Medical Devices and Risk Levels 
Device Name Risk 
classification Air Compressor L 
Amalgamator Dental L 
Ambulatory Ecg Analyser L 
Ambulatory Ecg Recorder L 
Arm Exerciser L 
Arrhythmia Simulator L 
Audiometer L 
Battery Care Unit L 
Battery Pack L 
Bed Electric L 
Bilirubinometer L 
Blood Glucose Meter L 
Blood Hemoglobin Analyser L 
Bp Monitor L 
Breast Pump L 
Camera L 
Camera Adaptor L 
Camera Control Unit L 
Centrifuge L 
Charger L 
Co2 Module L 
Computer L 
Control Module L 
Couch L 
Cpm Controller L 
Curing Light L 
Dental Chair L 
Dental Drill L 
Diathermy Smoke Evacuator L 
Doppler L 
Drill L 
Drying Cabinet L 
Ecg Analysis System L 
Ecg Module L 
Ecg Monitor L 
Ecg Recorder L 
Ecg Telemetry Receiver L 
Eeg Display Recorder L 
Electro Acupuncture Unit L 
Endoscopy Trolley L 
Enteral Feeding Pump L 
Entonox Regulator L 
Enuresis Alarm L 
Equipment Trolley L 
Examination Light L 
Exercise Bicycle L 
Exercise Machine L 
Exercise Treadmill L 
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Eye Test Chart L 
Fetal Monitor L 
Freezer L 
Fridge L 
Fume Cabinet L 
Ice Making Machine L 
Incubator Laboratory L 
Indirect Ophthalmoscope L 
Irrigation Pump L 
Jaundice Meter L 
Light Meter Phototherapy L 
Light Source L 
Limb Compression Pump L 
Mattress Pump & Heater L 
Microscope L 
Multi Gym L 
Multi Parameter Patient Module L 
Nasopharyngoscope L 
Nebuliser L 
Nerve Stimulator L 
Nerve Stimulator L 
Nibp Module L 
Nibp Monitor L 
Operating Lamp L 
Operating Microscope L 
Operating Table L 
Ophthalmascope L 
Opthalmic Echograph L 
Overhead  Theatre Lamp L 
Oxygen Analyser L 
Oxygen Controller L 
Patient Chair L 
Patient Couch Electric L 
Patient Couch Manual L 
Patient Heating Pad L 
Patient Trolley Electric L 
Patient Trolley Manual L 
Patient Warmer L 
Ph Meter L 
Phototherapy Unit L 
Plaster Saw L 
Plinth L 
Power Supply L 
Power Unit L 
Printer L 
Printer Module L 
Pulse Oximeter Module L 
Refractometer L 
Respirometer L 
Rowing Machine L 
Scales Infant L 
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Scales Laboratory L 
Scales Patient L 
Shaker L 
Slit Lamp L 
Spirometer L 
Step Exerciser L 
Suction Unit L 
Temp Module L 
Thermometer L 
Thermometer Tympanic L 
Tonometer L 
Trolley L 
Ultrasonic Bath L 
Ultrasonic Therapy Unit L 
Uninterruptable Power Supply L 
Urine Chemistry Analyser L 
Uv Lamp L 
Uv Treatment Unit L 
Vcr L 
Video Camera L 
Video Control Unit L 
Video Display Unit L 
Video Imager L 
Video Printer L 
Video System Trolley L 
Visual Field Analyser L 
Water Bath L 
Wax Bath L 
Apnoea Monitor M 
Baby Alarm M 
Bench Top Steriliser M 
Blood Warmer M 
Bronchoscope M 
Cautery Unit M 
Central Patient Monitor M 
Colonoscope M 
Colonoscope Evis M 
Colposcope M 
Cpap System M 
Cryogenic Treatment Unit M 
Emg Machine M 
Endoscope Washer M 




Infant Respiration Monitor M 
Infant Resuscitator M 
Infant Warming Unit M 
Insufflator M 
Interferential Unit M 
  Appendix 13 
Medical_Devices_Policy_Sept_13_ xxxx Trust  197 
Intusussception Insufflator M 
Laser Indirect Ophthalmic M 
Patient Monitor M 
Pulse Oximeter M 
Respiratory Gas Monitor M 
Short Wave Diathermy M 
Sigmoidoscope Flexible M 
Theatre Table M 
Tourniquet M 
Ultrasound Scanner M 
Ventilator Alarm M 
Anaesthetic Machine H 
Defibrillators H 
Electrosurgical Unit H 
Hyfrecator H 
Incubator Infant H 
Incubator Infant Transport H 
Infant Flow Driver H 
Infusion Pump Syringe H 
Infusion Pump Volumetric H 
Laser Argon Slit Lamp H 
Laser Yag H 
Pacemaker External H 
Resuscitaire Infant H 
RFLesion Generator H 
Ventilator Adult H 
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Appendix 4 - Form 1 - Staff Level Assessment Form 
 
NAME OF DEPARTMENT:  
 
The DEC is to list and categorise the staff level of all members of clinical staff that use medical 
devices, in the department.   
 Staff level 3: Staff indicated as trained as competent and authorised to use low, medium 
and high-risk medical device(s) 
 Staff level 2: Staff indicated as trained as competent and authorised to use low and 
medium risk medical device(s) 
 Staff level 1: Staff indicated as trained as competent and authorised to use low risk 
medical device(s) only 
 
NAME TITLE Staff Level 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
PLEASE NOTE: You must include yourself on this list, and keep it updated for all new members 
of staff and promotions 
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Appendix 5 - Medical Devices Training Passport 
This Medical Devices Training Passport should be signed annually 
during an appraisal by a line manager to confirm that all medical 
devices training has been reviewed in accordance with: 
 NHSLA risk management standard 2.7 
 CQC’s essential standards of quality and safety Outcome 
11 
 MHRA DB 2006 (05) Managing medical devices 
 
Print: Sign:   
Date: Appointment 
 
Print: Sign:    
Date: Appointment: 
 
Print: Sign:    
Date: Appointment: 
 
Print: Sign:    
Date: Appointment: 
 
Print: Sign:   
Date: Appointment: 
 

















Medical Devices Training Passport 
 
 
FORM 2 - MEDICAL DEVICES INDIVIDUAL TRAINING LOG FORM 
 
Staff Title:                                                                    Name:   Sign:  
 
The Assessment Criteria is that the Staff Member is: 
 Able to demonstrate the safe operation of the medical device. 
 Able to use appropriate cleaning materials for medical devices decontamination. 
 Able to demonstrate the ability to troubleshoot problems. 
 Able to explain the correct procedure for reporting faulty medical devices. 
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(a) (b) (c) (d) (e) (f) 
      
      
      
      
      






















(g) (h) (i) (j) (k) (l) 
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Appendix 6 - Fault Reporting Label 
 
Fault Reporting Label 
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Appendix 7 - Plant & Equipment Disposal Form 
Xxxx & Xxxx Hospitals NHS Trust 
Plant & Equipment Disposal Form 
 
To: FINANCIAL ACCOUNTANT   Date:  
 
From:       Tel: 
  (Name in block capitals) 
 
I request authorisation to dispose of the following asset:    
 
Asset Description  Model  Serial No. 
 
…………………………… ……..     …………………………      
 
…………………………… ……..     …………………………      
 
…………………………… ……..     …………………………      
 
(Please continue on a separate sheet if necessary) 
 





Detailed below is the estimated Market Value of the equipment, which is 
serviceable and not obsolete taking account of professional advice. (Delete as 
appropriate) EBME/MES / PATHOLOGY / RADIOLOGY / PHARMACY / IM&T / 
FACILITIES have advised that:- 
a) The assets have no disposal value 
b) The expected disposal value is less than £10,000 
c) Expected disposal value is over £10,000 and Supplies will obtain written 
competitive quotations on your authorization to proceed. 
d) Expected disposal value is greater than £25,000 and Supplies will commence 
tendering process on your authorisation to proceed. 
 
N.B.  Any supporting documentation should be attached 
 
Signed:…………………………………………………..Date:………… 
   ADO/Divisional Manager 
Countersigned:…………………………………………..Date:………… 
 
Pathology or Radiology or SM&T or Pharmacy Manager or EBME/MES - for Medical and 
Surgical Equipment 
 
N.B. No action will be taken without Counter Signature from a Professional Advisor. 
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For Finance use only 
 
I authorise you to:       
 
(Delete as necessary) 
 
a) dispose of the asset(s) forthwith (no payment will be made to the Trust for these items) 
b) obtain at least one quotation and dispose of the item for best value (< £10,000 ) 
c) obtain a minimum of  3 competitive quotations from Supplies and dispose of the assets 
for best value (> £10,000 ) 
c)                  d) dispose of the assets by competitive tender to be arranged by Supplies (> £25,000) 
 
Signed: …………………………………………………..Date: …………………… 



























































For Supplies use only (f, g & h) 
 
We hereby confirm that the following actions have been taken as per your instructions. 
 
(Delete as appropriate) 
 
f) Obtain at least one quotation and dispose of the item for best value (< £10,000 ) 
g) Obtain a minimum of  3 competitive quotations from Supplies and dispose of the assets 
for best value (> £10,000 ) 
h) Dispose of the assets by competitive tender to be arranged by Supplies (> £25,000 ) 
 










Signed: ………………………………….                                Date: ………………………… 
 (Supplies) 
  Appendix 13 
Medical_Devices_Policy_Sept_13_ xxxx Trust  204 
Appendix 8 - Medical Device Self-Certification Form 
MEDICAL DEVICE SELF-CERTIFICATION FORM 
 
This competency statement has been developed to meet the requirements of the:  
 NHSLA Risk Management Standards 
 MHRA DB 2006 (05): Managing Medical Devices  
 Health and Social Care Act, Regulation 16 – Outcome 11 Safety, Availability and 
Suitability of equipment 
 
Device Type Manufacturer Model Department 
    
 






Am I authorised to use this equipment?  
 Prompt:  Is it within my remit to use this equipment?  
   
Do I have access to the manufacturer’s operation manual for this device?  
 Prompt:  Do you know where the medical device manuals are kept and have you 
read them?  
 Prompt:  Have you the correct manuals for the devices in use?  
   
Do I understand the purpose and function of this device?  
 Prompt:  Do you know what this device does and do you know what it is used for?  
   
Do I know what patient type this device can be used on?  
 Prompt:  Are you able to use this device on neonates, paediatrics and/or adults?  
   
Do I understand the  “switch on test procedure” of this device?  
 Prompt:  Do you know the purpose of the self test? 
   
Am I confident and competent to carry out any pre-use checks on this device when 
required?  
 Prompt:  Can you competently carry out pre-use checks on this device or do you 
need training 
 Prompt:  Ensure all medical devices contain an asset number and an in date 
serviceability sticker 
   
Do I know how to safely and correctly connect this machine to a patient?  
 Prompt:  Do you know how to connect equipment safely ?  
 Prompt:  Can the keypad be locked on this device?  
 Prompt:  Am I able to lock and unlock the device if required?  
 Prompt:  Can you setup the correct parameters of this device to suit your patients’ 
needs?  
   
Can I inform the patient what the device does and why it is being used?  
 Prompt:  Can you explain the purpose of the equipment and why it is being used?  
   
Can I fully understand the operation of the control of this device?  
 Prompt:  Do you know what every dial, switch, button and indicator is used for on 
this device?  
   
Do I fully understand the purpose of the alarms of this device?  
 Prompt:  Do you know what the alarms signify and where to look to see what they 
signify?  
   
Can I effectively respond to any alarms that may occur with this device?  
 Prompt:  Do you know what to do if the machine goes into alarm?  
 Prompt:  Are you able to change the alarm parameters if required?  
   
Can I recognise any operational malfunctions of this device?  
 Prompt:  Do you know what the machine should be doing and therefore be able to 
diagnose a malfunction?  
   
Do I know what action to take in the event of device failure?  
 Prompt:  Are you aware of the Datix Adverse Incident Reporting procedure?  
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Am I familiar with the methods of reporting a defective device?  
 Prompt:  Contact the EBME help-line, leave your name, contact number and a 
brief description of the fault. A job number must be obtained.  
 Prompt:  Or contact the Medical Equipment Library on ext 3994.  
   
Am I able to clean, decontaminate and prepare this device for future use?  
 Prompt:  Can you safely clean/prepare this device for future use?  
 Prompt:  Are you aware of the Trust’s decontamination policy and where it is 
located?  
   
If you answer NO to any of the above questions highlighted in bold letters, then you should not to 
use the medical device on a patient  
 Print Name Sign Name Date 
Staff Member    
DEC/Ward 
Manager 
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Appendix 9 - Equipment Library Quick Guide 
 
Equipment Library Guide 
 
1 The Equipment Libraries were opened on both sites from 1
st
 September 2008. 
Medical/ Nursing Equipment from wards will be 'pooled' together and stored in the 
EBME Equipment Libraries located in: 
 Xxxx Hospital: Link corridor of the Medical Day Unit Extension:  xxxx 
 Xxxx: Lower ground floor, near Xxxx MES Department Extension: xxxx 
 
2 The Equipment Library was established to ensure that Medical Equipment such as 
infusion pumps were cleaned, serviced and always available – to ensure this system 
remains effective all  Equipment is signed out correctly, is only used for single patients 
and is returned as soon as the Equipment is no longer required for the patient.  
3 The Benefits of Service are: 
 The Equipment Libraries will ensure that core items of Medical Equipment are 
used to their maximum potential 
 Equipment is speedily, easily and accurately locatable 24 hours a day 
 No shortfall of equipment when in for repair 
 Departments have access to equipment 
 Staff become competent in selecting appropriate equipment and using it safely 
 Advice is available regarding equipment issues 
 All items are decontaminated after use, reducing the risk of cross infection 
 Items are regularly serviced and well maintained 
 Equipment shortfalls are accurately identified and purchases can be advised on 
behalf of all areas taking advantage of the service. (Discounts for multiple 
purchases) 
 Expensive and/or seldom used equipment can be distributed around wards 
(through the Library service) to ensure maximum usage, whilst giving better 
cost efficiency.   
 All items will be labelled with asset numbers and serviceability stickers and 
entered on a computer database. 
 
4 All wards will have access to the service, and some wards and departments will keep 
equipment on permanent loan. I.e. Theatres, Intensive care, Special Care Baby Units, 
etc. 
 
5 The hours of service are: 
 Monday - Friday 8.00am until 5.00pm 
 An out of hours service also available. 
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To request equipment: 
 
Complete request form. 
 
Contact Librarian on during the hours of 8am to 5pm: 
 
Xxxx  Ext:  Bleep:  
Xxxx Ext: Bleep:  
 
Out of Hours Site Manager Bleep:  
 
Xxxx  Bleep:  
Xxxx Bleep:  
 
To return equipment: 
 Clean/decontaminate equipment in accordance with manufacturer’s guidelines 
 Complete an ‘Equipment Return Form’ 
 Inform librarian (leave message on answer machine if unavailable)  
 
For operational procedures and forms please go to staff resources on the intranet and click on 
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Appendix 10 - Pre-Purchase Questionnaire  
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Appendix 11 - Launch Plan for Policy Development Framework 
 
1. As a newly revised Trust policy, this requires a launch plan. 
 
2. Following endorsement by the Trust Board, the following steps will be taken to ensure that 
the framework is publicised: 
 
 Post on Intranet with alert on home page. 
 Item in XXXX Now. 
 Item in Team Brief. 
 Item in XXXX Newsmail 
 Policies will not be approved by relevant committee unless they comply with the format 
and other requirements. 
 
3. Authors of policies will be informed of policy development framework and required to comply 
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Appendix 12 - Equality Impact Assessment First Stage Screening Template 
 
EQUALITY SCREENING TOOL – MEDICAL DEVICES POLICY CG04 
 Yes/No Comments (State any evidence available that 
helped you to answer the question) 
1. Does the policy/guideline 
affect one group less or more 
favourably than another on 
the basis of:  
No This Policy is a Clinical Governance document 
that applies to all staff within the Trust, regardless 
of race, nationality, ethnic origins, disability, 
Gender, Religious beliefs, sexual orientation, age 
or carer. 
Race, Nationality, Culture, 
Ethnic origins (including gypsies 
and travellers)  
No  
Disability No  
Gender No  
Religion or belief No  
Sexual orientation 
including lesbian,                               
gay and bisexual people 
No  
Age No  
Carers No  
2. Is there any evidence that 
some groups are affected 
differently? 
No  
3. Have you identified 
potential discrimination, or 
are any exceptions valid, legal 
and/or justifiable? 
No  
4. Is the impact of the 
policy/guidance likely to be 
negative? 
No  
5. If so can the impact be 
avoided? 
N/A  
6. What alternatives are there 
to achieving the 







7. Can we reduce the impact 
by taking different action? 
N/A  
State if this policy will be 
proceeding to a full impact 
assessment: Please tick as 
appropriate – 
No  
 
